<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Publishing DTD v2.3 20070202//EN" "journalpublishing.dtd">
<article article-type="review-article" dtd-version="2.3" xml:lang="EN" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">Front. Pharmacol.</journal-id>
<journal-title>Frontiers in Pharmacology</journal-title>
<abbrev-journal-title abbrev-type="pubmed">Front. Pharmacol.</abbrev-journal-title>
<issn pub-type="epub">1663-9812</issn>
<publisher>
<publisher-name>Frontiers Media S.A.</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="publisher-id">1117337</article-id>
<article-id pub-id-type="doi">10.3389/fphar.2023.1117337</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Pharmacology</subject>
<subj-group>
<subject>Review</subject>
</subj-group>
</subj-group>
</article-categories>
<title-group>
<article-title>Mitochondrial dysfunction-targeting therapeutics of natural products in Parkinson&#x2019;s disease</article-title>
<alt-title alt-title-type="left-running-head">He et al.</alt-title>
<alt-title alt-title-type="right-running-head">
<ext-link ext-link-type="uri" xlink:href="https://doi.org/10.3389/fphar.2023.1117337">10.3389/fphar.2023.1117337</ext-link>
</alt-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>He</surname>
<given-names>Ting</given-names>
</name>
<xref ref-type="fn" rid="fn1">
<sup>&#x2020;</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Lin</surname>
<given-names>Xiaoyan</given-names>
</name>
<xref ref-type="fn" rid="fn1">
<sup>&#x2020;</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Su</surname>
<given-names>Anping</given-names>
</name>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Zhang</surname>
<given-names>Yujie</given-names>
</name>
<uri xlink:href="https://loop.frontiersin.org/people/1787086/overview"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Xing</surname>
<given-names>Zhichao</given-names>
</name>
<uri xlink:href="https://loop.frontiersin.org/people/1895763/overview"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Mi</surname>
<given-names>Li</given-names>
</name>
<uri xlink:href="https://loop.frontiersin.org/people/1787444/overview"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Wei</surname>
<given-names>Tao</given-names>
</name>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Li</surname>
<given-names>Zhihui</given-names>
</name>
</contrib>
<contrib contrib-type="author" corresp="yes">
<name>
<surname>Wu</surname>
<given-names>Wenshuang</given-names>
</name>
<xref ref-type="corresp" rid="c001">&#x2a;</xref>
<uri xlink:href="https://loop.frontiersin.org/people/1699748/overview"/>
</contrib>
</contrib-group>
<aff>
<institution>Division of Thyroid Surgery</institution>, <institution>Department of General Surgery and Laboratory of Thyroid and Parathyroid Disease</institution>, <institution>Frontiers Science Center for Disease-related Molecular Network</institution>, <institution>West China Hospital</institution>, <institution>Sichuan University</institution>, <addr-line>Chengdu</addr-line>, <country>China</country>
</aff>
<author-notes>
<fn fn-type="edited-by">
<p>
<bold>Edited by:</bold> <ext-link ext-link-type="uri" xlink:href="https://loop.frontiersin.org/people/1891761/overview">Xin Wang</ext-link>, Hokkaido University, Japan</p>
</fn>
<fn fn-type="edited-by">
<p>
<bold>Reviewed by:</bold> <ext-link ext-link-type="uri" xlink:href="https://loop.frontiersin.org/people/318600/overview">Juan Segura-Aguilar</ext-link>, University of Chile, Chile</p>
<p>
<ext-link ext-link-type="uri" xlink:href="https://loop.frontiersin.org/people/2207040/overview">Xiaojuan Hu</ext-link>, Nanchang University, China</p>
</fn>
<corresp id="c001">&#x2a;Correspondence: Wenshuang Wu, <email>wenshuang_wu@163.com</email>
</corresp>
<fn fn-type="equal" id="fn1">
<label>
<sup>
<bold>&#x2020;</bold>
</sup>
</label>
<p>These authors have contributed equally to this work and share first authorship</p>
</fn>
</author-notes>
<pub-date pub-type="epub">
<day>10</day>
<month>05</month>
<year>2023</year>
</pub-date>
<pub-date pub-type="collection">
<year>2023</year>
</pub-date>
<volume>14</volume>
<elocation-id>1117337</elocation-id>
<history>
<date date-type="received">
<day>06</day>
<month>12</month>
<year>2022</year>
</date>
<date date-type="accepted">
<day>02</day>
<month>05</month>
<year>2023</year>
</date>
</history>
<permissions>
<copyright-statement>Copyright &#xa9; 2023 He, Lin, Su, Zhang, Xing, Mi, Wei, Li and Wu.</copyright-statement>
<copyright-year>2023</copyright-year>
<copyright-holder>He, Lin, Su, Zhang, Xing, Mi, Wei, Li and Wu</copyright-holder>
<license xlink:href="http://creativecommons.org/licenses/by/4.0/">
<p>This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.</p>
</license>
</permissions>
<abstract>
<p>Parkinson&#x2019;s disease (PD), the second most common neurodegenerative disease worldwide, often occurs in middle-aged and elderly individuals. The pathogenesis of PD is complex and includes mitochondrial dysfunction, and oxidative stress. Recently, natural products with multiple structures and their bioactive components have become one of the most important resources for small molecule PD drug research targeting mitochondrial dysfunction. Multiple lines of studies have proven that natural products display ameliorative benefits in PD treatment by regulating mitochondrial dysfunction. Therefore, a comprehensive search of recent published articles between 2012 and 2022 in PubMed, Web of Science, Elesvier, Wliey and Springer was carried out, focusing on original publications related to natural products against PD by restoring mitochondrial dysfunction. This paper presented the mechanisms of various kinds of natural products on PD-related mitochondrial dysfunction regulation and provided evidence that natural products are promising to be developed as drugs for PD therapeutics.</p>
</abstract>
<kwd-group>
<kwd>Parkinson&#x2019;s disease</kwd>
<kwd>natural products</kwd>
<kwd>mitochondrial dysfunction</kwd>
<kwd>pharmacological mechanisms</kwd>
<kwd>flavanoids</kwd>
<kwd>phenols</kwd>
</kwd-group>
<custom-meta-wrap>
<custom-meta>
<meta-name>section-at-acceptance</meta-name>
<meta-value>Ethnopharmacology</meta-value>
</custom-meta>
</custom-meta-wrap>
</article-meta>
</front>
<body>
<sec id="s1">
<title>1 Introduction</title>
<p>Parkinson&#x2019;s disease (PD) is a progressive debilitating neurodegenerative disease worldwide that affects approximately 0.1%&#x2013;0.2% of the general population but approximately 1% of the population over the age of 60&#xa0;years in modern countries (<xref ref-type="bibr" rid="B125">Wright Willis et al., 2010</xref>; <xref ref-type="bibr" rid="B136">Zou et al., 2014</xref>). As an age-related neurodegenerative disease, PD onset has shown a serious increase in prevalence rates in the past 60&#xa0;years (<xref ref-type="bibr" rid="B76">Muhammad et al., 2022</xref>). Due to global population aging, the prevalence of PD is expected to increase, and therapies for this disease may face large challenges in the future. The main clinical manifestations of PD are bradykinesia, tremor, postural instability, cognitive impairment and other nonmotor impairments (<xref ref-type="bibr" rid="B17">Blauwendraat et al., 2020</xref>; <xref ref-type="bibr" rid="B74">Mohammadipour et al., 2020</xref>), and the main pathological features are progressive loss of dopaminergic neurons in the substantia nigra striatum, deposition of neuronal &#x3b1;-synaptic nucleoproteins and formation of Lewy bodies with complex pathogenesis, including mitochondrial dysfunction, oxidative stress, neuroinflammation and so on (<xref ref-type="bibr" rid="B42">Kalia and Lang, 2015</xref>). Various treatment strategies have been put into effect, for example, clinical treatment with pharmacotherapy such as levodopa, dopamine agonists and anticholinergics, as well as nondrug interventions such as surgery and exercise (<xref ref-type="bibr" rid="B114">Voon et al., 2017</xref>). However, long-term use of these treatments can lead to serious side effects but fail to completely halt disease progression. Therefore, it is of great significance to develop novel drugs that are safe and effective for PD prevention and treatment.</p>
<p>Mitochondria are vital organelles that provide energy to cells and play a particularly important role as the cellular &#x201c;powerhouse&#x201d; of dopaminergic neurons (<xref ref-type="bibr" rid="B97">Schapira and Patel, 2014</xref>; <xref ref-type="bibr" rid="B35">Gao et al., 2022</xref>). Increasing evidence supports the critical role of mitochondrial dysfunction, such as adenosine triphosphate (ATP) depletion, oxidative stress elevation, aberrant mitochondria-dependent apoptosis and other effects, in the development of PD (<xref ref-type="bibr" rid="B23">Cong et al., 2016</xref>; <xref ref-type="bibr" rid="B99">Shahba et al., 2021</xref>), suggesting that targeting mitochondrial dysfunction is a promising therapeutic target for PD treatments. Natural products originated from plants, animals, or other natural sources have been applied as substances with therapeutic potential to treat different diseases. As reported in previous studies, many kinds of natural products, such as flavonoids and polyphenols, have manifested the strong effects of PD treatment by targeting mitochondrial dysfunction (<xref ref-type="bibr" rid="B50">Kim et al., 2017</xref>; <xref ref-type="bibr" rid="B111">van der Merwe et al., 2017</xref>). Therefore, this paper provides a brief review of the roles that various natural products play by targeting mitochondrial dysfunction in PD, highlighting the mechanisms of effects to shed light on developing novel therapeutics for PD.</p>
</sec>
<sec id="s2">
<title>2 Mitochondrial dysfunction and PD</title>
<p>Mitochondria are the energy suppliers of the cells. Mitochondrial respiration can support a vast amount of energy in the ATP form by the oxidative phosphorylation cycle and regulate energy-dependent cell functions, including intermediary metabolism, protein folding, and cell motility (<xref ref-type="bibr" rid="B115">Wallace et al., 1999</xref>; <xref ref-type="bibr" rid="B41">Jin et al., 2021</xref>). In addition, mitochondria are dynamic organelles that undergo constant fusion and fission (<xref ref-type="bibr" rid="B4">Ashrafi and Schwarz, 2013</xref>). Mitophagy is the selective clearance of damaged mitochondria via autophagy. Mitochondria strive to maintain a balance between biogenesis and mitophagy to maintain mitochondrial quality (<xref ref-type="bibr" rid="B112">Ventura-Clapier et al., 2008</xref>; <xref ref-type="bibr" rid="B113">Voigt et al., 2016</xref>; <xref ref-type="bibr" rid="B120">Wang et al., 2021</xref>). In addition, reactive oxygen species (ROS), which are intimately related to oxidative stress, can be generated through the electron carriers of the respiratory chain (<xref ref-type="bibr" rid="B122">Wang et al., 2015</xref>). ROS cause mitochondrial membrane lipid peroxidation and protein nitrification; damage mitochondrial DNA, mitochondrial membrane structure and electron transport chain enzyme complexes; weaken or prevent oxidative phosphorylation; reduce ATP production; release caspase-3; and trigger further mitochondrial damage, which leads to mitochondrial dysfunction (<xref ref-type="bibr" rid="B3">Ali et al., 2015</xref>; <xref ref-type="bibr" rid="B7">Badshah et al., 2016</xref>).</p>
<p>A number of studies have shown that dysfunction of related mitochondrial respiration is of great importance in PD progression (<xref ref-type="fig" rid="F1">Figure 1</xref>). Neurons have a higher energy demand to maintain their function. ATP deficiency induced by mitochondrial dysfunction leads to a decrease in vesicular dopamine uptake, resulting in increased dopaminergic degradation in PD neurons (<xref ref-type="bibr" rid="B126">Wu et al., 2021</xref>). ROS, which are a prime culprit for causing mitochondrial dysfunction, play a pivotal role in the pathogenesis of PD (<xref ref-type="bibr" rid="B14">Bhattacharjee and Borah, 2016</xref>; <xref ref-type="bibr" rid="B69">Lu et al., 2016</xref>). In previous studies, it was also reported that impaired mitochondrial biogenesis led to depletion of mitochondria and that the imbalance of biogenesis and mitophagy is a mechanism mediating PD (<xref ref-type="bibr" rid="B135">Zhu et al., 2012</xref>; <xref ref-type="bibr" rid="B66">Liu et al., 2021a</xref>). Mitochondrial fission is a process of mitochondrial dynamics. When equilibrium is disrupted, excessive mitochondrial fragmentation leads to mitochondrial dysfunction and neuronal death in PD (<xref ref-type="bibr" rid="B119">Wang et al., 2022</xref>). In addition, mitochondrial apoptosis has also been reported in many PD studies (<xref ref-type="bibr" rid="B44">Khan et al., 2018</xref>; <xref ref-type="bibr" rid="B11">Balakrishnan et al., 2021</xref>). Thus, it is obvious that neurons are highly sensitive to mitochondrial dysfunction in PD and that mitochondria may be a target with great potential.</p>
<fig id="F1" position="float">
<label>FIGURE 1</label>
<caption>
<p>Primary mitochondrial dysfunction associated pathways and disease progression in Parkinson&#x2019;s disease. Mechanisms of mitochondrial dysfunction in Parkinson&#x2019;s disease include dysregulation of mitochondrial respiration, apoptosis, dynamics, biogenesis and mitophagy related to a variety of molecules. Mitochondrial dysfunction resulted in progressive loss of dopaminergic neurons in the substantia nigra striatum and ultimately cause severe motor and nonmotor disorders in Parkinson&#x2019;s disease.</p>
</caption>
<graphic xlink:href="fphar-14-1117337-g001.tif"/>
</fig>
</sec>
<sec id="s3">
<title>3 Natural products targeting mitochondrial dysfunction in PD</title>
<p>Natural products have been shown to have therapeutic potential for various diseases. Many kinds of natural products, such as flavonoids, polyphenols, terpenoids, and glycosides, have strong effects on PD by targeting mitochondrial dysfunction (<xref ref-type="fig" rid="F2">Figure 2</xref>). Then, we reviewed the natural compounds and their molecular mechanisms by targeting mitochondrial dysfunction from different mechanisms of action (<xref ref-type="table" rid="T1">Table 1</xref>).</p>
<fig id="F2" position="float">
<label>FIGURE 2</label>
<caption>
<p>The structure of natural products targeting therapeutics in PD.</p>
</caption>
<graphic xlink:href="fphar-14-1117337-g002.tif"/>
</fig>
<table-wrap id="T1" position="float">
<label>TABLE 1</label>
<caption>
<p>Natural compounds targeting to mitochondrial dysfunction and PD models.</p>
</caption>
<table>
<thead valign="top">
<tr>
<th align="center">Category</th>
<th align="center">Compounds or extracts</th>
<th align="center">Biological source</th>
<th colspan="3" align="center">
<italic>In vitro</italic> experiments</th>
<th colspan="3" align="center">
<italic>In vivo</italic> experiments</th>
<th colspan="4" align="center">Mechanisms</th>
<th align="center">Refs</th>
</tr>
</thead>
<tbody valign="top">
<tr>
<td align="left"/>
<td align="left"/>
<td align="left"/>
<td align="left">Models</td>
<td align="left">Dosage</td>
<td align="left">Time</td>
<td align="left">Models</td>
<td align="left">Dosage</td>
<td align="left">Time</td>
<td align="left">Targeting mitochondrial respiration and bioenergetics</td>
<td align="left">Targeting mitochondrial biogenesis and mitophagy</td>
<td align="left">Targeting mitochondrial dynamics</td>
<td align="left">Targeting mitochondrial apoptosis</td>
<td align="left"/>
</tr>
<tr>
<td align="left">Flavanoids</td>
<td align="left">Baicalein</td>
<td align="left">
<italic>Scutellaria baicalensis</italic>
</td>
<td align="left">Rotenone-induced SH-SY5Y cells</td>
<td align="left">10&#xa0;&#xb5;M</td>
<td align="left">24&#xa0;h</td>
<td align="left">Rotenone-treated mice</td>
<td align="left">100&#xa0;mg/kg</td>
<td align="left">6&#xa0;weeks</td>
<td align="left">MMP&#x2191;</td>
<td align="left">LC3B-II&#x2191;, autophagic flux&#x2191;</td>
<td align="left">-</td>
<td align="left">Caspase-3 activity&#x2193;</td>
<td align="left">
<xref ref-type="bibr" rid="B53">Kuang et al. (2017)</xref>
</td>
</tr>
<tr>
<td align="left"/>
<td align="left">Calycosin</td>
<td align="left">
<italic>Astragalus membranaceus</italic>
</td>
<td align="left">-</td>
<td align="left">-</td>
<td align="left">-</td>
<td align="left">Paraquat-exposed drosophilas</td>
<td align="left">0&#x2013;400&#xa0;&#x3bc;M</td>
<td align="left">5&#xa0;days</td>
<td align="left">ATP, MMP, complex I and III activity&#x2191;</td>
<td align="left">p62, phosphorylation levels of S6K and 4EBP1&#x2193;</td>
<td align="left">-</td>
<td align="left">JNK phosphorylation and caspase-3 activation&#x2193;</td>
<td align="left">
<xref ref-type="bibr" rid="B20">Chaouhan et al. (2022)</xref>
</td>
</tr>
<tr>
<td align="left"/>
<td align="left">Hyperoside</td>
<td align="left">
<italic>Acer tegmentosum</italic>
</td>
<td align="left">6-OHDA-induced SH-SY5Y cells</td>
<td align="left">0.1&#x2013;2&#xa0;&#x3bc;M</td>
<td align="left">24&#xa0;h</td>
<td align="left">-</td>
<td align="left">-</td>
<td align="left">-</td>
<td align="left">MMP&#x2191;; ROS&#x2193;</td>
<td align="left">-</td>
<td align="left">-</td>
<td align="left">-</td>
<td align="left">
<xref ref-type="bibr" rid="B35">Gao et al. (2022)</xref>
</td>
</tr>
<tr>
<td rowspan="2" align="left"/>
<td rowspan="2" align="left">Icaritin</td>
<td rowspan="2" align="left">
<italic>Epimedium sagittatum maxim</italic>
</td>
<td rowspan="2" align="left">-</td>
<td rowspan="2" align="left">-</td>
<td rowspan="2" align="left">-</td>
<td rowspan="2" align="left">MPTP-injected mice</td>
<td rowspan="2" align="left">4.7&#x2013;18.9&#xa0;mg/kg</td>
<td rowspan="2" align="left">5&#xa0;days</td>
<td align="left">ATP, ADP, inosine, and citric acid&#x2191;</td>
<td rowspan="2" align="left">-</td>
<td rowspan="2" align="left">-</td>
<td rowspan="2" align="left">-</td>
<td rowspan="2" align="left">
<xref ref-type="bibr" rid="B126">Wu et al. (2021)</xref>
</td>
</tr>
<tr>
<td align="left">SDHA, VDAC and ATP5B&#x2191;</td>
</tr>
<tr>
<td rowspan="2" align="left"/>
<td rowspan="2" align="left">Myricitrin</td>
<td rowspan="2" align="left">
<italic>Myrica cerifera</italic>
</td>
<td rowspan="2" align="left">MGO-induced SH-SY5Y cells</td>
<td rowspan="2" align="left">0.1&#x2013;10&#xa0;&#x3bc;M</td>
<td rowspan="2" align="left">24&#xa0;h</td>
<td rowspan="2" align="left">-</td>
<td rowspan="2" align="left">-</td>
<td rowspan="2" align="left">-</td>
<td align="left">ATP, MMP&#x2191;; ROS&#x2193;</td>
<td rowspan="2" align="left">-</td>
<td rowspan="2" align="left">-</td>
<td rowspan="2" align="left">-</td>
<td rowspan="2" align="left">
<xref ref-type="bibr" rid="B123">Wang et al. (2014)</xref>
</td>
</tr>
<tr>
<td align="left">AGEs/RAGE/NF-&#x3ba;B pathway&#x2193;</td>
</tr>
<tr>
<td rowspan="2" align="left"/>
<td align="left">Naringenin</td>
<td align="left">
<italic>Citrus reticulata</italic>
</td>
<td align="left">MG-induced SH-SY5Y cells; Paraquat-induced SH-SY5Y cells</td>
<td align="left">10&#x2013;100&#xa0;&#x3bc;M</td>
<td align="left">2/24&#xa0;h</td>
<td align="left">Paraquat -exposed rats</td>
<td align="left">40&#xa0;mg/kg</td>
<td align="left">21&#xa0;days</td>
<td align="left">MMP, ATP, complex I and V activity&#x2191;</td>
<td align="left">-</td>
<td align="left">-</td>
<td align="left">Bcl-2&#x2191;; Bax, Cyt-c release, caspase-3/9 activation&#x2193;</td>
<td align="left">
<xref ref-type="bibr" rid="B24">de Oliveira et al. (2019),</xref> <xref ref-type="bibr" rid="B1">Ahmad et al. (2021)</xref>
</td>
</tr>
<tr>
<td align="left">Nobiletin</td>
<td align="left">
<italic>Citrus depressa</italic> or <italic>Citrus sinensis</italic>
</td>
<td align="left">Lipopolysaccharide-exposed BV-2 cells</td>
<td align="left">0&#x2013;100&#xa0;&#x3bc;M</td>
<td align="left">4&#xa0;h</td>
<td align="left">Lipopolysaccharide-exposed mice</td>
<td align="left">100&#xa0;mg/kg</td>
<td align="left">6&#xa0;weeks</td>
<td align="left">MMP, complex I-IV&#x2191;; ROS&#x2193;</td>
<td align="left">-</td>
<td align="left">-</td>
<td align="left">-</td>
<td align="left">
<xref ref-type="bibr" rid="B84">Qi et al. (2019)</xref>
</td>
</tr>
<tr>
<td align="left"/>
<td align="left">Quercetin</td>
<td align="left">
<italic>Bupleurum chinense</italic> or <italic>Crataegus pinnatifida</italic>
</td>
<td align="left">-</td>
<td align="left">-</td>
<td align="left">-</td>
<td align="left">Aluminumtreated rats</td>
<td align="left">10&#xa0;mg/kg</td>
<td align="left">12&#xa0;weeks</td>
<td align="left">ROS&#x2193;; superoxide dismutase activity&#x2191;</td>
<td align="left">-</td>
<td align="left">Improving the mitochondrial integrity</td>
<td align="left">Bax/Bcl-2 ratio, Cyt-c release, caspase-3&#x2193;</td>
<td align="left">
<xref ref-type="bibr" rid="B100">Sharma et al. (2016)</xref>
</td>
</tr>
<tr>
<td align="left"/>
<td align="left">Silibinin</td>
<td align="left">
<italic>Silybum marianum</italic> (L.) <italic>Gaertn</italic>
</td>
<td align="left">-</td>
<td align="left">-</td>
<td align="left">-</td>
<td align="left">MPTP (1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine)- induced mice</td>
<td align="left">70, 140 and 280&#xa0;mg/kg</td>
<td align="left">24&#xa0;days</td>
<td align="left">MMP&#x2191;</td>
<td align="left">PINK1, Parkin&#x2191;</td>
<td align="left">Mfn1&#x2191;; Drp1&#x2193;</td>
<td align="left">-</td>
<td align="left">
<xref ref-type="bibr" rid="B66">Liu et al. (2021a),</xref> <xref ref-type="bibr" rid="B67">Liu et al. (2021b)</xref>
</td>
</tr>
<tr>
<td align="left">Phenols and polyphenols</td>
<td align="left">Curcumin</td>
<td align="left">
<italic>Curcuma longa</italic> (turmeric)</td>
<td align="left">Paraquat -induced SH-SY5Y cells and PINK1 siRNA transfected SH-SY5Y cells</td>
<td align="left">2&#xa0;&#x3bc;M</td>
<td align="left">1&#xa0;h</td>
<td align="left">Rotenone-treated mice</td>
<td align="left">50, 100 and 200&#xa0;mg/kg</td>
<td align="left">21&#xa0;days</td>
<td align="left">MMP, complex II and IV activity, maximal respiration&#x2191;</td>
<td align="left">-</td>
<td align="left">-</td>
<td align="left">-</td>
<td align="left">
<xref ref-type="bibr" rid="B45">Khatri and Juvekar (2016),</xref> <xref ref-type="bibr" rid="B111">van der Merwe et al. (2017)</xref>
</td>
</tr>
<tr>
<td align="left"/>
<td align="left">Demethoxycurcumin</td>
<td align="left">A derivative of curcumin</td>
<td align="left">Rotenone-induced SH-SY5Y cells</td>
<td align="left">0&#x2013;1&#xa0;&#x3bc;M</td>
<td align="left">28&#xa0;h</td>
<td align="left"/>
<td align="left"/>
<td align="left">-</td>
<td align="left">MMP&#x2191;; ROS&#x2193;</td>
<td align="left">-</td>
<td align="left">-</td>
<td align="left">Bcl-2, Bcl-xL&#x2191;; Bax, Bad, caspase-3/6/8/9, Cyt-c release&#x2193;</td>
<td align="left">
<xref ref-type="bibr" rid="B88">Ramkumar et al. (2017)</xref>
</td>
</tr>
<tr>
<td align="left"/>
<td align="left">Green tea polyphenols</td>
<td align="left">-</td>
<td align="left">Glutamate-treated primary cortical neurons</td>
<td align="left">0.5&#x2013;10&#xa0;&#x3bc;M</td>
<td align="left">24&#xa0;h</td>
<td align="left">-</td>
<td align="left">-</td>
<td align="left">-</td>
<td align="left">-</td>
<td align="left">-</td>
<td align="left"/>
<td align="left">Bcl-2&#x2191;; Bax, caspase-3&#x2193;</td>
<td align="left">
<xref ref-type="bibr" rid="B23">Cong et al. (2016)</xref>
</td>
</tr>
<tr>
<td align="left"/>
<td align="left">Mangiferin</td>
<td align="left">
<italic>Mangifera indica</italic>
</td>
<td align="left">Rotenone-induced SK-N-SH cells</td>
<td align="left">2.5, 5, 10, 20 and 40&#xa0;&#x3bc;g/mL</td>
<td align="left">4&#xa0;h</td>
<td align="left">MPTP-induced mice</td>
<td align="left">10, 20 and 40&#xa0;mg/kg</td>
<td align="left">12&#xa0;days</td>
<td align="left">ATP, MMP&#x2191;</td>
<td align="left">-</td>
<td align="left">Improving the mitochondrial integrity</td>
<td align="left">Cyt-c release, caspase-3/9&#x2193;</td>
<td align="left">
<xref ref-type="bibr" rid="B43">Kavitha et al. (2014),</xref> <xref ref-type="bibr" rid="B119">Wang et al. (2022)</xref>
</td>
</tr>
<tr>
<td rowspan="2" align="left"/>
<td rowspan="2" align="left">Oleuropein</td>
<td rowspan="2" align="left">
<italic>Fraxinus rhynchophylla</italic>
</td>
<td rowspan="2" align="left">Glutamate-treated HT-22 cells</td>
<td rowspan="2" align="left">0&#x2013;20&#xa0;&#x3bc;M</td>
<td rowspan="2" align="left">1&#xa0;h</td>
<td rowspan="2" align="left">-</td>
<td rowspan="2" align="left">-</td>
<td rowspan="2" align="left">-</td>
<td rowspan="2" align="left">ATP&#x2191;; ROS&#x2193;</td>
<td rowspan="2" align="left">-</td>
<td align="left">Drp1&#x2193;</td>
<td rowspan="2" align="left">Bcl-2&#x2191;; Bax&#x2193;</td>
<td rowspan="2" align="left">
<xref ref-type="bibr" rid="B49">Kim et al. (2018)</xref>
</td>
</tr>
<tr>
<td align="left">fragmented mitochondria&#x2193;</td>
</tr>
<tr>
<td align="left"/>
<td align="left">Paeonolum</td>
<td align="left">
<italic>Paeonia suffruticos</italic>
</td>
<td align="left">MPP<sup>&#x2b;</sup>-treated PC12 cells</td>
<td align="left">10&#x2013;150&#xa0;&#x3bc;M</td>
<td align="left">24&#xa0;h</td>
<td align="left">MPP<sup>&#x2b;</sup>-exposed zebrafish</td>
<td align="left">100&#xa0;&#x3bc;M</td>
<td align="left">-</td>
<td align="left">MMP&#x2191;; ROS&#x2193;</td>
<td align="left">-</td>
<td align="left">-</td>
<td align="left">-</td>
<td align="left">
<xref ref-type="bibr" rid="B70">Lu et al. (2015)</xref>
</td>
</tr>
<tr>
<td align="left"/>
<td align="left">Polydatin</td>
<td align="left">A non-glycosylated derivative of resveratrol</td>
<td align="left">Rotenone-induced SH-SY5Y cells; Parkin shRNA transfected SH-SY5Y cells</td>
<td align="left">0&#x2013;500&#xa0;&#x3bc;M</td>
<td align="left">6&#xa0;h</td>
<td align="left">-</td>
<td align="left">-</td>
<td align="left">-</td>
<td align="left">-</td>
<td align="left">LC3-II&#x2191;, autophagic flux&#x2191;</td>
<td align="left">Mfn2&#x2191;; PGC-1&#x3b2;&#x2193;</td>
<td align="left">-</td>
<td align="left">
<xref ref-type="bibr" rid="B8">Bai et al. (2020)</xref>
</td>
</tr>
<tr>
<td align="left"/>
<td align="left">Resveratrol</td>
<td align="left">
<italic>Veratrum grandiflorum</italic> or <italic>Polygonum cuspidatum</italic>
</td>
<td align="left">Rotenone-induced SH-SY5Y cells, transfected SH-SY5Y cells; rotenone-induced PC12 cells; primary fibroblasts from two patients</td>
<td align="left">0&#x2013;50&#xa0;&#x3bc;M</td>
<td align="left">24/48&#xa0;h</td>
<td align="left">-</td>
<td align="left">-</td>
<td align="left">-</td>
<td align="left">ATP, MMP, complex I activity, citrate synthase activity, basal oxygen consumption&#x2191;; ROS&#x2193;</td>
<td align="left">LC3-II, PGC-1&#x3b1;, TFAM, COX 1, mtDNA/nDNA&#x2191;</td>
<td align="left">Short and fragmented mitochondria&#x2193;</td>
<td align="left">-</td>
<td align="left">
<xref ref-type="bibr" rid="B32">Ferretta et al. (2014),</xref> <xref ref-type="bibr" rid="B62">Lin et al. (2014),</xref> <xref ref-type="bibr" rid="B61">Lin et al. (2018),</xref> <xref ref-type="bibr" rid="B116">Wang et al. (2018)</xref>
</td>
</tr>
<tr>
<td align="left"/>
<td align="left">Sativex<sup>&#xae;</sup> (a mixture of tetrahydrocannabinol and cannabidiol)</td>
<td align="left">-</td>
<td align="left">-</td>
<td align="left">-</td>
<td align="left">-</td>
<td align="left">Transgenic mice</td>
<td align="left">4.63&#xa0;mg/kg of Sativex<sup>&#xae;</sup>
</td>
<td align="left">1&#xa0;month</td>
<td align="left">complex II and IV activity&#x2191;</td>
<td align="left">-</td>
<td align="left">-</td>
<td align="left">-</td>
<td align="left">
<xref ref-type="bibr" rid="B18">Casarejos et al. (2013)</xref>
</td>
</tr>
<tr>
<td align="left"/>
<td align="left">&#x3b1;-Arbutin</td>
<td align="left">
<italic>Ericaceae</italic> species</td>
<td align="left">Rotenone-induced SH-SY5Y cells</td>
<td align="left">1&#x2013;100&#xa0;&#x3bc;M</td>
<td align="left">6&#xa0;h</td>
<td align="left">Parkin-null <italic>drosophila</italic>
</td>
<td align="left">1&#xa0;mM</td>
<td align="left">20&#xa0;days</td>
<td align="left">MMP&#x2191;, ROS&#x2193;</td>
<td align="left">-</td>
<td align="left">-</td>
<td align="left">-</td>
<td align="left">
<xref ref-type="bibr" rid="B27">Ding et al. (2020)</xref>
</td>
</tr>
<tr>
<td align="left">Terpenoids</td>
<td align="left">Celastrol</td>
<td align="left">
<italic>Tripterygium wilfordii</italic>
</td>
<td align="left">Rotenone-induced SH-SY5Y cells</td>
<td align="left">1&#x2013;10&#xa0;nM</td>
<td align="left">24&#xa0;h</td>
<td align="left">-</td>
<td align="left">-</td>
<td align="left">-</td>
<td align="left">MMP&#x2191;; ROS&#x2193;</td>
<td align="left">-</td>
<td align="left">-</td>
<td align="left">-</td>
<td align="left">
<xref ref-type="bibr" rid="B22">Choi et al. (2014)</xref>
</td>
</tr>
<tr>
<td rowspan="2" align="left"/>
<td rowspan="2" align="left">Ginsenoside Re</td>
<td rowspan="2" align="left">
<italic>Panax ginseng</italic>
</td>
<td rowspan="2" align="left">PINK1 null dopaminergic cell lines</td>
<td rowspan="2" align="left">0&#x2013;5&#xa0;&#x3bc;M</td>
<td rowspan="2" align="left">-</td>
<td rowspan="2" align="left">-</td>
<td rowspan="2" align="left">-</td>
<td rowspan="2" align="left">-</td>
<td align="left">Complex IV activity, NO production&#x2191;</td>
<td rowspan="2" align="left">-</td>
<td rowspan="2" align="left">-</td>
<td rowspan="2" align="left">-</td>
<td rowspan="2" align="left">
<xref ref-type="bibr" rid="B48">Kim et al. (2012)</xref>
</td>
</tr>
<tr>
<td align="left">LRPPRC, Hsp90, and Hsp60&#x2191;</td>
</tr>
<tr>
<td rowspan="2" align="left"/>
<td rowspan="2" align="left">Mogroside V</td>
<td rowspan="2" align="left">
<italic>Siraitia grosvenorii</italic>
</td>
<td rowspan="2" align="left">Rotenone-induced SH-SY5Y cells</td>
<td rowspan="2" align="left">25&#x2013;100&#xa0;&#x3bc;M</td>
<td rowspan="2" align="left">24&#xa0;h</td>
<td rowspan="2" align="left">Rotenone-treated mice</td>
<td rowspan="2" align="left">2.5, 5 and 10&#xa0;mg/kg</td>
<td rowspan="2" align="left">6&#xa0;days</td>
<td align="left">ATP, MMP, oxygen consumption rate&#x2191;; ROS&#x2193;</td>
<td rowspan="2" align="left">-</td>
<td rowspan="2" align="left">-</td>
<td rowspan="2" align="left">Cyt-c release, caspase 3 activity&#x2193;</td>
<td rowspan="2" align="left">
<xref ref-type="bibr" rid="B71">Luo et al. (2022)</xref>
</td>
</tr>
<tr>
<td align="left">SIRT3&#x2191;</td>
</tr>
<tr>
<td align="left"/>
<td align="left">Urolithin A</td>
<td align="left">-</td>
<td align="left">LPS-induced BV2 cells</td>
<td align="left">2.5&#x2013;10&#xa0;&#x3bc;M</td>
<td align="left">2&#xa0;h</td>
<td align="left">MPTP-treated mice</td>
<td align="left">20&#xa0;mg/kg</td>
<td align="left">7&#xa0;days</td>
<td align="left">-</td>
<td align="left">LC3-II, Parkin, PINK1 protein&#x2191;; p62&#x2193;</td>
<td align="left">-</td>
<td align="left">-</td>
<td align="left">
<xref ref-type="bibr" rid="B86">Qiu et al. (2022)</xref>
</td>
</tr>
<tr>
<td align="left"/>
<td align="left">Ursolic acid</td>
<td align="left">
<italic>Malus domestica</italic>, <italic>Origanum majorana</italic>, <italic>Rosmarinus officinalis</italic>,etc</td>
<td align="left">-</td>
<td align="left">-</td>
<td align="left">-</td>
<td align="left">Rotenone-treated rat</td>
<td align="left">5 and 10&#xa0;mg/kg</td>
<td align="left">30&#xa0;days</td>
<td align="left">Complex I activity&#x2191;</td>
<td align="left">-</td>
<td align="left">COX1&#x2191;</td>
<td align="left">-</td>
<td align="left">
<xref ref-type="bibr" rid="B81">Peshattiwar et al. (2020)</xref>
</td>
</tr>
<tr>
<td align="left"/>
<td align="left">Vanillic acid</td>
<td align="left">-</td>
<td align="left">SH-SY5Y cells</td>
<td align="left">300&#xa0;&#x3bc;M</td>
<td align="left">24&#xa0;h</td>
<td align="left">-</td>
<td align="left">-</td>
<td align="left">-</td>
<td align="left">-</td>
<td align="left">PGC-1, TFAM&#x2191;</td>
<td align="left">-</td>
<td align="left">-</td>
<td align="left">
<xref ref-type="bibr" rid="B5">Ay (2022)</xref>
</td>
</tr>
<tr>
<td align="left">Glycosides</td>
<td align="left">Astragalus polysaccharide</td>
<td align="left">
<italic>Astragalus</italic>
</td>
<td align="left">-</td>
<td align="left">-</td>
<td align="left">-</td>
<td align="left">MPTP-induced mice</td>
<td align="left">10&#xa0;mg/kg</td>
<td align="left">14&#xa0;days</td>
<td align="left">MMP&#x2191;; ROS&#x2193;</td>
<td align="left">-</td>
<td align="left">-</td>
<td align="left">Bcl-2&#x2191;; Bax, Cyt-c release, pro-caspase-3, caspase-3&#x2193;</td>
<td align="left">
<xref ref-type="bibr" rid="B63">Liu et al. (2018a)</xref>
</td>
</tr>
<tr>
<td align="left"/>
<td align="left">Cordycepin</td>
<td align="left">
<italic>Cordyceps militaris</italic>
</td>
<td align="left">-</td>
<td align="left">-</td>
<td align="left">-</td>
<td align="left">Rotenone-treated mice</td>
<td align="left">2.5, 5 and 10&#xa0;mg/kg</td>
<td align="left">21&#xa0;days</td>
<td align="left">MMP, ATP, complex I activity&#x2191;; ROS&#x2193;</td>
<td align="left">-</td>
<td align="left">-</td>
<td align="left">-</td>
<td align="left">
<xref ref-type="bibr" rid="B132">Zhang et al. (2021)</xref>
</td>
</tr>
<tr>
<td align="left"/>
<td align="left">Echinacoside</td>
<td align="left">
<italic>Cistanche salsa</italic>
</td>
<td align="left">6-OHDA induced PC12 cells</td>
<td align="left">0.1&#x2013;10&#xa0;&#x3bc;M</td>
<td align="left">24&#xa0;h</td>
<td align="left">-</td>
<td align="left">-</td>
<td align="left">-</td>
<td align="left">MMP&#x2191;</td>
<td align="left">-</td>
<td align="left">-</td>
<td align="left">--</td>
<td align="left">
<xref ref-type="bibr" rid="B122">Wang et al. (2015)</xref>
</td>
</tr>
<tr>
<td align="left">Alkaloids</td>
<td align="left">Piperine and piperlonguminine</td>
<td align="left">
<italic>Piper longum</italic>
</td>
<td align="left">Rotenone-treated MN9D and SK-N-SH cells</td>
<td align="left">250&#xa0;&#x3bc;g/mL piperine and 5&#xa0;&#x3bc;g/mL piperlonguminine</td>
<td align="left">-</td>
<td align="left">Rotenone-treated rats</td>
<td align="left">12.5 and 25&#xa0;mg/kg</td>
<td align="left">1&#xa0;week</td>
<td align="left">MMP, complex I activity&#x2191;</td>
<td align="left">LC3-I/II&#x2191;</td>
<td align="left">-</td>
<td align="left">Cyt-c release&#x2193;</td>
<td align="left">
<xref ref-type="bibr" rid="B117">Wang et al. (2016)</xref>
</td>
</tr>
<tr>
<td align="left"/>
<td align="left">Nicotine and caffeine</td>
<td align="left">-</td>
<td align="left">Mn<sup>3&#x2b;</sup> or H<sub>2</sub>O<sub>2</sub> treated HEK293T, PC12 and SH-SY5Y cells</td>
<td align="left">1&#x2013;500&#xa0;&#x3bc;M</td>
<td align="left">-</td>
<td align="left">-</td>
<td align="left">-</td>
<td align="left">-</td>
<td align="left">-</td>
<td align="left">Nrf2/Keap1 and PGC-1&#x3b1; pathway&#x2191;</td>
<td align="left">-</td>
<td align="left">-</td>
<td align="left">
<xref ref-type="bibr" rid="B134">Zhou et al. (2019)</xref>
</td>
</tr>
<tr>
<td align="left">Quinones</td>
<td align="left">Anthraquinone</td>
<td align="left">
<italic>Pleurotus ostreatus</italic>
</td>
<td align="left">6-OHDA-induced SH-SY5Y cells</td>
<td align="left">5&#x2013;50&#xa0;nM</td>
<td align="left">2.5&#xa0;h</td>
<td align="left">-</td>
<td align="left">-</td>
<td align="left"/>
<td align="left">MMP&#x2191;</td>
<td align="left"/>
<td align="left"/>
<td align="left"/>
<td align="left">
<xref ref-type="bibr" rid="B41">Jin et al. (2021)</xref>
</td>
</tr>
<tr>
<td align="left"/>
<td align="left">Embelin</td>
<td align="left">
<italic>Embelia ribes Burm</italic>
</td>
<td align="left">N27 cells</td>
<td align="left">1&#x2013;5&#xa0;&#x3bc;M</td>
<td align="left">2&#x2013;24&#xa0;h</td>
<td align="left">MPTP-induced mice</td>
<td align="left">10&#xa0;mg/kg</td>
<td align="left">14&#xa0;days</td>
<td align="left">ATP, basal oxygen consumption rate&#x2191;</td>
<td align="left">mtDNA, pAMPK, SIRT1, PGC1&#x3b1;, nuclear respiratory factor 1/2 and TFAM&#x2191;</td>
<td align="left">-</td>
<td align="left">-</td>
<td align="left">
<xref ref-type="bibr" rid="B89">Rao et al. (2020)</xref>
</td>
</tr>
<tr>
<td align="left">Alkenes</td>
<td align="left">Isolongifolene</td>
<td align="left">
<italic>Murraya koenigii</italic>
</td>
<td align="left">-</td>
<td align="left">-</td>
<td align="left">-</td>
<td align="left">Rotenone-treated rats</td>
<td align="left">5, 10 and 20&#xa0;mg/kg</td>
<td align="left">4&#xa0;weeks</td>
<td align="left">-</td>
<td align="left">-</td>
<td align="left">-</td>
<td align="left">Bcl-2&#x2191;; Bax, Cyt-c release, caspases&#x2193;</td>
<td align="left">
<xref ref-type="bibr" rid="B11">Balakrishnan et al. (2021)</xref>
</td>
</tr>
<tr>
<td align="left">Extracts</td>
<td align="left">Ethanol and hexane leaf extracts</td>
<td align="left">
<italic>Calyptranthes grandifolia</italic>
</td>
<td align="left">6-OHDA-induced SH-SY5Y cells</td>
<td align="left">300&#xa0;&#x3bc;g/mL</td>
<td align="left">3&#xa0;h</td>
<td align="left">-</td>
<td align="left">-</td>
<td align="left">-</td>
<td align="left">MMP&#x2191;</td>
<td align="left">-</td>
<td align="left">-</td>
<td align="left">caspase-3/9 activity&#x2193;</td>
<td align="left">
<xref ref-type="bibr" rid="B46">Kich et al. (2016)</xref>
</td>
</tr>
<tr>
<td align="left"/>
<td align="left">Methanol and dichloromethane extracts</td>
<td align="left">
<italic>Sargassum muticum, Codium tomentosum, and Ulva compressa</italic>
</td>
<td align="left">6-OHDA-induced SH-SY5Y cells</td>
<td align="left">1&#xa0;mg/mL</td>
<td align="left">24&#xa0;h</td>
<td align="left">-</td>
<td align="left">-</td>
<td align="left">-</td>
<td align="left">MMP&#x2191;</td>
<td align="left">-</td>
<td align="left">-</td>
<td align="left">caspase-3/9 activity&#x2193;</td>
<td align="left">
<xref ref-type="bibr" rid="B102">Silva et al. (2018)</xref>
</td>
</tr>
<tr>
<td align="left"/>
<td align="left">Ethyl acetate stem bark extract</td>
<td align="left">
<italic>Eucommia ulmoides</italic>
</td>
<td align="left">6-OHDA-induced SH-SY5Y cells</td>
<td align="left">2.5&#x2013;100&#xa0;&#x3bc;g/mL</td>
<td align="left">24&#xa0;h</td>
<td align="left">-</td>
<td align="left">-</td>
<td align="left">-</td>
<td align="left">MMP&#x2191;; ROS&#x2193;</td>
<td align="left">-</td>
<td align="left">-</td>
<td align="left">Bcl-2&#x2191;; Bax, Cyt-c release and caspase-3/9&#x2193;</td>
<td align="left">
<xref ref-type="bibr" rid="B56">Kwon et al. (2014)</xref>
</td>
</tr>
<tr>
<td align="left"/>
<td align="left">Methanol fruits extract</td>
<td align="left">
<italic>Zizyphus spinachristi</italic>
</td>
<td align="left">MPP<sup>&#x2b;</sup>-induced SH-SY5Y cells</td>
<td align="left">20&#x2013;100&#xa0;&#x3bc;g (gallic acid equivalents)</td>
<td align="left">24&#xa0;h</td>
<td align="left">-</td>
<td align="left">-</td>
<td align="left">-</td>
<td align="left">MMP&#x2191;; ROS&#x2193;</td>
<td align="left">-</td>
<td align="left">-</td>
<td align="left">Cyt-c release, caspase-3/9 activity&#x2193;</td>
<td align="left">
<xref ref-type="bibr" rid="B105">Singh et al. (2018)</xref>
</td>
</tr>
<tr>
<td align="left"/>
<td align="left">Ethanol extract of the root and rhizome</td>
<td align="left">
<italic>Acanthopanax senticosus</italic>
</td>
<td align="left">-</td>
<td align="left">-</td>
<td align="left">-</td>
<td align="left">MPTP-induced mice</td>
<td align="left">45.5&#xa0;mg/kg</td>
<td align="left">20&#xa0;days</td>
<td align="left">ATP, MMP&#x2191;</td>
<td align="left">-</td>
<td align="left">-</td>
<td align="left">-</td>
<td align="left">
<xref ref-type="bibr" rid="B65">Liu et al. (2018b)</xref>
</td>
</tr>
<tr>
<td align="left"/>
<td align="left">Methanol extract</td>
<td align="left">
<italic>Ganoderma lucidum</italic>
</td>
<td align="left">MPP<sup>&#x2b;</sup>-treated neuro-2a</td>
<td align="left">100&#x2013;800&#xa0;&#x3bc;g/mL</td>
<td align="left">0&#x2013;48&#xa0;h</td>
<td align="left">MPTP-induced mice</td>
<td align="left">400&#xa0;mg/kg</td>
<td align="left">4&#xa0;weeks</td>
<td align="left">ATP, MMP&#x2191;</td>
<td align="left">-</td>
<td align="left">-</td>
<td align="left">Cyt-c release, caspase-3/9 activity&#x2193;</td>
<td align="left">
<xref ref-type="bibr" rid="B91">Ren et al. (2019)</xref>
</td>
</tr>
<tr>
<td align="left"/>
<td align="left">Standardized extract</td>
<td align="left">
<italic>Bacopa monnieri</italic>
</td>
<td align="left">Paraquat- or MPP<sup>&#x2b;</sup>-induced SK-N-SH cells; paraquat-induced PC12 cells</td>
<td align="left">12.5&#x2013;100&#xa0;&#x3bc;g/mL</td>
<td align="left">1&#x2013;3&#xa0;h</td>
<td align="left">Paraquat-treated mice</td>
<td align="left">200&#xa0;mg/kg</td>
<td align="left">4&#xa0;weeks</td>
<td align="left">MMP, complex I-III activity&#x2191;; ROS&#x2193;</td>
<td align="left">-</td>
<td align="left">-</td>
<td align="left">-</td>
<td align="left">
<xref ref-type="bibr" rid="B104">Singh et al., 2012</xref> (2013), <xref ref-type="bibr" rid="B39">Hosamani et al. (2016)</xref>
</td>
</tr>
<tr>
<td align="left"/>
<td align="left">Aqueous extract of tomato seeds</td>
<td align="left">-</td>
<td align="left">-</td>
<td align="left">-</td>
<td align="left">-</td>
<td align="left">Rotenone-exposed mice</td>
<td align="left">50 and 100&#xa0;mg/kg</td>
<td align="left">3&#xa0;weeks</td>
<td align="left">Complex I-III activity&#x2191;</td>
<td align="left">-</td>
<td align="left">-</td>
<td align="left">-</td>
<td align="left">
<xref ref-type="bibr" rid="B37">Gokul and Muralidhara (2014)</xref>
</td>
</tr>
<tr>
<td align="left"/>
<td align="left">Methanol extract od saffron stigmas</td>
<td align="left">
<italic>Crocus sativus</italic>
</td>
<td align="left">-</td>
<td align="left">-</td>
<td align="left">-</td>
<td align="left">Rotenone-treated drosophilas</td>
<td align="left">-</td>
<td align="left">1&#xa0;week</td>
<td align="left">Complex I-III activity&#x2191;</td>
<td align="left">-</td>
<td align="left">-</td>
<td align="left">-</td>
<td align="left">
<xref ref-type="bibr" rid="B90">Rao et al. (2016)</xref>
</td>
</tr>
<tr>
<td align="left"/>
<td align="left">Ethyl acetate fruits extract</td>
<td align="left">
<italic>Morinda citrifolia</italic>
</td>
<td align="left">-</td>
<td align="left">-</td>
<td align="left">-</td>
<td align="left">Rotenone-exposed mice</td>
<td align="left">150&#xa0;mg/kg</td>
<td align="left">1&#xa0;month</td>
<td align="left">Complex I and IV activity&#x2191;</td>
<td align="left">-</td>
<td align="left">-</td>
<td align="left">Bcl-2&#x2191;; Bax, Cyt-c release, caspase-3/9 activity&#x2193;</td>
<td align="left">
<xref ref-type="bibr" rid="B51">Kishore Kumar et al. (2017)</xref>
</td>
</tr>
<tr>
<td align="left"/>
<td align="left">Standardized extract</td>
<td align="left">
<italic>Centella asiatica</italic>
</td>
<td align="left">-</td>
<td align="left">-</td>
<td align="left">-</td>
<td align="left">Rotenone-exposed mice</td>
<td align="left">10&#x2013;100&#xa0;mg/kg</td>
<td align="left">20&#xa0;days</td>
<td align="left">Complex I&#x2191;; ROS&#x2193;</td>
<td align="left">-</td>
<td align="left">-</td>
<td align="left">-</td>
<td align="left">
<xref ref-type="bibr" rid="B109">Teerapattarakan et al. (2018)</xref>
</td>
</tr>
<tr>
<td align="left"/>
<td align="left">Aqueous extract of red clover flowers</td>
<td align="left">
<italic>Trifolium pratense</italic>
</td>
<td align="left">Rotenone-exposed E17 embryos of rats</td>
<td align="left">0.1&#x2013;20&#xa0;&#x3bc;g/mL</td>
<td align="left">24&#xa0;h</td>
<td align="left">-</td>
<td align="left">-</td>
<td align="left">-</td>
<td align="left">oxygen consumption rate&#x2191;; ROS&#x2193;</td>
<td align="left">-</td>
<td align="left">-</td>
<td align="left">-</td>
<td align="left">
<xref ref-type="bibr" rid="B25">de Rus Jacquet et al. (2021)</xref>
</td>
</tr>
<tr>
<td align="left"/>
<td align="left">Tris-HCl extract of Ginseng total protein</td>
<td align="left">
<italic>Panax ginseng</italic>
</td>
<td align="left">-</td>
<td align="left">-</td>
<td align="left">-</td>
<td align="left">Transgenic drosophilas</td>
<td align="left">0.02&#x2013;0.16&#xa0;mg/mL</td>
<td align="left">-</td>
<td align="left">-</td>
<td align="left">mtDNA&#x2191;</td>
<td align="left">-</td>
<td align="left">-</td>
<td align="left">
<xref ref-type="bibr" rid="B64">Liu et al. (2020)</xref>
</td>
</tr>
<tr>
<td align="left"/>
<td align="left">Hydroethanol extract of cocoa beans</td>
<td align="left">
<italic>Theobroma cocoa</italic>
</td>
<td align="left">MPP<sup>&#x2b;</sup>-treated SH-SY5Y cells</td>
<td align="left">0&#x2013;8&#xa0;&#x3bc;g/mL</td>
<td align="left">20&#xa0;h</td>
<td align="left">-</td>
<td align="left">-</td>
<td align="left">-</td>
<td align="left">-</td>
<td align="left">PPAR&#x3b3;, PGC1&#x3b1;, Nrf2, TFAM and COX4 proteins&#x2191;</td>
<td align="left">Fis1&#x2193;; Mfn2&#x2191;</td>
<td align="left">Bcl-2&#x2191;</td>
<td align="left">
<xref ref-type="bibr" rid="B21">Chidambaram et al. (2020)</xref>
</td>
</tr>
<tr>
<td align="left"/>
<td align="left">Ethanol extract of leaves</td>
<td align="left">
<italic>Artemisia argyi</italic>
</td>
<td align="left">MPP<sup>&#x2b;</sup>-treated SH-SY5Y cells</td>
<td align="left">10&#x2013;250&#xa0;&#x3bc;g/mL</td>
<td align="left">24&#xa0;h</td>
<td align="left">MPTP-treated mice</td>
<td align="left">100&#xa0;mg/kg</td>
<td align="left">2&#xa0;weeks</td>
<td align="left">-</td>
<td align="left">LC3B&#x2191;</td>
<td align="left">Drp1, p-Drp1&#x2193;</td>
<td align="left">-</td>
<td align="left">
<xref ref-type="bibr" rid="B127">Wu et al. (2022)</xref>
</td>
</tr>
<tr>
<td align="left"/>
<td align="left">Methanol extract of seeds</td>
<td align="left">
<italic>Mucuna pruriens</italic>
</td>
<td align="left">-</td>
<td align="left">-</td>
<td align="left">-</td>
<td align="left">Transgenic drosophilas</td>
<td align="left">-</td>
<td align="left">0&#x2013;3&#xa0;months</td>
<td align="left">-</td>
<td align="left">-</td>
<td align="left">Damaged, swollen and fragmented mitochondria&#x2193;</td>
<td align="left">-</td>
<td align="left">
<xref ref-type="bibr" rid="B82">Poddighe et al. (2014)</xref>
</td>
</tr>
<tr>
<td align="left"/>
<td align="left">Aqueous extract of roots</td>
<td align="left">
<italic>Decalepis hamiltonii</italic>
</td>
<td align="left">-</td>
<td align="left">-</td>
<td align="left">-</td>
<td align="left">Paraquat-treated drosophilas</td>
<td align="left">0.55&#x2013;2.75&#xa0;mM</td>
<td align="left">5&#xa0;days</td>
<td align="left">-</td>
<td align="left">-</td>
<td align="left">Fragmented mitochondrial cristae&#x2193;</td>
<td align="left">-</td>
<td align="left">
<xref ref-type="bibr" rid="B78">Niveditha and Shivanandappa (2018)</xref>
</td>
</tr>
<tr>
<td align="left"/>
<td align="left">Aqueous extract of edible bird&#x2019;s nest</td>
<td align="left">
<italic>Aerodramus</italic> (or <italic>Collocalia</italic>)</td>
<td align="left">6-OHDA-induced SH-SY5Y cells</td>
<td align="left">0&#x2013;500&#xa0;&#x3bc;g/mL</td>
<td align="left">48&#xa0;h</td>
<td align="left">-</td>
<td align="left">-</td>
<td align="left">-</td>
<td align="left">-</td>
<td align="left">-</td>
<td align="left">-</td>
<td align="left">caspase-3/9 activity&#x2193;</td>
<td align="left">
<xref ref-type="bibr" rid="B131">Yew et al. (2014)</xref>
</td>
</tr>
<tr>
<td align="left"/>
<td align="left">Petal juicing and freeze drying</td>
<td align="left">
<italic>Echium amoenum</italic>
</td>
<td align="left">-</td>
<td align="left">-</td>
<td align="left">-</td>
<td align="left">Mn<sup>2&#x2b;</sup> -induced mice</td>
<td align="left">5&#xa0;mg/kg</td>
<td align="left">15&#xa0;days</td>
<td align="left">-</td>
<td align="left">-</td>
<td align="left">-</td>
<td align="left">caspase-3/9 activity&#x2193;</td>
<td align="left">
<xref ref-type="bibr" rid="B94">Sadeghi et al. (2018)</xref>
</td>
</tr>
<tr>
<td align="left"/>
<td align="left">Ethanol extract of root bark</td>
<td align="left">
<italic>Paeonia suffruticosa</italic>
</td>
<td align="left">Embryos of rats</td>
<td align="left">0.1&#x2013;1&#xa0;&#x3bc;g/mL</td>
<td align="left">1&#xa0;h</td>
<td align="left">MPTP-treated mice</td>
<td align="left">1&#x2013;50&#xa0;mg/kg</td>
<td align="left">12&#xa0;days</td>
<td align="left">-</td>
<td align="left">-</td>
<td align="left">-</td>
<td align="left">Bcl-2&#x2191;; Bax, Cyt-c release, caspase-3/9 activity&#x2193;</td>
<td align="left">
<xref ref-type="bibr" rid="B47">Kim et al. (2014)</xref>
</td>
</tr>
<tr>
<td align="left"/>
<td align="left">Methanol extract and ethanol extract</td>
<td align="left">
<italic>Humulus japonicus</italic>
</td>
<td align="left">6-OHDA-induced SH-SY5Y cells</td>
<td align="left">0&#x2013;200&#xa0;&#x3bc;g/mL</td>
<td align="left">24&#xa0;h</td>
<td align="left">6-OHDA-treated mice</td>
<td align="left">300, 500&#xa0;mg/kg</td>
<td align="left">3&#xa0;days</td>
<td align="left">-</td>
<td align="left">-</td>
<td align="left">-</td>
<td align="left">Cyt-c release, cleaved PARP, cleaved caspase-9 and cleaved caspase-3&#x2193;</td>
<td align="left">
<xref ref-type="bibr" rid="B93">Ryu et al. (2017)</xref>
</td>
</tr>
<tr>
<td align="left"/>
<td align="left">Hand-squeezed juice</td>
<td align="left">
<italic>Citrus bergamia</italic>
</td>
<td align="left">6-OHDA- or H<sub>2</sub>O<sub>2</sub>-induced SH-SY5Y cells</td>
<td align="left">-</td>
<td align="left">1&#xa0;h</td>
<td align="left">-</td>
<td align="left">-</td>
<td align="left">-</td>
<td align="left">MMP&#x2191;; ROS&#x2193;</td>
<td align="left">-</td>
<td align="left">-</td>
<td align="left">Bcl-2&#x2191;; Bax and p53&#x2193;</td>
<td align="left">
<xref ref-type="bibr" rid="B30">Ferlazzo et al. (2020)</xref>
</td>
</tr>
</tbody>
</table>
</table-wrap>
<sec id="s3-1">
<title>3.1 Targeting mitochondrial respiration and bioenergetics</title>
<p>Mitochondria are double-layer organelles where aerobic respiration occurs. It is the major site that generates ATP via oxidative phosphorylation. The electron transfer chain, which is composed of approximately 80 polypeptides and located in the inner membrane of mitochondria, plays a vital role in ATP production. The inner membrane of mitochondria contains different transmembrane protein complexes (I-V) (<xref ref-type="bibr" rid="B128">Yadav et al., 2022</xref>). Along with the circulation of electrons through the entire electron transfer chain, different protein complexes set up mitochondrial membrane potential (MMP) across the inner mitochondria membrane and maintain mitochondrial integrity and perform its normal function (<xref ref-type="bibr" rid="B80">Papa et al., 2012</xref>). Electrons are prone to leak out of complex I and complex III in the electron transfer chain and transfer to O<sub>2</sub> to produce superoxide radicals and hydrogen peroxide, which are referred as ROS (<xref ref-type="bibr" rid="B101">Sies et al., 2017</xref>). A balanced amount of mitochondrial ROS is involved in various beneficial processes such as various signaling pathways (<xref ref-type="bibr" rid="B13">Bhat et al., 2015</xref>). However, aberrant production of ROS causes severe oxidative stress and triggers PD pathogenesis via mtDNA damage, and lipid peroxidation associated with mitochondrial dysfunction (<xref ref-type="bibr" rid="B3">Ali et al., 2015</xref>; <xref ref-type="bibr" rid="B7">Badshah et al., 2016</xref>). In the respiratory chain, damage to any of the complexes also causes severe cell and mitochondrial dysfunction such as loss of MMP in PD (<xref ref-type="bibr" rid="B84">Qi et al., 2019</xref>). Mitochondrial respiration is an important process through which mitochondria can provide energy that supports physiological activity and body function. Many natural compounds and plant extracts can beneficially function in mitochondrial dysregulation. Most of them are flavonoids and polyphenols, in addition to glycosides, terpenoids, <italic>etc.</italic>
</p>
<sec id="s3-1-1">
<title>3.1.1 Flavanoids</title>
<p>Flavanoids isolated from various sources induced mitochondrial protection and improved mitochondrial function in PD by upregulating the production of ATP, and ROS, and maintaining the mitochondrial membrane potential and activity of mitochondrial complexes. The dicarbonyl compound methylglyoxal (MG) has been shown to be linked to PD development by inducing mitochondrial dysfunction (<xref ref-type="bibr" rid="B10">Bakala et al., 2012</xref>). Exposure of SH-SY5Y cells to MG caused decreases in cell viability, intracellular ATP, and mitochondrial membrane potential. The flavonoid naringenin is extracted from the pericarp of <italic>Citrus reticulata</italic> Blanco, known as 5,7-dihydroxy-2-(4-hydroxyphenyl)-2,3-dihydrochromen-4-one. It is one of the most important polyphenolic flavanones and has been reported to have neuroprotective effects in PD possessing potent free radical scavenging properties (<xref ref-type="bibr" rid="B68">Lou et al., 2014</xref>). SH-SY5Y cells were pretreated for 2&#xa0;h with naringenin (at 10&#x2013;80&#xa0;&#x3bc;M) and then challenged with MG at 500&#xa0;&#x3bc;M for 24&#xa0;h. Naringenin significantly increased MMP, ATP, and complex I and V activity, and attenuated the effects on mitochondrial function and the redox environment (<xref ref-type="bibr" rid="B24">de Oliveira et al., 2019</xref>). In another study, 80&#xa0;&#x3bc;M Naringenin treatment in paraquat-induced SH-SY5Y cells resulted in increased cell viability, reduced oxidative stress, elevated MMP, and higher cellular ATP levels. In paraquat-induced rats, 40&#xa0;mg/kg naringenin treatment resulted in significant neuroprotection against paraquat -induced behavioral deficits, oxidative stress, mitochondrial dysfunction, and astrocytosis (<xref ref-type="bibr" rid="B1">Ahmad et al., 2021</xref>). Calycosin, an isoflavonoid extracted from <italic>Astragalus membranaceus</italic>. , has been revealed to exhibit neuroprotective functions against cerebral ischemia and reperfusion-induced neurological injury, high glucose-induced oxidative stress and neuroinflammation, as well as neuronal apoptosis in earlier studies (<xref ref-type="bibr" rid="B121">Wang and Zhao, 2016</xref>; <xref ref-type="bibr" rid="B40">Hsu et al., 2020</xref>). <xref ref-type="bibr" rid="B20">Chaouhan et al. (2022)</xref> reported that calycosin administration increased ATP and MMP. Flies feed with 100&#xa0;&#x3bc;M calycosin exhibited significant resistance against paraquat-induced mortality and locomotor deficits in terms of reduced oxidative stress, loss of DA neurons, depletion of dopamine content. Nobiletin is a natural polymethoxylated flavone. The disruption of mitochondrial respiratory complexes I-IV and the enhancement of ROS induced by lipopolysaccharide were ameliorated by nobiletin pretreatment, which also enhanced MMP in BV-2 microglial cells (<xref ref-type="bibr" rid="B84">Qi et al., 2019</xref>). Silibinin is a flavonoid extracted and isolated from the fruit of <italic>Silybum marianum</italic> (L.) <italic>Gaertn</italic> and has been widely used to exploit drugs for the treatment of diseases. Previous studies showed that silibinin could potentially exert protective effects against neuronal diseases including PD (<xref ref-type="bibr" rid="B54">Kujawska and Jodynis-Liebert, 2018</xref>). Silibinin restored MMP decline in mitochondrial respiration (<xref ref-type="bibr" rid="B67">Liu et al., 2021b</xref>). Baicalein, 5, 6, 7-trihydroxyflavone, is a flavonoid and is mainly derived from the root of the herb <italic>Scutellaria baicalensis</italic> Georgi, which is a well-known traditional Chinese medicine (<xref ref-type="bibr" rid="B53">Kuang et al., 2017</xref>). Baicalein has neuroprotective effects in PD models by exerting anti-inflammatory, anti-apoptosis, and antioxidative effects. In previous studies, it has been manifested that baicalein protected PC12 and SH-SY5Y cells against neurotoxicity induced by several toxic substances and ameliorated the neurotoxicity in rats (<xref ref-type="bibr" rid="B75">Mu et al., 2009</xref>; <xref ref-type="bibr" rid="B133">Zhang et al., 2012</xref>). It has been reported that 10&#xa0;&#x3bc;M baicalein increased cell viability and restored mitochondrial function in SH-SY5Y cells. Baicalein administration (5&#xa0;mg/kg) prevented rotenone-induced behavioral deficits, dopaminergic neuronal loss, and mitochondrial dysfunction in mice by restoring mitochondrial disorders of MMP decline. Hyperoside, which is a flavonoid glycoside, maintained MMP and ROS and improved mitochondrial function (<xref ref-type="bibr" rid="B55">Kwon et al., 2019</xref>). Quercetin (3,5,7,30,40-pentahydroxyflavone), found in <italic>Bupleurum chinense</italic> or <italic>Crataegus pinnatifida</italic>, has been proven to have neuroprotective and cognitive enhancing effects in different brain injury models (<xref ref-type="bibr" rid="B98">Selvakumar et al., 2012</xref>). A recent study reported that administration of quercetin (10&#xa0;mg/kg) reduced aluminum-induced oxidative stress including decreasing ROS production and increasing mitochondrial superoxide dismutase (<xref ref-type="bibr" rid="B100">Sharma et al., 2016</xref>).</p>
<p>In addition, advanced glycation end products (AGEs) ligate to the receptor of AGEs (RAGE), improving activation of the transcription factor NF-&#x3ba;B, which may be involved in the development of neurodegenerative diseases (<xref ref-type="bibr" rid="B85">Qin et al., 2009</xref>). Myricitrin, a flavanoid contained in the root bark of <italic>Myrica cerifera</italic>, alleviated MG-induced dysfunction of mitochondrial bioenergetics, including an increase in ATP and MMP and a decrease in ROS at concentrations of 1 and 10&#xa0;&#x3bc;m, and the possible mechanism is through inhibiting the AGE/RAGE/NF-&#x3ba;B pathway (<xref ref-type="bibr" rid="B123">Wang et al., 2014</xref>). Icaritin, a flavonoid extracted from <italic>Epimedium sagittatum maxim</italic>, reversed the decline in the levels of ATP, ADP, inosine, and citric acid in the substantia nigra of PD mice induced by MPTP. Icaritin improved the levels of SDHA, VDAC and ATP5B, which are closely related to mitochondrial respiration and energy supply (<xref ref-type="bibr" rid="B126">Wu et al., 2021</xref>).</p>
</sec>
<sec id="s3-1-2">
<title>3.1.2 Phenols and polyphenols</title>
<p>In previous studies, various phenols and polyphenols exerted potent mitochondrial protection effects, such as resveratrol, mangiferin, curcumin, tea polyphenols, <italic>etc.</italic> Resveratrol is a natural polyphenolic compound sustained in a variety of plant species, such as <italic>Veratrum grandiflorum</italic> and <italic>Polygonum cuspidatum</italic>. It has been reported that resveratrol has potent potential for PD therapy via multiple mitochondria-related pathways (<xref ref-type="bibr" rid="B128">Yadav et al., 2022</xref>). The functional impacts of resveratrol on mitochondrial bioenergetics included a decrease in ROS, an increase in complex I and citrate synthase activities, basal oxygen consumption, mitochondrial ATP production, and an attenuated loss of MMP (<xref ref-type="bibr" rid="B32">Ferretta et al., 2014</xref>; <xref ref-type="bibr" rid="B61">Lin et al., 2018</xref>; <xref ref-type="bibr" rid="B116">Wang et al., 2018</xref>). Mangiferin is the primary polyphenol component of <italic>Mangifera</italic> indica L., possessing neuroprotective effects in PD. Mangiferin (20&#xa0;&#x3bc;g/mL) pretreatment of rotenone- or MPTP-treated cells resulted in a higher MMP and significantly enhanced ATP levels in SK-N-SH neuroblastoma cells and a PD mouse model (<xref ref-type="bibr" rid="B43">Kavitha et al., 2014</xref>; <xref ref-type="bibr" rid="B119">Wang et al., 2022</xref>). Demethoxycurcumin (a natural derivative of curcumin), paeonolum and &#x3b1;-Arbutin, which are extracted from <italic>Curcuma longa</italic>, <italic>Ericaceae</italic> species, and Moutan cortex, respectively, have been shown to prevent MMP loss and ROS production (<xref ref-type="bibr" rid="B70">Lu et al., 2015</xref>; <xref ref-type="bibr" rid="B88">Ramkumar et al., 2017</xref>; <xref ref-type="bibr" rid="B27">Ding et al., 2020</xref>). In addition, Sativex<sup>&#xae;</sup> (a mixture of 9-tetrahydrocannabinol and cannabidiol) significantly increased mitochondrial complex II activity and complex IV protein levels in mice (<xref ref-type="bibr" rid="B45">Khatri and Juvekar, 2016</xref>). Oleuropein, isolated from <italic>Fraxinus rhynchophylla</italic>, plays a role as a protective molecule against glutamate-induced mitochondrial dysfunction by regulating ATP and ROS levels (<xref ref-type="bibr" rid="B49">Kim et al., 2018</xref>). Additionally, Parkin deficiency is able to trigger mitochondrial dysfunction and dopaminergic neuronal loss (<xref ref-type="bibr" rid="B60">Lim and Ng, 2009</xref>). Polydatin, a nonglycosylated derivative of resveratrol extracted from grapes, protected mitochondrial function by increasing MMP and decreasing ROS in cells exposed to rotenone or knocked down Parkin (<xref ref-type="bibr" rid="B8">Bai et al., 2020</xref>). Putative kinase 1 (PINK1), linked to familial Parkinson&#x2019;s disease, is known to affect mitochondrial function (<xref ref-type="bibr" rid="B48">Kim et al., 2012</xref>). Curcumin is an active natural polyphenolic compound extracted from rhizomes of <italic>C. longa</italic>, which is widely used. It has been reported that curcumin has multiple pharmacological effects, including the ability to inhibit the key characteristic features of PD such as ROS production, apoptosis, and cognitive deficits in cell cultures and animal models (<xref ref-type="bibr" rid="B129">Yang et al., 2005</xref>). In a recent study, it was shown that curcumin at different doses (50, 100, and 200&#xa0;mg/kg) could significantly rescue complex II activity in mice that were given chronic administration of rotenone for 3&#xa0;weeks and had significant alterations in mitochondrial enzyme complex activity (<xref ref-type="bibr" rid="B45">Khatri and Juvekar, 2016</xref>). The PINK1 gene plays a vital role in the maintenance and regulation of healthy mitochondria, and mutations in the PINK1 gene result in an autosomal recessive form of early-onset PD (<xref ref-type="bibr" rid="B96">Schapira AH et al., 1998</xref>). Subsequently, it was also reported that curcumin at a concentration of 2&#xa0;&#x3bc;M increased MMP and spare respiratory capacity in paraquat-treated PINK1 siRNA and control SH-SY5Y cells (<xref ref-type="bibr" rid="B111">van der Merwe et al., 2017</xref>).</p>
</sec>
<sec id="s3-1-3">
<title>3.1.3 Terpenoids</title>
<p>Several triterpenoids are capable of repairing the function of mitochondrial bioenergetics, including ginsenoside Re, ursolic, celastrol and mogroside V. Ginsenoside Re is one of the primary biologically active components of ginseng. Ginsenoside Re enhanced NO production and was capable of reversing the deficit in complex IV activity in PINK1 null cells by increasing LRPPRC, Hsp90, and Hsp60 levels, which are mitochondria-related complex IV assembly factors (<xref ref-type="bibr" rid="B48">Kim et al., 2012</xref>). Ursolic acid, a pentacyclic triterpenoid carboxylic acid, is found in many plant species. In rotenone-induced damage rats, treatment with ursolic acid at 5 and 10&#xa0;mg/kg prevented inhibition of mitochondrial complex I activity in the mid-brain (<xref ref-type="bibr" rid="B81">Peshattiwar et al., 2020</xref>). Celastrol, a natural triterpene, protected SH-SY5Y cells from rotenone-induced MMP loss and ROS production (<xref ref-type="bibr" rid="B22">Choi et al., 2014</xref>). SIRT3 is present in the mitochondria and participates in multiple mitochondrial functions, including maintaining ATP levels (<xref ref-type="bibr" rid="B2">Ahn et al., 2008</xref>). Mogroside V, as a bioactive triterpene, recovered ROS and increased MMP, ATP production and the oxygen consumption rate in a dose-dependent manner, which may be associated with SIRT3 upregulation (<xref ref-type="bibr" rid="B71">Luo et al., 2022</xref>).</p>
</sec>
<sec id="s3-1-4">
<title>3.1.4 Glycosides</title>
<p>Treatment with the phenylethanoid glycoside echinacoside significantly attenuated the MMP decrease induced by 6-hydroxydopamine (6-OHDA) in PC12 cells (<xref ref-type="bibr" rid="B122">Wang et al., 2015</xref>). Astragalus polysaccharide is one of the main active ingredients in astragalus. Astragalus polysaccharide maintained MMP and ROS and improved mitochondrial function (<xref ref-type="bibr" rid="B63">Liu H. et al., 2018</xref>). Additionally, cordycepin (3&#x2032;-deoxyadenosine) is the main bioactive ingredient isolated from <italic>Cordyceps militaris</italic>. It effectively preserves mitochondrial function by increasing MMP, ATP content, and complex I activity and decreasing ROS levels (<xref ref-type="bibr" rid="B132">Zhang et al., 2021</xref>).</p>
</sec>
<sec id="s3-1-5">
<title>3.1.5 Quinones</title>
<p>Pretreatment of cells with 50&#xa0;nM anthraquinone, extracted from edible fungi <italic>Pleurotus ostreatus</italic>, reversed the decrease in MMP induced by 6-OHDA (<xref ref-type="bibr" rid="B15">Bindhu et al., 2020</xref>). Treatment with 5&#xa0;&#x3bc;M embelin resulted in a time-dependent enhancement of the basal oxygen consumption rate and ATP production in rat N27 cells (<xref ref-type="bibr" rid="B89">Rao et al., 2020</xref>).</p>
</sec>
<sec id="s3-1-6">
<title>3.1.6 Plant extracts</title>
<p>Many plant extracts restored MMP and decreased mitochondrial depolarization, including the extracts of <italic>Calyptranthes grandifolia</italic> leaves (<xref ref-type="bibr" rid="B46">Kich et al., 2016</xref>) and the seaweeds <italic>Sargassum muticum</italic>, <italic>Codium tomentosum</italic>, and <italic>Ulva compressa</italic> (<xref ref-type="bibr" rid="B102">Silva et al., 2018</xref>). The extracts of <italic>Eucommia ulmoides</italic>, <italic>Zizyphus spinachristi</italic> fruits and <italic>Citrus bergamia</italic> fruits restored both MMP and ROS (<xref ref-type="bibr" rid="B56">Kwon et al., 2014</xref>; <xref ref-type="bibr" rid="B105">Singh et al., 2018</xref>; <xref ref-type="bibr" rid="B30">Ferlazzo et al., 2020</xref>). Extracts of <italic>Acanthopanax senticosus</italic> and <italic>Ganoderma lucidum</italic> reversed mitochondrial membrane potential collapse and ATP depletion caused by MPTP (<xref ref-type="bibr" rid="B65">Liu S. M. et al., 2018</xref>; <xref ref-type="bibr" rid="B91">Ren et al., 2019</xref>). <italic>Bacopa monnieri</italic> L. has been proven to have neuroprotective effects, and the standardized extract also plays a role by targeting mitochondrial respiration. Pretreatment with a standardized extract of <italic>Bacopa monnieria</italic> maintained complex I activity in SK-N-SH cells and complexes II-III activity in the mouse striatal region and prevented MMP loss and ROS production (<xref ref-type="bibr" rid="B104">Singh et al., 2012</xref>, <xref ref-type="bibr" rid="B103">2013</xref>; <xref ref-type="bibr" rid="B39">Hosamani et al., 2016</xref>). Tomato seed extracts efficiently restored ROT-induced activity loss of complexes I-II (in the hippocampus) and complexes II-III (in the striatum) (<xref ref-type="bibr" rid="B37">Gokul and Muralidhara, 2014</xref>). <xref ref-type="bibr" rid="B90">Rao et al. (2016)</xref> studied the neuroprotective efficacy of saffron methanolic extract and its bioactive constituent crocin. They both increased the activity of complexes I-III (<xref ref-type="bibr" rid="B90">Rao et al., 2016</xref>). Supplementation of the ethyl acetate extract of <italic>Morinda citrifolia</italic> significantly augmented the activity of complex I by 22% and complex IV by 23% compared to only ROT-treated rats (<xref ref-type="bibr" rid="B51">Kishore Kumar et al., 2017</xref>). The standardized extract of <italic>Centella asiatica</italic> ECa233 (30&#xa0;mg/kg) protected against the inhibition of complex I and an increase in ROS (<xref ref-type="bibr" rid="B109">Teerapattarakan et al., 2018</xref>). <italic>Selaginella delicatula</italic> extract restored rotenone-induced perturbations in the activity levels of complexes I-II, MMP and activity of ATPases to normalcy among mice (<xref ref-type="bibr" rid="B137">Chandran and Muralidhara, 2013</xref>). <italic>Piper longum</italic> L. extract, containing two active alkaloids, reversed the reduction in MMP in MN9D cells caused by rotenone and protected mitochondrial complex I activity (<xref ref-type="bibr" rid="B117">Wang et al., 2016</xref>). Pretreatment with red clover (<italic>Trifolium pratense</italic>) extract and the individual isoflavone daidzein both decreased ROS levels and enhanced the oxygen consumption rate (<xref ref-type="bibr" rid="B25">de Rus Jacquet et al., 2021</xref>).</p>
</sec>
</sec>
<sec id="s3-2">
<title>3.2 Targeting mitochondrial biogenesis and mitophagy</title>
<p>Mitochondrial biogenesis is a pivotal biological process that plays a critical role in maintaining mitochondrial homeostasis, and ultimately adapts to the cellular physiological demand for energy supply. Mitochondrial biogenesis is the process in which existing mitochondria divide directly to produce new mitochondria. The original mtDNA is indispensable for the mitochondrial biogenesis process due to its obligation to encode essential mitochondrial tRNAs and RNAs (<xref ref-type="bibr" rid="B92">Richter-Dennerlein et al., 2015</xref>). Peroxisome proliferator-activated receptor gamma coactivator (PGC)-1&#x3b1; is a member of a family of transcription coactivators that play a central role in the regulation of mitochondrial biogenesis and cellular energy metabolism (<xref ref-type="bibr" rid="B34">Finck and Kelly, 2006</xref>; <xref ref-type="bibr" rid="B38">Handschin and Spiegelman, 2006</xref>). PGC-1&#x3b1; activation is attributed to adenosine monophosphate-activated protein kinase (AMPK) induced by SIRT1 (<xref ref-type="bibr" rid="B31">Fernandez-Marcos and Auwerx, 2011</xref>). PGC-1&#x3b1; can function to activate nuclear respiratory factor (Nrf) 1/2 as a transcriptional modulator, and then bind to the mitochondrial transcription factor A (TFAM) promoter to activate TFAM and complete and promote the replication and transcription of mtDNA. Cytochrome c oxidase (MtCO-1/COX1) is a mtDNA-encoded polypeptide and is a downstream target of PGC-1&#x3b1;. Upregulation of COX1 transcripts provides evidence for the activation of mitochondrial biogenesis and respiratory activity (<xref ref-type="bibr" rid="B81">Peshattiwar et al., 2020</xref>). Therefore, the biogenesis of new mitochondria depends on the activation of SIRT1/AMPK/PGC-1&#x3b1;-Nrf-TFAM pathway. Plenty of studies have shown that anomalous expression of SIRT1/AMPK and the decreased expression of PGC-1&#x3b1;, Nrf and TFAM leaded to mitochondrial dysfunction in PD (<xref ref-type="bibr" rid="B59">Li et al., 2017</xref>; <xref ref-type="bibr" rid="B74">Mohammadipour et al., 2020</xref>).</p>
<p>Mitophagy is a type of selective autophagy that controls the quantity and quality of mitochondria and maintains the normal function of the mitochondrial network. Abnormal mitophagy can cause many pathological changes that can lead to Alzheimer&#x2019;s disease and Parkinson&#x2019;s disease (<xref ref-type="bibr" rid="B29">Fang X et al., 2022</xref>). Phosphatase and tensin homolog (PTEN)-induced PINK1 and Parkin, the two PD-associated genes, are involved in the selective removal of damaged mitochondria (<xref ref-type="bibr" rid="B36">Geisler et al., 2010</xref>). PINK1 acts upstream of Parkin in the mitochondrial quality control pathway, and the two synergistically mediate the polyubiquitination process of damaged mitochondrial surface structures or functional proteins, and play a key role in depolarizing mitophagy degradation (<xref ref-type="bibr" rid="B72">Matsuda et al., 2010</xref>). LC3 is the most widely used autophagosome marker to evaluate autophagic flux. During autophagy, LC3I, the cytoplasmic form, is conjugated with phosphatidylethanolamine to form LC3II, which is recruited to autophagosome membranes (<xref ref-type="bibr" rid="B52">Klionsky et al., 2021</xref>). During the late stages of autophagy, p62 and p62-bound polyubiquitinated proteins that are incorporated into the autophagosome are degraded in autolysosomes. Accordingly, the level of p62 indicates damaged mitochondria accumulation instead of mitophagy (<xref ref-type="bibr" rid="B62">Lin et al., 2014</xref>). Studies have revealed that PINK1/Parkin-dependent mitophagy augmentation occurred in treated PD models and exerted neuroprotective effects along with decreased p62 protein and increased Parkin and LC3-II levels (<xref ref-type="bibr" rid="B53">Kuang et al., 2017</xref>; <xref ref-type="bibr" rid="B79">Palikaras and Tavernarakis, 2020</xref>; <xref ref-type="bibr" rid="B20">Chaouhan et al., 2022</xref>).</p>
<p>Balance maintenance of mitochondrial biogenesis and autophagy plays a crucial role in controlling mitochondrial physiology and function (<xref ref-type="bibr" rid="B77">Narendra et al., 2008</xref>). Mitochondrial dysfunction of impaired mitochondrial biogenesis has been observed in neurodegenerative diseases, including Parkinson&#x2019;s disease (<xref ref-type="bibr" rid="B135">Zhu et al., 2012</xref>). Various natural products have shown significant effects on regulating mitochondrial biogenesis and mitophagy.</p>
<sec id="s3-2-1">
<title>3.2.1 Flavanoids</title>
<p>The flavonoid baicalein could also increase autophagic flux in rotenone-treated mice by increasing the LC3B-II protein level (<xref ref-type="bibr" rid="B53">Kuang et al., 2017</xref>). PTEN-induced PINK1 and Parkin, the two PD-associated genes, are involved in the selective removal of damaged mitophagy (<xref ref-type="bibr" rid="B36">Geisler et al., 2010</xref>). Silibinin promoted clearance of the toxic effects of damaged mitochondria. MPTP-injected mice were protected against dopaminergic neuronal loss by oral administration of silibinin (280&#xa0;mg/kg), which increased the expression of PTEN-PINK1 and Parkin, suggesting mitophagy activation (<xref ref-type="bibr" rid="B66">Liu et al., 2021a</xref>). The level of p62, an essential mitophagy regulator that indicates the accumulation of damaged mitochondria, was observed to be dramatically increased in paraquat-exposed flies. However, calycosin treatment inhibited this effect. It also decreased the phosphorylation levels of S6K and 4EBP1, indicating mitophagy stimulation (<xref ref-type="bibr" rid="B20">Chaouhan et al., 2022</xref>).</p>
</sec>
<sec id="s3-2-2">
<title>3.2.2 Phenols and polyphenols</title>
<p>Resveratrol regulated mitochondrial biogenesis and mitophagy in PD by regulating the PGC-1&#x3b1;, LC3-II, p62 protein-related pathways, <italic>etc.</italic> Resveratrol also promoted LC3-II accumulation, inhibited p62 expression and augmented autophagic flux, which was inhibited by rotenone in SH-SY5Y cells (<xref ref-type="bibr" rid="B62">Lin et al., 2014</xref>; <xref ref-type="bibr" rid="B61">Lin et al., 2018</xref>). A significant resveratrol (25&#xa0;&#x3bc;M) -mediated increase in the PGC-1&#x3b1; transcriptional activity of downstream genes TFAM and COX 1, the mtDNA/nDNA ratio, and enhanced macroautophagic flux through upregulating LC3-II levels was observed in skin fibroblasts from PD patients (<xref ref-type="bibr" rid="B32">Ferretta et al., 2014</xref>). Resveratrol at a concentration of 20&#xa0;&#x3bc;M promoted LC3-II accumulation, inhibited p62 expression and augmented autophagic flux, which was inhibited by rotenone in SH-SY5Y cells (<xref ref-type="bibr" rid="B62">Lin et al., 2014</xref>; <xref ref-type="bibr" rid="B61">Lin et al., 2018</xref>). Vanillic acid is a phenolic compound found in various plants and fruits. Its treatment resulted in significant increases in the mRNA expression of PGC-1&#x3b1; and TFAM, and treatment with 300&#xa0;&#xb5;M for 24&#xa0;h significantly elevated the mtDNA copy number and mitochondrial mass of SH-SY5Y cells (<xref ref-type="bibr" rid="B5">Ay, 2022</xref>). Urolithin A, a natural compound produced by gut bacteria from ingested ellagitannins and ellagic acid, decreased p62 protein levels and increased LC3-II and other related protein levels of Parkin and PINK1, regulating mitophagy (<xref ref-type="bibr" rid="B86">Qiu et al., 2022</xref>). Polydatin increased the expression of LC3-II, indicating that autophagic flux was augmented by polydatin (<xref ref-type="bibr" rid="B8">Bai et al., 2020</xref>).</p>
</sec>
<sec id="s3-2-3">
<title>3.2.3 Terpenoids</title>
<p>Ursolic acid caused a prominent upregulation of COX1, the downstream gene of PGC-1&#x3b1;, in treated rats at a dose of 10&#xa0;mg/kg, manifesting the promotion of mitochondrial biogenesis (<xref ref-type="bibr" rid="B81">Peshattiwar et al., 2020</xref>).</p>
</sec>
<sec id="s3-2-4">
<title>3.2.4 Alkaloids</title>
<p>Pretreatment with the alkaloids piperine and piperlonguminine upregulated LC3-I/II in neurons compared to those without pretreatment, implying an increase in mitophagy (<xref ref-type="bibr" rid="B117">Wang et al., 2016</xref>). Nuclear factor erythroid 2-related factor 2-keap1 signaling pathways function to promote mitochondrial biogenesis and cell proliferation (<xref ref-type="bibr" rid="B12">Barone et al., 2011</xref>). The alkaloids nicotine and caffeine played a role in the activation of the nuclear factor erythroid 2-related factor 2-Keap1 and PGC-1&#x3b1; signaling pathways, thus regulating mitochondrial biogenesis (<xref ref-type="bibr" rid="B134">Zhou et al., 2019</xref>).</p>
</sec>
<sec id="s3-2-5">
<title>3.2.5 Quinones</title>
<p>Embelin, a natural benzoquinone compound, increased mtDNA levels in a dose- and time-dependent manner in N27 cells. It also caused a substantial increase in the mitochondrial biogenesis regulators of pAMPK, SIRT1, PGC1&#x3b1; and mRNA levels of its downstream targets (Nrf 1/2 and TFAM) (<xref ref-type="bibr" rid="B89">Rao et al., 2020</xref>).</p>
</sec>
<sec id="s3-2-6">
<title>3.2.6 Plant extracts</title>
<p>Incubation of PC12 cells with alkaloid component extracts from <italic>Huperzia selago</italic> and <italic>Diphasiastrum complanatum</italic> for 24&#xa0;h evoked significant upregulation of the expression of the gene for DNA polymerase &#x3b3; (Polg), which is responsible for replication of mtDNA and its repair processes (<xref ref-type="bibr" rid="B57">Lenkiewicz et al., 2016</xref>). Ginseng total protein administration led to an increase in mtDNA levels and supported mitochondrial biogenesis in PINK1<sup>B9</sup>-mutated <italic>Drosophila</italic> (<xref ref-type="bibr" rid="B64">Liu et al., 2020</xref>). <italic>Theobroma cocoa</italic> extract at a concentration of 10&#xa0;&#x3bc;g/mL produced significant upregulation of PPAR&#x3b3;, PGC1&#x3b1;, Nrf2, TFAM, and COX4 proteins in 1-methyl-4-phenyl-1,2,3,6- pyridine (MPP<sup>&#x2b;</sup>)-treated SH-SY5Y cells, mediating mitochondrial biogenesis (<xref ref-type="bibr" rid="B21">Chidambaram et al., 2020</xref>). Supplementation with <italic>Artemisia argyi</italic> extract increased LC3B expression in a dose-dependent manner in comparison with cells treated with MPP<sup>&#x2b;</sup> alone (<xref ref-type="bibr" rid="B127">Wu et al., 2022</xref>).</p>
</sec>
</sec>
<sec id="s3-3">
<title>3.3 Targeting mitochondrial dynamics</title>
<p>Mitochondria are dynamic organelles that undergo constant fusion and fission and control mitochondrial morphology, providing energy for cells, which is vital for retaining the usual mitochondrial functions as well as cell endurance (<xref ref-type="bibr" rid="B107">Suarez-Rivero et al., 2016</xref>). Mitochondrial fusion supplements enzymes and mitochondrial gene products in partially damaged mitochondria to optimize mitochondrial function and reduce the accumulation of age-related mutations in the mitochondrial genome (<xref ref-type="bibr" rid="B124">Westermann, 2012</xref>). Fission events create multiple small mitochondria and contribute to separating the fragments of damaged mitochondria from healthy mitochondria, further facilitating their clearance by mitophagy or apoptosis when under high levels of cellular stress (<xref ref-type="bibr" rid="B110">Twig et al., 2008</xref>; <xref ref-type="bibr" rid="B61">Lin et al., 2018</xref>). Several GTPases mediate mitochondrial dynamics, such as mitochondrial fission 1 (Fis1) and dynamin-related protein-1 (Drp1) for fission in the cytoplasm and mitofusions (Mfn1 and Mfn2) and Optic Atrophy-1 (Opa1) for fusion located on the mitochondrial membrane (<xref ref-type="bibr" rid="B132">Zhang et al., 2021</xref>). In addition, the balance between mitochondrial fusion and fission events has been reported to be regulated by PGC-1&#x3b1; and 1&#x3b2; (<xref ref-type="bibr" rid="B95">Scarpulla, 2011</xref>). Unbalanced fusion and fission occur in PD with increased fragmented mitochondria or aberrant expression of related genes, and ultimately increased oxidative stress (<xref ref-type="bibr" rid="B49">Kim et al., 2018</xref>; <xref ref-type="bibr" rid="B61">Lin et al., 2018</xref>) (<xref ref-type="bibr" rid="B19">Chandra et al., 2019</xref>).</p>
<sec id="s3-3-1">
<title>3.3.1 Flavanoids</title>
<p>Silibinin administration to MPTP-treated mice restored mitochondrial dynamic disorder by decreasing Drp1 expression and increasing Mfn1 expression in the hippocampus (<xref ref-type="bibr" rid="B67">Liu et al., 2021b</xref>). Quercetin attenuated aluminum-induced mitochondrial swelling, loss of cristae and chromatin condensation and restored the size of mitochondria to normality in the aluminum-treated rat hippocampus, improving mitochondrial integrity and function (<xref ref-type="bibr" rid="B100">Sharma et al., 2016</xref>).</p>
</sec>
<sec id="s3-3-2">
<title>3.3.2 Phenols and polyphenols</title>
<p>Resveratrol pretreatment reversed high percentages of short and fragmented mitochondria in rotenone-exposed SH-SY5Y cells (<xref ref-type="bibr" rid="B61">Lin et al., 2018</xref>). Oleuropein, a polyphenolic compound extracted from <italic>F. rhynchophylla,</italic> amended a glutamate-induced mitochondrial dynamic imbalance and reduced the number of cells with fragmented mitochondria, regulating the phosphorylation of Drp1 at amino acid residue serine 637 (<xref ref-type="bibr" rid="B49">Kim et al., 2018</xref>). MPTP promoted Drp1 translocation to mitochondria. However, mangiferin (10 and 40&#xa0;mg/kg) markedly inhibited this effect to prevent MPTP-induced excessive mitochondrial fission with reversed expression of mitophagic proteins, including PINK1, Parkin, NIX, BNIP3, FUNDC1 and p62, and mitigated mitochondria with a disrupted and swollen structure, vague mitochondrial cristae, and condensate matrix (<xref ref-type="bibr" rid="B119">Wang et al., 2022</xref>).</p>
</sec>
<sec id="s3-3-3">
<title>3.3.3 Plant extracts</title>
<p>Treatment with 0.1% standardized methanolic extract of <italic>Mucuna pruriens</italic> seeds significantly reduced the number of damaged, swollen and clearly fragmented mitochondria in presynaptic boutons of antennal lobes of PINK1<sup>B9</sup> mutant flies compared with untreated mutants (<xref ref-type="bibr" rid="B82">Poddighe et al., 2014</xref>). 4-Hydroxyisophthalic acid is a bioactive component extracted from the roots of <italic>Decalepis hamiltonii</italic>. Fragmented mitochondrial cristae caused by paraquat exposure could be markedly reduced in the brains of flies fed 4-hydroxyisophthalic acid (<xref ref-type="bibr" rid="B78">Niveditha and Shivanandappa, 2018</xref>). Pretreatment with cocoa (10&#xa0;&#x3bc;g/mL) extract downregulated the expression of mitochondrial Fis1 and upregulated the expression of Mfn2 proteins to balance mitochondrial dynamics in SH-SY5Y cells (<xref ref-type="bibr" rid="B21">Chidambaram et al., 2020</xref>). Artemisia leaf extract downregulated mitochondrial fission proteins (Drp1 and p-Drp1) and protected the mitochondria (<xref ref-type="bibr" rid="B127">Wu et al., 2022</xref>).</p>
</sec>
</sec>
<sec id="s3-4">
<title>3.4 Targeting mitochondrial apoptosis</title>
<p>Mitochondria are crucial to the regulation of intrinsic apoptosis. In the mitochondrial apoptotic pathway, the antiapoptotic Bcl-2 and proapoptotic Bax/Bak markers have a primary role. Bax and Bak can be activated and accumulate at the outer mitochondrial membrane (<xref ref-type="bibr" rid="B26">Debatin et al., 2002</xref>). Then, they oligomerize and create multimeric pore complexes that alter the permeability of the outer mitochondrial membrane sufficiently, and induce leakage and overactivation of Cytochrome C (Cyt-c) (<xref ref-type="bibr" rid="B41">Jin et al., 2021</xref>). Cyt-c is an important mediator in the mitochondrial-associated pathway, which ultimately leads to activation of caspases (<xref ref-type="bibr" rid="B6">Badshah et al., 2015</xref>). Inappropriate mitochondrial apoptosis is a crucial process causing neurotoxicity in PD. Thus, a variety of natural products inhibit mitochondrial apoptosis to exert neuroprotective effects by regulating related molecules.</p>
<sec id="s3-4-1">
<title>3.4.1 Flavanoids</title>
<p>Baicalein inhibited the rotenone-induced increase in caspase-3 activity and significantly prevented rotenone-induced cleaved caspase-3 protein expression in mice (<xref ref-type="bibr" rid="B53">Kuang et al., 2017</xref>). Quercetin significantly reduced the Bax/Bcl-2 ratio and prevented the release of Cyt-c and subsequent activation of caspase-3, protecting the hippocampal region of the rat brain (<xref ref-type="bibr" rid="B100">Sharma et al., 2016</xref>). Pretreatment with naringenin increased the antiapoptotic protein Bcl-2 while decreasing the proapoptotic protein Bax and inhibited the MG-triggered release of Cyt-c from the mitochondria to the cytosol in SH-SY5Y cells. Meanwhile, it also significantly attenuated proapoptotic enzyme caspase-3/9 activation (<xref ref-type="bibr" rid="B24">de Oliveira et al., 2019</xref>). In addition, calycosin supplements alleviate paraquat -induced neurodegeneration by suppressing JNK phosphorylation and caspase-3 activation, which is responsible for DA neuronal cell death in exposed organisms (<xref ref-type="bibr" rid="B20">Chaouhan et al., 2022</xref>).</p>
</sec>
<sec id="s3-4-2">
<title>3.4.2 Phenols and polyphenols</title>
<p>Glutamate treatment induced a decrease in Bcl-2 and an increase in Bax compared to control HT-22 cells. However, pretreatment with oleuropein maintained Bax/Bcl-2 expression levels in HT-22 cells exposed to glutamate treatment (<xref ref-type="bibr" rid="B49">Kim et al., 2018</xref>). Mangiferin prevented the increase in the expression of cytosolic Cyt-c and caspase-3/9 observed in rotenone -treated SK-N-SH cells (<xref ref-type="bibr" rid="B43">Kavitha et al., 2014</xref>). Green tea polyphenols increased the dysfunction of the mitochondrial apoptosis-related protein Bcl-2 and decreased Bax and caspase-3. When neurons were incubated with siBcl-2, the neuroprotective effect was abrogated (<xref ref-type="bibr" rid="B23">Cong et al., 2016</xref>). In rotenone-treated SH-SY5Y cells, the expression of Bax, Bad, caspase-3, caspase-6, caspase-8, and caspase-9 in mitochondria and Cyt-c in the cytosol was increased, whereas the distribution of Bcl-2, Bcl-xL and Cyt-c in mitochondria was significantly decreased. Pretreatment of cells with demethoxycurcumin gradually restored the excessive expression of these proteins (<xref ref-type="bibr" rid="B88">Ramkumar et al., 2017</xref>).</p>
</sec>
<sec id="s3-4-3">
<title>3.4.3 Terpenoids</title>
<p>Caspase 3 activity and Cyt-c release into the cytosol were found to be decreased following dose-dependent treatment with mogroside V, indicating that mogroside V inhibited mitochondrial apoptosis (<xref ref-type="bibr" rid="B71">Luo et al., 2022</xref>).</p>
</sec>
<sec id="s3-4-4">
<title>3.4.4 Glycosides</title>
<p>Astragalus polysaccharide played a role in MPTP-induced PD mice by increasing Bcl-2 and decreasing the expression of Bax, Cyt-c, pro-caspase-3, and caspase-3 protein significantly compared with the control group (<xref ref-type="bibr" rid="B63">Liu H. et al., 2018</xref>).</p>
</sec>
<sec id="s3-4-5">
<title>3.4.5 Alkaloids</title>
<p>MN9D cells exposed to the alkaloids piperine and piperlonguminine prior to rotenone application had lower cytosolic Cyt-c levels than cells treated with rotenone only, which indicated that the apoptosis induced by rotenone was inhibited (<xref ref-type="bibr" rid="B117">Wang et al., 2016</xref>).</p>
</sec>
<sec id="s3-4-6">
<title>3.4.6 Alkenes</title>
<p>Isolongifolene is a novel tricyclic sesquiterpene compound isolated from the herb <italic>Murraya koenigii</italic>. The biochemical effects of mitochondrial apoptosis in rotenone-treated rats were mitigated by isolongifolene (10&#xa0;mg/kg), which increased the expression of anti-apoptotic Bcl-2, reduced the expression of pro-apoptotic Bax, inhibited Cyt-c release from mitochondria, and reduced the activation of caspases (<xref ref-type="bibr" rid="B11">Balakrishnan et al., 2021</xref>).</p>
</sec>
<sec id="s3-4-7">
<title>3.4.6 Plant extracts</title>
<p>Plant extracts also have outstanding effects on hindering mitochondrial apoptosis. Many natural product extracts regulated apoptosis by inhibiting the activity of caspase-3/9, including the water extract of the Edible bird&#x2019;s nest (<xref ref-type="bibr" rid="B131">Yew et al., 2014</xref>), ethanol and hexane extracts of <italic>C. grandifolia</italic> leaves (<xref ref-type="bibr" rid="B46">Kich et al., 2016</xref>), extracts of seaweeds (<italic>S. muticum</italic>, <italic>C. tomentosum</italic>, <italic>Padina pavonica</italic>, <italic>U. compressa</italic>) (<xref ref-type="bibr" rid="B102">Silva et al., 2018</xref>), and extracts <italic>of Echium amoenum</italic> petals (<xref ref-type="bibr" rid="B94">Sadeghi et al., 2018</xref>). <italic>Ganoderma lucidum</italic> extract and <italic>Z. spinachristi</italic> fruit extract suppressed the activation of caspase-3/9 and Cyt-c release from mitochondria into the cytoplasm (<xref ref-type="bibr" rid="B105">Singh et al., 2018</xref>; <xref ref-type="bibr" rid="B91">Ren et al., 2019</xref>). In addition, many plant extracts significantly upregulated the level of anti-apoptotic Bcl-2, downregulated the level of pro-apoptotic Bax and caspase-3/9 and blocked Cyt-c release into the cytosol, thereby alleviating neuronal loss, including the root bark extract of <italic>Paeonia suffruticosa</italic>, stem bark extract of <italic>E. ulmoides</italic>, and fruit extract of <italic>M. citrifolia</italic> (<xref ref-type="bibr" rid="B47">Kim et al., 2014</xref>; <xref ref-type="bibr" rid="B56">Kwon et al., 2014</xref>; <xref ref-type="bibr" rid="B51">Kishore Kumar et al., 2017</xref>). <italic>Theobroma cocoa</italic> extract increased the expression of the antiapoptotic protein Bcl-2 (<xref ref-type="bibr" rid="B21">Chidambaram et al., 2020</xref>). Additionally, pretreatment with the methanol extract of <italic>Humulus japonicus</italic> (100 and 200&#xa0;&#x3bc;g/mL) significantly decreased the expression of cleaved PARP, cleaved caspase-9 and cleaved caspase-3. Meanwhile, Cyt-c release from the mitochondria to the cytosol was also significantly suppressed (<xref ref-type="bibr" rid="B93">Ryu et al., 2017</xref>). The incubation of SH-SY5Y cells with 6-OHDA significantly upregulated Bax and p53 proteins as well as downregulated Bcl-2 protein and the activity of caspase-3, which were significantly counteracted by preexposure to bergamot juice at both 0.5% and 1% concentrations (<xref ref-type="bibr" rid="B30">Ferlazzo et al., 2020</xref>).</p>
</sec>
</sec>
<sec id="s3-5">
<title>3.5 Other effects</title>
<p>As the study demonstrated, <italic>G. lucidum</italic> extract treatment could regulate mitochondrial mobility by increasing and decreasing the speed in the anterograde and retrograde directions, respectively (<xref ref-type="bibr" rid="B91">Ren et al., 2019</xref>). Pretreatment of SK-N-SH cells with the alkaloids piperine and piperlonguminine blocked the opening of the mitochondrial permeability transition pore (<xref ref-type="bibr" rid="B117">Wang et al., 2016</xref>).</p>
</sec>
</sec>
<sec id="s4">
<title>4 Toxicology studies of several natural products</title>
<p>Previous <italic>in vitro</italic> and clinical studies have shown that most natural compounds have no significant toxic effects within the concentration range of administration in PD (<xref ref-type="bibr" rid="B53">Kuang et al., 2017</xref>; <xref ref-type="bibr" rid="B27">Ding et al., 2020</xref>; <xref ref-type="bibr" rid="B1">Ahmad et al., 2021</xref>). Baicalein is not mutagenic or genotoxic and showed safety profile in preclinical and clinical toxicity studies. In a Phase I, randomized, double-blind, single-dose trial, baicalein was safe with no signs of toxicity at oral doses of 100&#x2013;2,800&#xa0;mg in healthy humans (<xref ref-type="bibr" rid="B130">Yarla et al., 2016</xref>). Silybin, silydianin, and silychristin were not cytotoxic or genotoxic at a concentration of 100&#xa0;&#x3bc;M. Silymarin is safe in humans at therapeutic doses and is well tolerated even at a high dose of 700&#xa0;mg three times a day for 24&#xa0;weeks (<xref ref-type="bibr" rid="B106">Soleimani et al., 2019</xref>).</p>
<p>Natural components have high safety and serve neuroprotective roles through multiple molecular pathways. However, for this reason, when they are pharmacologically active, they exert nonspecific off-target effects on normal tissues. The toxic effects of natural products vary with the biological species and route of administration. Additionally, several natural compounds may transform into toxic substances in the process of metabolism. Therefore, side effects cannot be neglected while achieving therapeutic efficacy. Quercetin is a flavonoid that can form a semiquinone in the metabolic process, thus causing cytotoxicity (<xref ref-type="bibr" rid="B73">Metodiewa D et al., 1999</xref>). When several flavonoids such as naringin, and quercetin were detected, quercetin showed mutagenicity, and mutagenic activity could be detected (<xref ref-type="bibr" rid="B16">Bjeldanes and Chang., 1977</xref>). 945&#xa0;mg/m<sup>2</sup> was a safe dose of quercetin, while some patients exhibited emesis, hypertension, nephrotoxicity, and decreased serum potassium with its higher dose (<xref ref-type="bibr" rid="B33">Ferry DR et al., 1996</xref>; <xref ref-type="bibr" rid="B9">Bai et al., 2023</xref>). It has been reported that high dose curcumin induced apoptosis of normal human lymphocytes and noncancer cell lines (<xref ref-type="bibr" rid="B58">Li W et al., 2017</xref>; <xref ref-type="bibr" rid="B28">Eguchi et al., 2022</xref>). Nephrotoxic toxicity and gastrointestinal problems were detected after administration of resveratrol (<xref ref-type="bibr" rid="B108">Talib et al., 2022</xref>). Ursolic acid may cause liver injury at higher doses of 74, 98, and 130&#xa0;mg/m<sup>2</sup> with some patients exhibiting diarrhoea and elevated serum activity of aspartate aminotransferase, alanine aminotransferase and c-glu-tamyltransferase (<xref ref-type="bibr" rid="B118">Wang XH et al., 2013</xref>). In particular, piperine was related to decreased serum protein and increased levels of aspartate aminotransferase and alkaline phosphatase in rats, suggestive of the hepatotoxicity of piperine (<xref ref-type="bibr" rid="B9">Bai et al., 2023</xref>). Oral administration of anthraquinones can cause different side effects. It has been reported that a short-term toxicity of 6&#xa0;weeks of 120&#xa0;mg/kg oral administration was observed in female rats including disintegration, necrotic changes, and perinuclear vacuolation in the liver and kidney, which were relieved after embelin discontinuance (<xref ref-type="bibr" rid="B83">Poojari, 2014</xref>). When the animals received 5.44&#xa0;mg/kg body weight or more of anthraquinone, acute and subchronic oral toxicity of anthraquinones including anemia and hypothyroidism, was observed in both the male and female rats (<xref ref-type="bibr" rid="B87">Qu et al., 2022</xref>).</p>
</sec>
<sec id="s5">
<title>5 Conclusion and outlook</title>
<p>Here, we presented studies of the neuroprotective effects of multiple natural products by targeting PD mitochondrial dysfunction. Targeting mitochondrial dysfunction is quite important for PD therapeutics, in which various kinds of natural products can play a part. Not only can pure natural products that cover diversiform structures ameliorate mitochondrial damage, but plant extracts sustaining variant components can also come into play; thus, the treatment and improvement of PD disease by natural products can be realized. As summarized above, the pharmacological mechanisms of natural products mainly include regulating mitochondrial respiration, dynamics, apoptosis, biogenesis and mitophagy. Most natural products (such as varieties of flavonoids, polyphenols, terpenoids, <italic>etc.</italic>) can regulate mitochondrial respiration through the production of ATP, maintenance of MMP and so on. Furthermore, in apoptosis, natural products also exert significant effects by regulating related apoptotic proteins. However, on the sides of dynamics, biogenesis and mitophagy, there are relatively few reports and in-depth investigations. In addition, it is essential to emphasize that it is difficult to illustrate the explicit structure-bioactivity relationship between natural products with structural diversity and PD established on different experimental models.</p>
<p>While many natural products have shown potential to treat PD, there are currently some limitations and challenges. First, many natural products can only be studied <italic>in vitro</italic> or in animal trials, and more clinical trials are needed to demonstrate their efficacy and safety in humans with Parkinson&#x2019;s disease. In addition, the efficacy and dosage of natural products are not stable, which brings some risks to the treatment of PD. In order to overcome these limitations and challenges, future research requires more basic experimental studies to gain insight into the mechanism of action of natural products on mitochondrial dysfunction. In addition, more clinical studies are needed to evaluate the safety of natural products and their efficacy in treating human PD. Some of the best natural products can be synthesized and yield more stable, safe and controllable therapeutic doses, which will be a priority for future research.</p>
<p>In conclusion, natural products have great potential to be developed into new drugs for PD with exact effects on mitochondrial dysfunction. Substances of natural origins seem to be accepted more easily by patients since they are considered healthier than fully synthetic drugs. It is necessary to conduct further studies on the related mitochondrial dysfunction mechanisms of PD and other preclinical and clinical studies.</p>
</sec>
</body>
<back>
<sec id="s6">
<title>Author contributions</title>
<p>WW and TH guided the scope and research background of the research, and wrote the manuscript. TH and XL wrote the original version of this manuscript. AS and YZ performed the figures. ZX, LM, TW, and ZL critically revised the manuscript. All authors listed have made a substantial, direct, and intellectual contribution to the work and approved it for publication. All authors contributed to the article and approved the submitted version.</p>
</sec>
<sec id="s7">
<title>Funding</title>
<p>This work was financially supported by the Support Program for Science and Technology Department of Sichuan Province (No. 2021YFS0230) and the Clinical Research Incubation Program of West China Hospital (No. 19HXFH010).</p>
</sec>
<sec sec-type="COI-statement" id="s8">
<title>Conflict of interest</title>
<p>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</p>
</sec>
<sec sec-type="disclaimer" id="s9">
<title>Publisher&#x2019;s note</title>
<p>All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.</p>
</sec>
<ref-list>
<title>References</title>
<ref id="B1">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ahmad</surname>
<given-names>M. H.</given-names>
</name>
<name>
<surname>Fatima</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Ali</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Rizvi</surname>
<given-names>M. A.</given-names>
</name>
<name>
<surname>Mondal</surname>
<given-names>A. C.</given-names>
</name>
</person-group> (<year>2021</year>). <article-title>Naringenin alleviates paraquat-induced dopaminergic neuronal loss in SH-SY5Y cells and a rat model of Parkinson&#x27;s disease</article-title>. <source>Neuropharmacology</source> <volume>201</volume>, <fpage>108831</fpage>. <pub-id pub-id-type="doi">10.1016/j.neuropharm.2021.108831</pub-id>
</citation>
</ref>
<ref id="B2">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ahn</surname>
<given-names>B. H.</given-names>
</name>
<name>
<surname>Kim</surname>
<given-names>H. S.</given-names>
</name>
<name>
<surname>Song</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Lee</surname>
<given-names>I. H.</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Vassilopoulos</surname>
<given-names>A.</given-names>
</name>
<etal/>
</person-group> (<year>2008</year>). <article-title>A role for the mitochondrial deacetylase Sirt3 in regulating energy homeostasis</article-title>. <source>Proc. Natl. Acad. Sci. U. S. A.</source> <volume>105</volume> (<issue>38</issue>), <fpage>14447</fpage>&#x2013;<lpage>14452</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.0803790105</pub-id>
</citation>
</ref>
<ref id="B3">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ali</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Badshah</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Kim</surname>
<given-names>T. H.</given-names>
</name>
<name>
<surname>Kim</surname>
<given-names>M. O.</given-names>
</name>
</person-group> (<year>2015</year>). <article-title>Melatonin attenuates D-galactose-induced memory impairment, neuroinflammation and neurodegeneration via RAGE/NF-K B/JNK signaling pathway in aging mouse model</article-title>. <source>J. Pineal Res.</source> <volume>58</volume> (<issue>1</issue>), <fpage>71</fpage>&#x2013;<lpage>85</lpage>. <pub-id pub-id-type="doi">10.1111/jpi.12194</pub-id>
</citation>
</ref>
<ref id="B4">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ashrafi</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Schwarz</surname>
<given-names>T. L.</given-names>
</name>
</person-group> (<year>2013</year>). <article-title>The pathways of mitophagy for quality control and clearance of mitochondria</article-title>. <source>Cell Death Differ.</source> <volume>20</volume> (<issue>1</issue>), <fpage>31</fpage>&#x2013;<lpage>42</lpage>. <pub-id pub-id-type="doi">10.1038/cdd.2012.81</pub-id>
</citation>
</ref>
<ref id="B5">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ay</surname>
<given-names>M.</given-names>
</name>
</person-group> (<year>2022</year>). <article-title>Vanillic acid induces mitochondrial biogenesis in SH-SY5Y cells</article-title>. <source>Mol. Biol. Rep.</source> <volume>49</volume> (<issue>6</issue>), <fpage>4443</fpage>&#x2013;<lpage>4449</lpage>. <pub-id pub-id-type="doi">10.1007/s11033-022-07284-6</pub-id>
</citation>
</ref>
<ref id="B6">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Badshah</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Ali</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Kim</surname>
<given-names>M. J.</given-names>
</name>
<name>
<surname>Kim</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Abid</surname>
<given-names>N. B.</given-names>
</name>
<name>
<surname>Shah</surname>
<given-names>S. A.</given-names>
</name>
<etal/>
</person-group> (<year>2015</year>). <article-title>Co-treatment with anthocyanins and vitamin C ameliorates ethanol- induced neurodegeneration via modulation of GABAB receptor signaling in the adult rat brain</article-title>. <source>CNS neurological Disord. drug targets</source> <volume>14</volume> (<issue>6</issue>), <fpage>791</fpage>&#x2013;<lpage>803</lpage>. <pub-id pub-id-type="doi">10.2174/1871527314666150225142919</pub-id>
</citation>
</ref>
<ref id="B7">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Badshah</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Ali</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Kim</surname>
<given-names>M. O.</given-names>
</name>
</person-group> (<year>2016</year>). <article-title>Osmotin attenuates LPS-induced neuroinflammation and memory impairments via the TLR4/NF&#x3ba;B signaling pathway</article-title>. <source>Sci. Rep.</source> <volume>6</volume>, <fpage>24493</fpage>. <pub-id pub-id-type="doi">10.1038/srep24493</pub-id>
</citation>
</ref>
<ref id="B8">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bai</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Ding</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Kong</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Xin</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Yang</surname>
<given-names>X.</given-names>
</name>
<etal/>
</person-group> (<year>2020</year>). <article-title>Polydatin protects SH-SY5Y in models of Parkinson&#x27;s disease by promoting Atg5-mediated but parkin-independent autophagy</article-title>. <source>Neurochem. Int.</source> <volume>134</volume>, <fpage>104671</fpage>. <pub-id pub-id-type="doi">10.1016/j.neuint.2020.104671</pub-id>
</citation>
</ref>
<ref id="B9">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bai</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Bian</surname>
<given-names>Z.</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>M.</given-names>
</name>
</person-group> (<year>2023</year>). <article-title>Targeting the Nrf2 signaling pathway using phytochemical ingredients: A novel therapeutic road map to combat neurodegenerative diseases</article-title>. <source>Phytomedicine</source> <volume>109</volume>, <fpage>154582</fpage>. <pub-id pub-id-type="doi">10.1016/j.phymed.2022.154582</pub-id>
</citation>
</ref>
<ref id="B10">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bakala</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Hamelin</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Mary</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Borot-Laloi</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Friguet</surname>
<given-names>B.</given-names>
</name>
</person-group> (<year>2012</year>). <article-title>Catalase, a target of glycation damage in rat liver mitochondria with aging</article-title>. <source>Biochim. Biophys. Acta</source> <volume>1822</volume> (<issue>10</issue>), <fpage>1527</fpage>&#x2013;<lpage>1534</lpage>. <pub-id pub-id-type="doi">10.1016/j.bbadis.2012.05.016</pub-id>
</citation>
</ref>
<ref id="B11">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Balakrishnan</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Vijayraja</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Mohankumar</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Manimaran</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Ganesan</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Choi</surname>
<given-names>D. K.</given-names>
</name>
<etal/>
</person-group> (<year>2021</year>). <article-title>Isolongifolene mitigates rotenone-induced dopamine depletion and motor deficits through anti-oxidative and anti-apoptotic effects in a rat model of Parkinson&#x27;s disease</article-title>. <source>J. Chem. Neuroanat.</source> <volume>112</volume>, <fpage>101890</fpage>. <pub-id pub-id-type="doi">10.1016/j.jchemneu.2020.101890</pub-id>
</citation>
</ref>
<ref id="B12">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Barone</surname>
<given-names>M. C.</given-names>
</name>
<name>
<surname>Sykiotis</surname>
<given-names>G. P.</given-names>
</name>
<name>
<surname>Bohmann</surname>
<given-names>D.</given-names>
</name>
</person-group> (<year>2011</year>). <article-title>Genetic activation of Nrf2 signaling is sufficient to ameliorate neurodegenerative phenotypes in a Drosophila model of Parkinson&#x27;s disease</article-title>. <source>Dis. Model Mech.</source> <volume>4</volume> (<issue>5</issue>), <fpage>701</fpage>&#x2013;<lpage>707</lpage>. <pub-id pub-id-type="doi">10.1242/dmm.007575</pub-id>
</citation>
</ref>
<ref id="B13">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bhat</surname>
<given-names>A. H.</given-names>
</name>
<name>
<surname>Dar</surname>
<given-names>K. B.</given-names>
</name>
<name>
<surname>Anees</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Zargar</surname>
<given-names>M. A.</given-names>
</name>
<name>
<surname>Masood</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Sofi</surname>
<given-names>M. A.</given-names>
</name>
<etal/>
</person-group> (<year>2015</year>). <article-title>Oxidative stress, mitochondrial dysfunction and neurodegenerative diseases; a mechanistic insight</article-title>. <source>Biomed. Pharmacother.</source> <volume>74</volume>, <fpage>101</fpage>&#x2013;<lpage>110</lpage>. <pub-id pub-id-type="doi">10.1016/j.biopha.2015.07.025</pub-id>
</citation>
</ref>
<ref id="B14">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bhattacharjee</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Borah</surname>
<given-names>A.</given-names>
</name>
</person-group> (<year>2016</year>). <article-title>Oxidative stress and mitochondrial dysfunction are the underlying events of dopaminergic neurodegeneration in homocysteine rat model of Parkinson&#x27;s disease</article-title>. <source>Neurochem. Int.</source> <volume>101</volume>, <fpage>48</fpage>&#x2013;<lpage>55</lpage>. <pub-id pub-id-type="doi">10.1016/j.neuint.2016.10.001</pub-id>
</citation>
</ref>
<ref id="B15">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bindhu</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Das</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Sakthivel</surname>
<given-names>K. M.</given-names>
</name>
</person-group> (<year>2020</year>). <article-title>Anthraquinone from edible fungi Pleurotus ostreatus protects human SH-SY5Y neuroblastoma cells against 6-hydroxydopamine-induced cell death-preclinical validation of gene knockout possibilities of PARK7, PINK1, and SNCA1 using CRISPR SpCas9</article-title>. <source>Appl. Biochem. Biotechnol.</source> <volume>191</volume> (<issue>2</issue>), <fpage>555</fpage>&#x2013;<lpage>566</lpage>. <pub-id pub-id-type="doi">10.1007/s12010-019-03188-7</pub-id>
</citation>
</ref>
<ref id="B16">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bjeldanes</surname>
<given-names>L. .F.</given-names>
</name>
<name>
<surname>Chang</surname>
<given-names>G. .W.</given-names>
</name>
</person-group> (<year>1977</year>). <article-title>Mutagenic activity of quercetin and related compounds</article-title>. <source>Science</source> <volume>197</volume> (<issue>4303</issue>), <fpage>577</fpage>&#x2013;<lpage>578</lpage>. <pub-id pub-id-type="doi">10.1126/science.327550</pub-id>
</citation>
</ref>
<ref id="B17">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Blauwendraat</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Nalls</surname>
<given-names>M. A.</given-names>
</name>
<name>
<surname>Singleton</surname>
<given-names>A. B.</given-names>
</name>
</person-group> (<year>2020</year>). <article-title>The genetic architecture of Parkinson&#x27;s disease</article-title>. <source>Lancet Neurol.</source> <volume>19</volume> (<issue>2</issue>), <fpage>170</fpage>&#x2013;<lpage>178</lpage>. <pub-id pub-id-type="doi">10.1016/S1474-4422(19)30287-X</pub-id>
</citation>
</ref>
<ref id="B18">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Casarejos</surname>
<given-names>M. J.</given-names>
</name>
<name>
<surname>Perucho</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Gomez</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Munoz</surname>
<given-names>M. P.</given-names>
</name>
<name>
<surname>Fernandez-Estevez</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Sagredo</surname>
<given-names>O.</given-names>
</name>
<etal/>
</person-group> (<year>2013</year>). <article-title>Natural cannabinoids improve dopamine neurotransmission and tau and amyloid pathology in a mouse model of tauopathy</article-title>. <source>J. Alzheimers Dis.</source> <volume>35</volume> (<issue>3</issue>), <fpage>525</fpage>&#x2013;<lpage>539</lpage>. <pub-id pub-id-type="doi">10.3233/JAD-130050</pub-id>
</citation>
</ref>
<ref id="B19">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Chandra</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Shenoi</surname>
<given-names>R. A.</given-names>
</name>
<name>
<surname>Anand</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Rajamma</surname>
<given-names>U.</given-names>
</name>
<name>
<surname>Mohanakumar</surname>
<given-names>K. P.</given-names>
</name>
</person-group> (<year>2019</year>). <article-title>Reinforcing mitochondrial functions in aging brain: An insight into Parkinson&#x27;s disease therapeutics</article-title>. <source>J. Chem. Neuroanat.</source> <volume>95</volume>, <fpage>29</fpage>&#x2013;<lpage>42</lpage>. <pub-id pub-id-type="doi">10.1016/j.jchemneu.2017.12.004</pub-id>
</citation>
</ref>
<ref id="B137">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Chandran</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Muralidhara</surname>
</name>
</person-group> (<year>2013</year>). <article-title>Neuroprotective effect of aqueous extract of Selaginella delicatula as evidenced by abrogation of rotenone-induced motor deficits, oxidative dysfunctions, and neurotoxicity in mice</article-title>. <source>Cell Mol. Neurobiol.</source> <volume>33 (7)</volume>, <fpage>929</fpage>&#x2013;<lpage>942</lpage>. <pub-id pub-id-type="doi">10.1007/s10571-013-9959-y</pub-id>
</citation>
</ref>
<ref id="B20">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Chaouhan</surname>
<given-names>H. S.</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Sun</surname>
<given-names>K. T.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>I. K.</given-names>
</name>
<name>
<surname>Yu</surname>
<given-names>T. M.</given-names>
</name>
<name>
<surname>Yu</surname>
<given-names>S. H.</given-names>
</name>
<etal/>
</person-group> (<year>2022</year>). <article-title>Calycosin alleviates paraquat-induced neurodegeneration by improving mitochondrial functions and regulating autophagy in a Drosophila model of Parkinson&#x27;s disease</article-title>. <source>Antioxidants (Basel)</source> <volume>11</volume> (<issue>2</issue>), <fpage>222</fpage>. <pub-id pub-id-type="doi">10.3390/antiox11020222</pub-id>
</citation>
</ref>
<ref id="B21">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Chidambaram</surname>
<given-names>S. B.</given-names>
</name>
<name>
<surname>Bhat</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Ray</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Sugumar</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Muthukumar</surname>
<given-names>S. P.</given-names>
</name>
<name>
<surname>Manivasagam</surname>
<given-names>T.</given-names>
</name>
<etal/>
</person-group> (<year>2020</year>). <article-title>Cocoa beans improve mitochondrial biogenesis via PPAR&#x3b3;/PGC1&#x3b1; dependent signalling pathway in MPP&#x2b; intoxicated human neuroblastoma cells (SH-SY5Y)</article-title>. <source>Nutr. Neurosci.</source> <volume>23</volume> (<issue>6</issue>), <fpage>471</fpage>&#x2013;<lpage>480</lpage>. <pub-id pub-id-type="doi">10.1080/1028415X.2018.1521088</pub-id>
</citation>
</ref>
<ref id="B22">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Choi</surname>
<given-names>B. S.</given-names>
</name>
<name>
<surname>Kim</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Lee</surname>
<given-names>H. J.</given-names>
</name>
<name>
<surname>Sapkota</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Park</surname>
<given-names>S. E.</given-names>
</name>
<name>
<surname>Kim</surname>
<given-names>S.</given-names>
</name>
<etal/>
</person-group> (<year>2014</year>). <article-title>Celastrol from &#x27;Thunder God Vine&#x27; protects SH-SY5Y cells through the preservation of mitochondrial function and inhibition of p38 MAPK in a rotenone model of Parkinson&#x27;s disease</article-title>. <source>Neurochem. Res.</source> <volume>39</volume> (<issue>1</issue>), <fpage>84</fpage>&#x2013;<lpage>96</lpage>. <pub-id pub-id-type="doi">10.1007/s11064-013-1193-y</pub-id>
</citation>
</ref>
<ref id="B23">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Cong</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Cao</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Cheng</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Qin</surname>
<given-names>X. Y.</given-names>
</name>
</person-group> (<year>2016</year>). <article-title>Green tea polyphenols attenuated glutamate excitotoxicity via antioxidative and antiapoptotic pathway in the primary cultured cortical neurons</article-title>. <source>Oxid. Med. Cell Longev.</source> <volume>2016</volume>, <fpage>2050435</fpage>. <pub-id pub-id-type="doi">10.1155/2016/2050435</pub-id>
</citation>
</ref>
<ref id="B24">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>de Oliveira</surname>
<given-names>M. R.</given-names>
</name>
<name>
<surname>Custodio de Souza</surname>
<given-names>I. C.</given-names>
</name>
<name>
<surname>Furstenau</surname>
<given-names>C. R.</given-names>
</name>
</person-group> (<year>2019</year>). <article-title>Promotion of mitochondrial protection by naringenin in methylglyoxal-treated SH-SY5Y cells: Involvement of the Nrf2/GSH axis</article-title>. <source>Chem. Biol. Interact.</source> <volume>310</volume>, <fpage>108728</fpage>. <pub-id pub-id-type="doi">10.1016/j.cbi.2019.108728</pub-id>
</citation>
</ref>
<ref id="B25">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>de Rus Jacquet</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Ambaw</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Tambe</surname>
<given-names>M. A.</given-names>
</name>
<name>
<surname>Ma</surname>
<given-names>S. Y.</given-names>
</name>
<name>
<surname>Timmers</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Grace</surname>
<given-names>M. H.</given-names>
</name>
<etal/>
</person-group> (<year>2021</year>). <article-title>Neuroprotective mechanisms of red clover and soy isoflavones in Parkinson&#x27;s disease models</article-title>. <source>Food Funct.</source> <volume>12</volume> (<issue>23</issue>), <fpage>11987</fpage>&#x2013;<lpage>12007</lpage>. <pub-id pub-id-type="doi">10.1039/d1fo00007a</pub-id>
</citation>
</ref>
<ref id="B26">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Debatin</surname>
<given-names>K. M.</given-names>
</name>
<name>
<surname>Poncet</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Kroemer</surname>
<given-names>G.</given-names>
</name>
</person-group> (<year>2002</year>). <article-title>Chemotherapy: Targeting the mitochondrial cell death pathway</article-title>. <source>Oncogene</source> <volume>21</volume> (<issue>57</issue>), <fpage>8786</fpage>&#x2013;<lpage>8803</lpage>. <pub-id pub-id-type="doi">10.1038/sj.onc.1206039</pub-id>
</citation>
</ref>
<ref id="B27">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ding</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Kong</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Zhou</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Yang</surname>
<given-names>N. D.</given-names>
</name>
<name>
<surname>Xin</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Xu</surname>
<given-names>J.</given-names>
</name>
<etal/>
</person-group> (<year>2020</year>). <article-title>&#x3b1;-Arbutin protects against Parkinson&#x27;s disease-associated mitochondrial dysfunction <italic>in vitro</italic> and <italic>in vivo</italic>
</article-title>. <source>Neuromolecular Med.</source> <volume>22</volume> (<issue>1</issue>), <fpage>56</fpage>&#x2013;<lpage>67</lpage>. <pub-id pub-id-type="doi">10.1007/s12017-019-08562-6</pub-id>
</citation>
</ref>
<ref id="B28">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Eguchi</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Damyar</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Alexander</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Dafoe</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Lakey</surname>
<given-names>J. R. T.</given-names>
</name>
<name>
<surname>Ichii</surname>
<given-names>H.</given-names>
</name>
</person-group> (<year>2022</year>). <article-title>Anti-oxidative therapy in islet cell transplantation</article-title>. <source>Antioxidants (Basel)</source> <volume>11</volume> (<issue>6</issue>), <fpage>1038</fpage>. <pub-id pub-id-type="doi">10.3390/antiox11061038</pub-id>
</citation>
</ref>
<ref id="B29">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Fang</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Wu</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Wei</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Miao</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>Y.</given-names>
</name>
</person-group> (<year>2022</year>). <article-title>Research progress on the pharmacological effects of berberine targeting mitochondria</article-title>. <source>Front. Endocrinol. (Lausanne)</source> <volume>13</volume>, <fpage>982145</fpage>. <pub-id pub-id-type="doi">10.3389/fendo.2022.982145</pub-id>
</citation>
</ref>
<ref id="B30">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ferlazzo</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Cirmi</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Maugeri</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Russo</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Lombardo</surname>
<given-names>G. E.</given-names>
</name>
<name>
<surname>Gangemi</surname>
<given-names>S.</given-names>
</name>
<etal/>
</person-group> (<year>2020</year>). <article-title>Neuroprotective effect of bergamot juice in 6-OHDA-induced SH-SY5Y cell death, an <italic>in vitro</italic> model of Parkinson&#x27;s disease</article-title>. <source>Pharmaceutics</source> <volume>12</volume> (<issue>4</issue>), <fpage>326</fpage>. <pub-id pub-id-type="doi">10.3390/pharmaceutics12040326</pub-id>
</citation>
</ref>
<ref id="B31">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Fernandez-Marcos</surname>
<given-names>P. J.</given-names>
</name>
<name>
<surname>Auwerx</surname>
<given-names>J.</given-names>
</name>
</person-group> (<year>2011</year>). <article-title>Regulation of PGC-1&#x3b1;, a nodal regulator of mitochondrial biogenesis</article-title>. <source>Am. J. Clin. Nutr.</source> <volume>93</volume> (<issue>4</issue>), <fpage>884S</fpage>&#x2013;<lpage>890S</lpage>. <pub-id pub-id-type="doi">10.3945/ajcn.110.001917</pub-id>
</citation>
</ref>
<ref id="B32">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ferretta</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Gaballo</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Tanzarella</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Piccoli</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Capitanio</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Nico</surname>
<given-names>B.</given-names>
</name>
<etal/>
</person-group> (<year>2014</year>). <article-title>Effect of resveratrol on mitochondrial function: Implications in parkin-associated familiar Parkinson&#x27;s disease</article-title>. <source>Biochim. Biophys. Acta</source> <volume>1842</volume> (<issue>7</issue>), <fpage>902</fpage>&#x2013;<lpage>915</lpage>. <pub-id pub-id-type="doi">10.1016/j.bbadis.2014.02.010</pub-id>
</citation>
</ref>
<ref id="B33">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ferry</surname>
<given-names>D. .R.</given-names>
</name>
<name>
<surname>Smith</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Malkhandi</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Fyfe</surname>
<given-names>D. .W.</given-names>
</name>
<name>
<surname>deTakats</surname>
<given-names>P. .G.</given-names>
</name>
<name>
<surname>Anderson</surname>
<given-names>D.</given-names>
</name>
<etal/>
</person-group> (<year>1996</year>). <article-title>Phase I clinical trial of the flavonoid quercetin: Pharmacokinetics and evidence for <italic>in vivo</italic> tyrosine kinase inhibition</article-title>. <source>Clin. Cancer Res.</source> <volume>2</volume> (<issue>4</issue>), <fpage>659</fpage>&#x2013;<lpage>668</lpage>.</citation>
</ref>
<ref id="B34">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Finck</surname>
<given-names>B. N.</given-names>
</name>
<name>
<surname>Kelly</surname>
<given-names>D. P.</given-names>
</name>
</person-group> (<year>2006</year>). <article-title>PGC-1 coactivators: Inducible regulators of energy metabolism in health and disease</article-title>. <source>J. Clin. Invest.</source> <volume>116</volume> (<issue>3</issue>), <fpage>615</fpage>&#x2013;<lpage>622</lpage>. <pub-id pub-id-type="doi">10.1172/JCI27794</pub-id>
</citation>
</ref>
<ref id="B35">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Gao</surname>
<given-names>X. Y.</given-names>
</name>
<name>
<surname>Yang</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Gu</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Sun</surname>
<given-names>X. H.</given-names>
</name>
</person-group> (<year>2022</year>). <article-title>Mitochondrial dysfunction in Parkinson&#x27;s disease: From mechanistic insights to therapy</article-title>. <source>Front. Aging Neurosci.</source> <volume>14</volume>, <fpage>885500</fpage>. <pub-id pub-id-type="doi">10.3389/fnagi.2022.885500</pub-id>
</citation>
</ref>
<ref id="B36">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Geisler</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Holmstrom</surname>
<given-names>K. M.</given-names>
</name>
<name>
<surname>Skujat</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Fiesel</surname>
<given-names>F. C.</given-names>
</name>
<name>
<surname>Rothfuss</surname>
<given-names>O. C.</given-names>
</name>
<name>
<surname>Kahle</surname>
<given-names>P. J.</given-names>
</name>
<etal/>
</person-group> (<year>2010</year>). <article-title>PINK1/Parkin-mediated mitophagy is dependent on VDAC1 and p62/SQSTM1</article-title>. <source>Nat. Cell Biol.</source> <volume>12</volume> (<issue>2</issue>), <fpage>119</fpage>&#x2013;<lpage>131</lpage>. <pub-id pub-id-type="doi">10.1038/ncb2012</pub-id>
</citation>
</ref>
<ref id="B37">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Gokul</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Muralidhara</surname>
</name>
</person-group> (<year>2014</year>). <article-title>Oral supplements of aqueous extract of tomato seeds alleviate motor abnormality, oxidative impairments and neurotoxicity induced by rotenone in mice: Relevance to Parkinson&#x27;s disease</article-title>. <source>Neurochem. Res.</source> <volume>39</volume> (<issue>7</issue>), <fpage>1382</fpage>&#x2013;<lpage>1394</lpage>. <pub-id pub-id-type="doi">10.1007/s11064-014-1323-1</pub-id>
</citation>
</ref>
<ref id="B38">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Handschin</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Spiegelman</surname>
<given-names>B. M.</given-names>
</name>
</person-group> (<year>2006</year>). <article-title>Peroxisome proliferator-activated receptor gamma coactivator 1 coactivators, energy homeostasis, and metabolism</article-title>. <source>Endocr. Rev.</source> <volume>27</volume> (<issue>7</issue>), <fpage>728</fpage>&#x2013;<lpage>735</lpage>. <pub-id pub-id-type="doi">10.1210/er.2006-0037</pub-id>
</citation>
</ref>
<ref id="B39">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hosamani</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Krishna</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Muralidhara</surname>
</name>
</person-group> (<year>2016</year>). <article-title>Standardized Bacopa monnieri extract ameliorates acute paraquat-induced oxidative stress, and neurotoxicity in prepubertal mice brain</article-title>. <source>Nutr. Neurosci.</source> <volume>19</volume> (<issue>10</issue>), <fpage>434</fpage>&#x2013;<lpage>446</lpage>. <pub-id pub-id-type="doi">10.1179/1476830514Y.0000000149</pub-id>
</citation>
</ref>
<ref id="B40">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hsu</surname>
<given-names>C. C.</given-names>
</name>
<name>
<surname>Kuo</surname>
<given-names>T. W.</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>W. P.</given-names>
</name>
<name>
<surname>Chang</surname>
<given-names>C. P.</given-names>
</name>
<name>
<surname>Lin</surname>
<given-names>H. J.</given-names>
</name>
</person-group> (<year>2020</year>). <article-title>Calycosin preserves BDNF/TrkB signaling and reduces post-stroke neurological injury after cerebral ischemia by reducing accumulation of hypertrophic and TNF-alpha-containing microglia in rats</article-title>. <source>J. Neuroimmune Pharmacol.</source> <volume>15</volume> (<issue>2</issue>), <fpage>326</fpage>&#x2013;<lpage>339</lpage>. <pub-id pub-id-type="doi">10.1007/s11481-019-09903-9</pub-id>
</citation>
</ref>
<ref id="B41">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Jin</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Guo</surname>
<given-names>J. L.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Zhong</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Yao</surname>
<given-names>W. F.</given-names>
</name>
<name>
<surname>Gao</surname>
<given-names>H.</given-names>
</name>
<etal/>
</person-group> (<year>2021</year>). <article-title>Natural products as pharmacological modulators of mitochondrial dysfunctions for the treatments of alzheimer&#x27;s disease: A comprehensive review</article-title>. <source>Eur. J. Med. Chem.</source> <volume>218</volume>, <fpage>113401</fpage>. <pub-id pub-id-type="doi">10.1016/j.ejmech.2021.113401</pub-id>
</citation>
</ref>
<ref id="B42">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kalia</surname>
<given-names>L. V.</given-names>
</name>
<name>
<surname>Lang</surname>
<given-names>A. E.</given-names>
</name>
</person-group> (<year>2015</year>). <article-title>Parkinson&#x27;s disease</article-title>. <source>Lancet</source> <volume>386</volume> (<issue>9996</issue>), <fpage>896</fpage>&#x2013;<lpage>912</lpage>. <pub-id pub-id-type="doi">10.1016/S0140-6736(14)61393-3</pub-id>
</citation>
</ref>
<ref id="B43">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kavitha</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Manivasagam</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Essa</surname>
<given-names>M. M.</given-names>
</name>
<name>
<surname>Tamilselvam</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Selvakumar</surname>
<given-names>G. P.</given-names>
</name>
<name>
<surname>Karthikeyan</surname>
<given-names>S.</given-names>
</name>
<etal/>
</person-group> (<year>2014</year>). <article-title>Mangiferin antagonizes rotenone: Induced apoptosis through attenuating mitochondrial dysfunction and oxidative stress in SK-N-sh neuroblastoma cells</article-title>. <source>Neurochem. Res.</source> <volume>39</volume> (<issue>4</issue>), <fpage>668</fpage>&#x2013;<lpage>676</lpage>. <pub-id pub-id-type="doi">10.1007/s11064-014-1249-7</pub-id>
</citation>
</ref>
<ref id="B44">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Khan</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Ali</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Rehman</surname>
<given-names>S. U.</given-names>
</name>
<name>
<surname>Khan</surname>
<given-names>M. S.</given-names>
</name>
<name>
<surname>Alam</surname>
<given-names>S. I.</given-names>
</name>
<name>
<surname>Ikram</surname>
<given-names>M.</given-names>
</name>
<etal/>
</person-group> (<year>2018</year>). <article-title>Neuroprotective effect of quercetin against the detrimental effects of LPS in the adult mouse brain</article-title>. <source>Front. Pharmacol.</source> <volume>9</volume>, <fpage>1383</fpage>. <pub-id pub-id-type="doi">10.3389/fphar.2018.01383</pub-id>
</citation>
</ref>
<ref id="B45">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Khatri</surname>
<given-names>D. K.</given-names>
</name>
<name>
<surname>Juvekar</surname>
<given-names>A. R.</given-names>
</name>
</person-group> (<year>2016</year>). <article-title>Neuroprotective effect of curcumin as evinced by abrogation of rotenone-induced motor deficits, oxidative and mitochondrial dysfunctions in mouse model of Parkinson&#x27;s disease</article-title>. <source>Pharmacol. Biochem. Behav.</source> <volume>150</volume>, <fpage>39</fpage>&#x2013;<lpage>47</lpage>. <pub-id pub-id-type="doi">10.1016/j.pbb.2016.09.002</pub-id>
</citation>
</ref>
<ref id="B46">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kich</surname>
<given-names>D. M.</given-names>
</name>
<name>
<surname>Bitencourt</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Alves</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Silva</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Pinteus</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Pedrosa</surname>
<given-names>R.</given-names>
</name>
<etal/>
</person-group> (<year>2016</year>). <article-title>Neuromodulatory effects of Calyptranthes grandifolia extracts against 6-hydroxydopamine-induced neurotoxicity in SH-SY5Y cells</article-title>. <source>Biomed. Pharmacother.</source> <volume>84</volume>, <fpage>382</fpage>&#x2013;<lpage>386</lpage>. <pub-id pub-id-type="doi">10.1016/j.biopha.2016.09.063</pub-id>
</citation>
</ref>
<ref id="B47">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kim</surname>
<given-names>H. G.</given-names>
</name>
<name>
<surname>Park</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Piao</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Kang</surname>
<given-names>M. S.</given-names>
</name>
<name>
<surname>Pak</surname>
<given-names>Y. K.</given-names>
</name>
<name>
<surname>Hong</surname>
<given-names>S. P.</given-names>
</name>
<etal/>
</person-group> (<year>2014</year>). <article-title>Effects of the root bark of Paeonia suffruticosa on mitochondria-mediated neuroprotection in an MPTP-induced model of Parkinson&#x27;s disease</article-title>. <source>Food Chem. Toxicol.</source> <volume>65</volume>, <fpage>293</fpage>&#x2013;<lpage>300</lpage>. <pub-id pub-id-type="doi">10.1016/j.fct.2013.12.037</pub-id>
</citation>
</ref>
<ref id="B48">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kim</surname>
<given-names>K. H.</given-names>
</name>
<name>
<surname>Song</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Yoon</surname>
<given-names>S. H.</given-names>
</name>
<name>
<surname>Shehzad</surname>
<given-names>O.</given-names>
</name>
<name>
<surname>Kim</surname>
<given-names>Y. S.</given-names>
</name>
<name>
<surname>Son</surname>
<given-names>J. H.</given-names>
</name>
</person-group> (<year>2012</year>). <article-title>Rescue of PINK1 protein null-specific mitochondrial complex IV deficits by ginsenoside Re activation of nitric oxide signaling</article-title>. <source>J. Biol. Chem.</source> <volume>287</volume> (<issue>53</issue>), <fpage>44109</fpage>&#x2013;<lpage>44120</lpage>. <pub-id pub-id-type="doi">10.1074/jbc.M112.408146</pub-id>
</citation>
</ref>
<ref id="B49">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kim</surname>
<given-names>M. H.</given-names>
</name>
<name>
<surname>Min</surname>
<given-names>J. S.</given-names>
</name>
<name>
<surname>Lee</surname>
<given-names>J. Y.</given-names>
</name>
<name>
<surname>Chae</surname>
<given-names>U.</given-names>
</name>
<name>
<surname>Yang</surname>
<given-names>E. J.</given-names>
</name>
<name>
<surname>Song</surname>
<given-names>K. S.</given-names>
</name>
<etal/>
</person-group> (<year>2018</year>). <article-title>Oleuropein isolated from Fraxinus rhynchophylla inhibits glutamate-induced neuronal cell death by attenuating mitochondrial dysfunction</article-title>. <source>Nutr. Neurosci.</source> <volume>21</volume> (<issue>7</issue>), <fpage>520</fpage>&#x2013;<lpage>528</lpage>. <pub-id pub-id-type="doi">10.1080/1028415X.2017.1317449</pub-id>
</citation>
</ref>
<ref id="B50">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kim</surname>
<given-names>S. M.</given-names>
</name>
<name>
<surname>Park</surname>
<given-names>Y. J.</given-names>
</name>
<name>
<surname>Shin</surname>
<given-names>M. S.</given-names>
</name>
<name>
<surname>Kim</surname>
<given-names>H. R.</given-names>
</name>
<name>
<surname>Kim</surname>
<given-names>M. J.</given-names>
</name>
<name>
<surname>Lee</surname>
<given-names>S. H.</given-names>
</name>
<etal/>
</person-group> (<year>2017</year>). <article-title>Acacetin inhibits neuronal cell death induced by 6-hydroxydopamine in cellular Parkinson&#x27;s disease model</article-title>. <source>Bioorg Med. Chem. Lett.</source> <volume>27</volume> (<issue>23</issue>), <fpage>5207</fpage>&#x2013;<lpage>5212</lpage>. <pub-id pub-id-type="doi">10.1016/j.bmcl.2017.10.048</pub-id>
</citation>
</ref>
<ref id="B51">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kishore Kumar</surname>
<given-names>S. N.</given-names>
</name>
<name>
<surname>Deepthy</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Saraswathi</surname>
<given-names>U.</given-names>
</name>
<name>
<surname>Thangarajeswari</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Yogesh Kanna</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Ezhil</surname>
<given-names>P.</given-names>
</name>
<etal/>
</person-group> (<year>2017</year>). <article-title>
<italic>Morinda citrifolia</italic> mitigates rotenone-induced striatal neuronal loss in male Sprague-Dawley rats by preventing mitochondrial pathway of intrinsic apoptosis</article-title>. <source>Redox Rep.</source> <volume>22</volume> (<issue>6</issue>), <fpage>418</fpage>&#x2013;<lpage>429</lpage>. <pub-id pub-id-type="doi">10.1080/13510002.2016.1253449</pub-id>
</citation>
</ref>
<ref id="B52">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Klionsky</surname>
<given-names>D. J.</given-names>
</name>
<name>
<surname>Abdel-Aziz</surname>
<given-names>A. K.</given-names>
</name>
<name>
<surname>Abdelfatah</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Abdellatif</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Abdoli</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Abel</surname>
<given-names>S.</given-names>
</name>
<etal/>
</person-group> (<year>2021</year>). <article-title>Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition)<sup>1</sup>
</article-title>. <source>Autophagy</source> <volume>17</volume> (<issue>1</issue>), <fpage>1</fpage>&#x2013;<lpage>382</lpage>. <pub-id pub-id-type="doi">10.1080/15548627.2020.1797280</pub-id>
</citation>
</ref>
<ref id="B53">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kuang</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Cao</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Lu</surname>
<given-names>Z.</given-names>
</name>
</person-group> (<year>2017</year>). <article-title>Baicalein protects against rotenone-induced neurotoxicity through induction of autophagy</article-title>. <source>Biol. Pharm. Bull.</source> <volume>40</volume> (<issue>9</issue>), <fpage>1537</fpage>&#x2013;<lpage>1543</lpage>. <pub-id pub-id-type="doi">10.1248/bpb.b17-00392</pub-id>
</citation>
</ref>
<ref id="B54">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kujawska</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Jodynis-Liebert</surname>
<given-names>J.</given-names>
</name>
</person-group> (<year>2018</year>). <article-title>Polyphenols in Parkinson&#x27;s disease: A systematic review of <italic>in vivo</italic> studies</article-title>. <source>Nutrients</source> <volume>10</volume> (<issue>5</issue>), <fpage>642</fpage>. <pub-id pub-id-type="doi">10.3390/nu10050642</pub-id>
</citation>
</ref>
<ref id="B55">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kwon</surname>
<given-names>S. H.</given-names>
</name>
<name>
<surname>Lee</surname>
<given-names>S. R.</given-names>
</name>
<name>
<surname>Park</surname>
<given-names>Y. J.</given-names>
</name>
<name>
<surname>Ra</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Lee</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Pang</surname>
<given-names>C.</given-names>
</name>
<etal/>
</person-group> (<year>2019</year>). <article-title>Suppression of 6-hydroxydopamine-induced oxidative stress by hyperoside via activation of Nrf2/HO-1 signaling in dopaminergic neurons</article-title>. <source>Int. J. Mol. Sci.</source> <volume>20</volume> (<issue>23</issue>), <fpage>5832</fpage>. <pub-id pub-id-type="doi">10.3390/ijms20235832</pub-id>
</citation>
</ref>
<ref id="B56">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kwon</surname>
<given-names>S. H.</given-names>
</name>
<name>
<surname>Ma</surname>
<given-names>S. X.</given-names>
</name>
<name>
<surname>Hong</surname>
<given-names>S. I.</given-names>
</name>
<name>
<surname>Kim</surname>
<given-names>S. Y.</given-names>
</name>
<name>
<surname>Lee</surname>
<given-names>S. Y.</given-names>
</name>
<name>
<surname>Jang</surname>
<given-names>C. G.</given-names>
</name>
</person-group> (<year>2014</year>). <article-title>Eucommia ulmoides Oliv. bark. attenuates 6-hydroxydopamine-induced neuronal cell death through inhibition of oxidative stress in SH-SY5Y cells</article-title>. <source>J. Ethnopharmacol.</source> <volume>152</volume> (<issue>1</issue>), <fpage>173</fpage>&#x2013;<lpage>182</lpage>. <pub-id pub-id-type="doi">10.1016/j.jep.2013.12.048</pub-id>
</citation>
</ref>
<ref id="B57">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lenkiewicz</surname>
<given-names>A. M.</given-names>
</name>
<name>
<surname>Czapski</surname>
<given-names>G. A.</given-names>
</name>
<name>
<surname>Jesko</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Wilkaniec</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Szypula</surname>
<given-names>W.</given-names>
</name>
<name>
<surname>Pietrosiuk</surname>
<given-names>A.</given-names>
</name>
<etal/>
</person-group> (<year>2016</year>). <article-title>Potent effects of alkaloid-rich extract from Huperzia selago against sodium nitroprusside-evoked PC12 cells damage via attenuation of oxidative stress and apoptosis</article-title>. <source>Folia Neuropathol.</source> <volume>54</volume> (<issue>2</issue>), <fpage>156</fpage>&#x2013;<lpage>166</lpage>. <pub-id pub-id-type="doi">10.5114/fn.2016.60361</pub-id>
</citation>
</ref>
<ref id="B58">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Li</surname>
<given-names>P. A.</given-names>
</name>
<name>
<surname>Hou</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Hao</surname>
<given-names>S.</given-names>
</name>
</person-group> (<year>2017</year>). <article-title>Mitochondrial biogenesis in neurodegeneration</article-title>. <source>J. Neurosci. Res.</source> <volume>95</volume> (<issue>10</issue>), <fpage>2025</fpage>&#x2013;<lpage>2029</lpage>. <pub-id pub-id-type="doi">10.1002/jnr.24042</pub-id>
</citation>
</ref>
<ref id="B59">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Li</surname>
<given-names>W.</given-names>
</name>
<name>
<surname>Zhou</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Yang</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>H. H.</given-names>
</name>
<name>
<surname>Zhao</surname>
<given-names>S. L.</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>T.</given-names>
</name>
<etal/>
</person-group> (<year>2017</year>). <article-title>Curcumin induces apoptosis and protective autophagy in human gastric cancer cells with different degree of differentiation</article-title>. <source>Zhonghua Zhong Liu Za Zhi</source> <volume>39</volume> (<issue>7</issue>), <fpage>490</fpage>&#x2013;<lpage>496</lpage>. <pub-id pub-id-type="doi">10.3760/cma.j.issn.0253-3766.2017.07.003</pub-id>
</citation>
</ref>
<ref id="B60">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lim</surname>
<given-names>K. L.</given-names>
</name>
<name>
<surname>Ng</surname>
<given-names>C. H.</given-names>
</name>
</person-group> (<year>2009</year>). <article-title>Genetic models of Parkinson disease</article-title>. <source>Biochim. Biophys. Acta</source> <volume>1792</volume> (<issue>7</issue>), <fpage>604</fpage>&#x2013;<lpage>615</lpage>. <pub-id pub-id-type="doi">10.1016/j.bbadis.2008.10.005</pub-id>
</citation>
</ref>
<ref id="B61">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lin</surname>
<given-names>K. L.</given-names>
</name>
<name>
<surname>Lin</surname>
<given-names>K. J.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>P. W.</given-names>
</name>
<name>
<surname>Chuang</surname>
<given-names>J. H.</given-names>
</name>
<name>
<surname>Lin</surname>
<given-names>H. Y.</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>S. D.</given-names>
</name>
<etal/>
</person-group> (<year>2018</year>). <article-title>Resveratrol provides neuroprotective effects through modulation of mitochondrial dynamics and ERK1/2 regulated autophagy</article-title>. <source>Free Radic. Res.</source> <volume>52</volume> (<issue>11-12</issue>), <fpage>1371</fpage>&#x2013;<lpage>1386</lpage>. <pub-id pub-id-type="doi">10.1080/10715762.2018.1489128</pub-id>
</citation>
</ref>
<ref id="B62">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lin</surname>
<given-names>T. K.</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>S. D.</given-names>
</name>
<name>
<surname>Chuang</surname>
<given-names>Y. C.</given-names>
</name>
<name>
<surname>Lin</surname>
<given-names>H. Y.</given-names>
</name>
<name>
<surname>Huang</surname>
<given-names>C. R.</given-names>
</name>
<name>
<surname>Chuang</surname>
<given-names>J. H.</given-names>
</name>
<etal/>
</person-group> (<year>2014</year>). <article-title>Resveratrol partially prevents rotenone-induced neurotoxicity in dopaminergic SH-SY5Y cells through induction of heme oxygenase-1 dependent autophagy</article-title>. <source>Int. J. Mol. Sci.</source> <volume>15</volume> (<issue>1</issue>), <fpage>1625</fpage>&#x2013;<lpage>1646</lpage>. <pub-id pub-id-type="doi">10.3390/ijms15011625</pub-id>
</citation>
</ref>
<ref id="B63">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Liu</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Guo</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Tang</surname>
<given-names>W.</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>W.</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>Y.</given-names>
</name>
</person-group> (<year>2018a</year>). <article-title>Astragalus polysaccharide protects neurons and stabilizes mitochondrial in a mouse model of Parkinson disease</article-title>. <source>Med. Sci. Monit.</source> <volume>24</volume>, <fpage>5192</fpage>&#x2013;<lpage>5199</lpage>. <pub-id pub-id-type="doi">10.12659/MSM.908021</pub-id>
</citation>
</ref>
<ref id="B64">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Liu</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Yu</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Qiao</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>S.</given-names>
</name>
<etal/>
</person-group> (<year>2020</year>). <article-title>Ginseng protein protects against mitochondrial dysfunction and neurodegeneration by inducing mitochondrial unfolded protein response in <italic>Drosophila melanogaster</italic> PINK1 model of Parkinson&#x27;s disease</article-title>. <source>J. Ethnopharmacol.</source> <volume>247</volume>, <fpage>112213</fpage>. <pub-id pub-id-type="doi">10.1016/j.jep.2019.112213</pub-id>
</citation>
</ref>
<ref id="B65">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Liu</surname>
<given-names>S. M.</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>X. Z.</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>S. N.</given-names>
</name>
<name>
<surname>Yang</surname>
<given-names>Z. M.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>K. X.</given-names>
</name>
<name>
<surname>Lu</surname>
<given-names>F.</given-names>
</name>
<etal/>
</person-group> (<year>2018b</year>). <article-title>Acanthopanax senticosus protects structure and function of mesencephalic mitochondria in A mouse model of Parkinson&#x27;s disease</article-title>. <source>Chin. J. Integr. Med.</source> <volume>24</volume> (<issue>11</issue>), <fpage>835</fpage>&#x2013;<lpage>843</lpage>. <pub-id pub-id-type="doi">10.1007/s11655-018-2935-5</pub-id>
</citation>
</ref>
<ref id="B66">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Liu</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>W.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Hayashi</surname>
<given-names>T.</given-names>
</name>
<etal/>
</person-group> (<year>2021a</year>). <article-title>Silibinin attenuates motor dysfunction in a mouse model of Parkinson&#x27;s disease by suppression of oxidative stress and neuroinflammation along with promotion of mitophagy</article-title>. <source>Physiol. Behav.</source> <volume>239</volume>, <fpage>113510</fpage>. <pub-id pub-id-type="doi">10.1016/j.physbeh.2021.113510</pub-id>
</citation>
</ref>
<ref id="B67">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Liu</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>W.</given-names>
</name>
<name>
<surname>Song</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Fu</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Hayashi</surname>
<given-names>T.</given-names>
</name>
<etal/>
</person-group> (<year>2021b</year>). <article-title>Oral administration of silibinin ameliorates cognitive deficits of Parkinson&#x27;s disease mouse model by restoring mitochondrial disorders in Hippocampus</article-title>. <source>Neurochem. Res.</source> <volume>46</volume> (<issue>9</issue>), <fpage>2317</fpage>&#x2013;<lpage>2332</lpage>. <pub-id pub-id-type="doi">10.1007/s11064-021-03363-5</pub-id>
</citation>
</ref>
<ref id="B68">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lou</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Jing</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Wei</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Shi</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Ren</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>X.</given-names>
</name>
</person-group> (<year>2014</year>). <article-title>Naringenin protects against 6-OHDA-induced neurotoxicity via activation of the Nrf2/ARE signaling pathway</article-title>. <source>Neuropharmacology</source> <volume>79</volume>, <fpage>380</fpage>&#x2013;<lpage>388</lpage>. <pub-id pub-id-type="doi">10.1016/j.neuropharm.2013.11.026</pub-id>
</citation>
</ref>
<ref id="B69">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lu</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Su</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Qiao</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Bian</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Ding</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Hu</surname>
<given-names>G.</given-names>
</name>
</person-group> (<year>2016</year>). <article-title>Metformin prevents dopaminergic neuron death in MPTP/P-induced mouse model of Parkinson&#x27;s disease via autophagy and mitochondrial ROS clearance</article-title>. <source>Int. J. Neuropsychopharmacol.</source> <volume>19</volume> (<issue>9</issue>), <fpage>pyw047</fpage>. <pub-id pub-id-type="doi">10.1093/ijnp/pyw047</pub-id>
</citation>
</ref>
<ref id="B70">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lu</surname>
<given-names>X. L.</given-names>
</name>
<name>
<surname>Lin</surname>
<given-names>Y. H.</given-names>
</name>
<name>
<surname>Wu</surname>
<given-names>Q.</given-names>
</name>
<name>
<surname>Su</surname>
<given-names>F. J.</given-names>
</name>
<name>
<surname>Ye</surname>
<given-names>C. H.</given-names>
</name>
<name>
<surname>Shi</surname>
<given-names>L.</given-names>
</name>
<etal/>
</person-group> (<year>2015</year>). <article-title>Paeonolum protects against MPP(&#x2b;)-induced neurotoxicity in zebrafish and PC12 cells</article-title>. <source>BMC Complement. Altern. Med.</source> <volume>15</volume>, <fpage>137</fpage>. <pub-id pub-id-type="doi">10.1186/s12906-015-0661-0</pub-id>
</citation>
</ref>
<ref id="B71">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Luo</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Peng</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Xu</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Peng</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Shi</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>Q.</given-names>
</name>
<etal/>
</person-group> (<year>2022</year>). <article-title>The protective effects of mogroside V against neuronal damages by attenuating mitochondrial dysfunction via upregulating Sirtuin3</article-title>. <source>Mol. Neurobiol.</source> <volume>59</volume> (<issue>4</issue>), <fpage>2068</fpage>&#x2013;<lpage>2084</lpage>. <pub-id pub-id-type="doi">10.1007/s12035-021-02689-z</pub-id>
</citation>
</ref>
<ref id="B72">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Matsuda</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Sato</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Shiba</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Okatsu</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Saisho</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Gautier</surname>
<given-names>C. A.</given-names>
</name>
<etal/>
</person-group> (<year>2010</year>). <article-title>PINK1 stabilized by mitochondrial depolarization recruits Parkin to damaged mitochondria and activates latent Parkin for mitophagy</article-title>. <source>J. Cell Biol.</source> <volume>189</volume> (<issue>2</issue>), <fpage>211</fpage>&#x2013;<lpage>221</lpage>. <pub-id pub-id-type="doi">10.1083/jcb.200910140</pub-id>
</citation>
</ref>
<ref id="B73">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Metodiewa</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Jaiswal</surname>
<given-names>A. .K.</given-names>
</name>
<name>
<surname>Cenas</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Dickancait&#xe9;</surname>
<given-names>E.</given-names>
</name>
</person-group> (<year>1999</year>). <article-title>Quercetin may act as a cytotoxic prooxidant after its metabolic activation to semiquinone and quinoidal product</article-title>. <source>Free Radic. Biol. Med.</source> <volume>26</volume> (<issue>1-2</issue>), <fpage>107</fpage>&#x2013;<lpage>116</lpage>. <pub-id pub-id-type="doi">10.1016/s0891-5849(98)00167-1</pub-id>
</citation>
</ref>
<ref id="B74">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Mohammadipour</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Haghir</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Ebrahimzadeh Bideskan</surname>
<given-names>A.</given-names>
</name>
</person-group> (<year>2020</year>). <article-title>A link between nanoparticles and Parkinson&#x27;s disease. Which nanoparticles are most harmful?</article-title> <source>Rev. Environ. Health</source> <volume>35</volume> (<issue>4</issue>), <fpage>545</fpage>&#x2013;<lpage>556</lpage>. <pub-id pub-id-type="doi">10.1515/reveh-2020-0043</pub-id>
</citation>
</ref>
<ref id="B75">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Mu</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>He</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Cheng</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Xu</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Du</surname>
<given-names>G.</given-names>
</name>
</person-group> (<year>2009</year>). <article-title>Baicalein exerts neuroprotective effects in 6-hydroxydopamine-induced experimental parkinsonism <italic>in vivo</italic> and <italic>in vitro</italic>
</article-title>. <source>Pharmacol. Biochem. Behav.</source> <volume>92</volume> (<issue>4</issue>), <fpage>642</fpage>&#x2013;<lpage>648</lpage>. <pub-id pub-id-type="doi">10.1016/j.pbb.2009.03.008</pub-id>
</citation>
</ref>
<ref id="B76">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Muhammad</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Zhou</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Yang</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>H.</given-names>
</name>
</person-group> (<year>2022</year>). <article-title>Antioxidative role of traditional Chinese medicine in Parkinson&#x27;s disease</article-title>. <source>J. Ethnopharmacol.</source> <volume>285</volume>, <fpage>114821</fpage>. <pub-id pub-id-type="doi">10.1016/j.jep.2021.114821</pub-id>
</citation>
</ref>
<ref id="B77">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Narendra</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Tanaka</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Suen</surname>
<given-names>D. F.</given-names>
</name>
<name>
<surname>Youle</surname>
<given-names>R. J.</given-names>
</name>
</person-group> (<year>2008</year>). <article-title>Parkin is recruited selectively to impaired mitochondria and promotes their autophagy</article-title>. <source>J. Cell Biol.</source> <volume>183</volume> (<issue>5</issue>), <fpage>795</fpage>&#x2013;<lpage>803</lpage>. <pub-id pub-id-type="doi">10.1083/jcb.200809125</pub-id>
</citation>
</ref>
<ref id="B78">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Niveditha</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Shivanandappa</surname>
<given-names>T.</given-names>
</name>
</person-group> (<year>2018</year>). <article-title>Neuroprotective action of 4-Hydroxyisophthalic acid against paraquat-induced motor impairment involves amelioration of mitochondrial damage and neurodegeneration in Drosophila</article-title>. <source>Neurotoxicology</source> <volume>66</volume>, <fpage>160</fpage>&#x2013;<lpage>169</lpage>. <pub-id pub-id-type="doi">10.1016/j.neuro.2018.04.006</pub-id>
</citation>
</ref>
<ref id="B79">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Palikaras</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Tavernarakis</surname>
<given-names>N.</given-names>
</name>
</person-group> (<year>2020</year>). <article-title>Regulation and roles of mitophagy at synapses</article-title>. <source>Mech. Ageing Dev.</source> <volume>187</volume>, <fpage>111216</fpage>. <pub-id pub-id-type="doi">10.1016/j.mad.2020.111216</pub-id>
</citation>
</ref>
<ref id="B80">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Papa</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Martino</surname>
<given-names>P. L.</given-names>
</name>
<name>
<surname>Capitanio</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Gaballo</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>De Rasmo</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Signorile</surname>
<given-names>A.</given-names>
</name>
<etal/>
</person-group> (<year>2012</year>). <article-title>The oxidative phosphorylation system in mammalian mitochondria</article-title>. <source>Adv. Exp. Med. Biol.</source> <volume>942</volume>, <fpage>3</fpage>&#x2013;<lpage>37</lpage>. <pub-id pub-id-type="doi">10.1007/978-94-007-2869-1_1</pub-id>
</citation>
</ref>
<ref id="B81">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Peshattiwar</surname>
<given-names>V.</given-names>
</name>
<name>
<surname>Muke</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Kaikini</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Bagle</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Dighe</surname>
<given-names>V.</given-names>
</name>
<name>
<surname>Sathaye</surname>
<given-names>S.</given-names>
</name>
</person-group> (<year>2020</year>). <article-title>Mechanistic evaluation of Ursolic acid against rotenone induced Parkinson&#x27;s disease-emphasizing the role of mitochondrial biogenesis</article-title>. <source>Brain Res. Bull.</source> <volume>160</volume>, <fpage>150</fpage>&#x2013;<lpage>161</lpage>. <pub-id pub-id-type="doi">10.1016/j.brainresbull.2020.03.003</pub-id>
</citation>
</ref>
<ref id="B82">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Poddighe</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>De Rose</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Marotta</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Ruffilli</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Fanti</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Secci</surname>
<given-names>P. P.</given-names>
</name>
<etal/>
</person-group> (<year>2014</year>). <article-title>Mucuna pruriens (Velvet bean) rescues motor, olfactory, mitochondrial and synaptic impairment in PINK1B9 <italic>Drosophila melanogaster</italic> genetic model of Parkinson&#x27;s disease</article-title>. <source>PLoS One</source> <volume>9</volume> (<issue>10</issue>), <fpage>e110802</fpage>. <pub-id pub-id-type="doi">10.1371/journal.pone.0110802</pub-id>
</citation>
</ref>
<ref id="B83">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Poojari</surname>
<given-names>R.</given-names>
</name>
</person-group> (<year>2014</year>). <article-title>Embelin - a drug of antiquity: Shifting the paradigm towards modern medicine</article-title>. <source>Expert Opin. Investig. Drugs</source> <volume>23</volume> (<issue>3</issue>), <fpage>427</fpage>&#x2013;<lpage>444</lpage>. <pub-id pub-id-type="doi">10.1517/13543784.2014.867016</pub-id>
</citation>
</ref>
<ref id="B84">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Qi</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Mi</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Fan</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>Z.</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>X.</given-names>
</name>
</person-group> (<year>2019</year>). <article-title>Nobiletin protects against systemic inflammation-stimulated memory impairment via MAPK and NF-&#x3ba;B signaling pathways</article-title>. <source>J. Agric. Food Chem.</source> <volume>67</volume> (<issue>18</issue>), <fpage>5122</fpage>&#x2013;<lpage>5134</lpage>. <pub-id pub-id-type="doi">10.1021/acs.jafc.9b00133</pub-id>
</citation>
</ref>
<ref id="B85">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Qin</surname>
<given-names>Y. H.</given-names>
</name>
<name>
<surname>Dai</surname>
<given-names>S. M.</given-names>
</name>
<name>
<surname>Tang</surname>
<given-names>G. S.</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Ren</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>Z. W.</given-names>
</name>
<etal/>
</person-group> (<year>2009</year>). <article-title>HMGB1 enhances the proinflammatory activity of lipopolysaccharide by promoting the phosphorylation of MAPK p38 through receptor for advanced glycation end products</article-title>. <source>J. Immunol.</source> <volume>183</volume> (<issue>10</issue>), <fpage>6244</fpage>&#x2013;<lpage>6250</lpage>. <pub-id pub-id-type="doi">10.4049/jimmunol.0900390</pub-id>
</citation>
</ref>
<ref id="B86">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Qiu</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Zhuo</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>B.</given-names>
</name>
<etal/>
</person-group> (<year>2022</year>). <article-title>Urolithin A promotes mitophagy and suppresses NLRP3 inflammasome activation in lipopolysaccharide-induced BV2 microglial cells and MPTP-induced Parkinson&#x27;s disease model</article-title>. <source>Neuropharmacology</source> <volume>207</volume>, <fpage>108963</fpage>. <pub-id pub-id-type="doi">10.1016/j.neuropharm.2022.108963</pub-id>
</citation>
</ref>
<ref id="B87">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Qu</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Pei</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Fu</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Yong</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Xiao</surname>
<given-names>X.</given-names>
</name>
<etal/>
</person-group> (<year>2022</year>). <article-title>Acute and subchronic oral toxicity of anthraquinone in sprague dawley rats</article-title>. <source>Int. J. Environ. Res. Public Health</source> <volume>19</volume> (<issue>16</issue>), <fpage>10413</fpage>. <pub-id pub-id-type="doi">10.3390/ijerph191610413</pub-id>
</citation>
</ref>
<ref id="B88">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ramkumar</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Rajasankar</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Gobi</surname>
<given-names>V. V.</given-names>
</name>
<name>
<surname>Dhanalakshmi</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Manivasagam</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Justin Thenmozhi</surname>
<given-names>A.</given-names>
</name>
<etal/>
</person-group> (<year>2017</year>). <article-title>Neuroprotective effect of Demethoxycurcumin, a natural derivative of Curcumin on rotenone induced neurotoxicity in SH-SY 5Y Neuroblastoma cells</article-title>. <source>BMC Complement. Altern. Med.</source> <volume>17</volume> (<issue>1</issue>), <fpage>217</fpage>. <pub-id pub-id-type="doi">10.1186/s12906-017-1720-5</pub-id>
</citation>
</ref>
<ref id="B89">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Rao</surname>
<given-names>S. P.</given-names>
</name>
<name>
<surname>Sharma</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Kalivendi</surname>
<given-names>S. V.</given-names>
</name>
</person-group> (<year>2020</year>). <article-title>Embelin averts MPTP-induced dysfunction in mitochondrial bioenergetics and biogenesis via activation of SIRT1</article-title>. <source>Biochim. Biophys. Acta Bioenerg.</source> <volume>1861</volume> (<issue>3</issue>), <fpage>148157</fpage>. <pub-id pub-id-type="doi">10.1016/j.bbabio.2020.148157</pub-id>
</citation>
</ref>
<ref id="B90">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Rao</surname>
<given-names>S. V.</given-names>
</name>
<name>
<surname>MuralidharaYenisetti</surname>
<given-names>S. C.</given-names>
</name>
<name>
<surname>Rajini</surname>
<given-names>P. S.</given-names>
</name>
</person-group> (<year>2016</year>). <article-title>Evidence of neuroprotective effects of saffron and crocin in a Drosophila model of parkinsonism</article-title>. <source>Neurotoxicology</source> <volume>52</volume>, <fpage>230</fpage>&#x2013;<lpage>242</lpage>. <pub-id pub-id-type="doi">10.1016/j.neuro.2015.12.010</pub-id>
</citation>
</ref>
<ref id="B91">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ren</surname>
<given-names>Z. L.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>C. D.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Ding</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Zhou</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Yang</surname>
<given-names>N.</given-names>
</name>
<etal/>
</person-group> (<year>2019</year>). <article-title>Ganoderma lucidum extract ameliorates MPTP-induced parkinsonism and protects dopaminergic neurons from oxidative stress via regulating mitochondrial function, autophagy, and apoptosis</article-title>. <source>Acta Pharmacol. Sin.</source> <volume>40</volume> (<issue>4</issue>), <fpage>441</fpage>&#x2013;<lpage>450</lpage>. <pub-id pub-id-type="doi">10.1038/s41401-018-0077-8</pub-id>
</citation>
</ref>
<ref id="B92">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Richter-Dennerlein</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Dennerlein</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Rehling</surname>
<given-names>P.</given-names>
</name>
</person-group> (<year>2015</year>). <article-title>Integrating mitochondrial translation into the cellular context</article-title>. <source>Nat. Rev. Mol. Cell Biol.</source> <volume>16</volume> (<issue>10</issue>), <fpage>586</fpage>&#x2013;<lpage>592</lpage>. <pub-id pub-id-type="doi">10.1038/nrm4051</pub-id>
</citation>
</ref>
<ref id="B93">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ryu</surname>
<given-names>Y. K.</given-names>
</name>
<name>
<surname>Kang</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Go</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Park</surname>
<given-names>H. Y.</given-names>
</name>
<name>
<surname>Noh</surname>
<given-names>J. R.</given-names>
</name>
<name>
<surname>Kim</surname>
<given-names>Y. H.</given-names>
</name>
<etal/>
</person-group> (<year>2017</year>). <article-title>Humulus japonicus prevents dopaminergic neuron death in 6-hydroxydopamine-induced models of Parkinson&#x27;s disease</article-title>. <source>J. Med. Food</source> <volume>20</volume> (<issue>2</issue>), <fpage>116</fpage>&#x2013;<lpage>123</lpage>. <pub-id pub-id-type="doi">10.1089/jmf.2016.3851</pub-id>
</citation>
</ref>
<ref id="B94">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sadeghi</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Tanwir</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Yousefi Babadi</surname>
<given-names>V.</given-names>
</name>
</person-group> (<year>2018</year>). <article-title>Physiological and biochemical effects of Echium amoenum extract on Mn(2&#x2b;)-imposed Parkinson like disorder in rats</article-title>. <source>Adv. Pharm. Bull.</source> <volume>8</volume> (<issue>4</issue>), <fpage>705</fpage>&#x2013;<lpage>713</lpage>. <pub-id pub-id-type="doi">10.15171/apb.2018.079</pub-id>
</citation>
</ref>
<ref id="B95">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Scarpulla</surname>
<given-names>R. C.</given-names>
</name>
</person-group> (<year>2011</year>). <article-title>Metabolic control of mitochondrial biogenesis through the PGC-1 family regulatory network</article-title>. <source>Biochimica Biophysica Acta (BBA) - Mol. Cell Res.</source> <volume>1813</volume> (<issue>7</issue>), <fpage>1269</fpage>&#x2013;<lpage>1278</lpage>. <pub-id pub-id-type="doi">10.1016/j.bbamcr.2010.09.019</pub-id>
</citation>
</ref>
<ref id="B96">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Schapira</surname>
<given-names>A. H.</given-names>
</name>
<name>
<surname>Gu</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Taanman</surname>
<given-names>J. W.</given-names>
</name>
<name>
<surname>Tabrizi</surname>
<given-names>S. J.</given-names>
</name>
<name>
<surname>Seaton</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Cleeter</surname>
<given-names>M.</given-names>
</name>
<etal/>
</person-group> (<year>1998</year>). <article-title>Mitochondria in the etiology and pathogenesis of Parkinson&#x27;s disease</article-title>. <source>Ann. Neurol.</source> <volume>448</volume> (<issue>3</issue>), <fpage>S89</fpage>&#x2013;<lpage>S98</lpage>. <pub-id pub-id-type="doi">10.1002/ana.410440714</pub-id>
</citation>
</ref>
<ref id="B97">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Schapira</surname>
<given-names>A. H.</given-names>
</name>
<name>
<surname>Patel</surname>
<given-names>S.</given-names>
</name>
</person-group> (<year>2014</year>). <article-title>Targeting mitochondria for neuroprotection in Parkinson disease</article-title>. <source>JAMA Neurol.</source> <volume>71</volume> (<issue>5</issue>), <fpage>537</fpage>&#x2013;<lpage>538</lpage>. <pub-id pub-id-type="doi">10.1001/jamaneurol.2014.64</pub-id>
</citation>
</ref>
<ref id="B98">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Selvakumar</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Bavithra</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Suganthi</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Benson</surname>
<given-names>C. S.</given-names>
</name>
<name>
<surname>Elumalai</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Arunkumar</surname>
<given-names>R.</given-names>
</name>
<etal/>
</person-group> (<year>2012</year>). <article-title>Protective role of quercetin on PCBs-induced oxidative stress and apoptosis in hippocampus of adult rats</article-title>. <source>Neurochem. Res.</source> <volume>37</volume> (<issue>4</issue>), <fpage>708</fpage>&#x2013;<lpage>721</lpage>. <pub-id pub-id-type="doi">10.1007/s11064-011-0661-5</pub-id>
</citation>
</ref>
<ref id="B99">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Shahba</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Mehrzad</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Malvandi</surname>
<given-names>A. M.</given-names>
</name>
</person-group> (<year>2021</year>). <article-title>Neuroimmune disruptions from naturally occurring levels of mycotoxins</article-title>. <source>Environ. Sci. Pollut. Res. Int.</source> <volume>28</volume>, <fpage>32156</fpage>&#x2013;<lpage>32176</lpage>. <pub-id pub-id-type="doi">10.1007/s11356-021-14146-4</pub-id>
</citation>
</ref>
<ref id="B100">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sharma</surname>
<given-names>D. R.</given-names>
</name>
<name>
<surname>Wani</surname>
<given-names>W. Y.</given-names>
</name>
<name>
<surname>Sunkaria</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Kandimalla</surname>
<given-names>R. J.</given-names>
</name>
<name>
<surname>Sharma</surname>
<given-names>R. K.</given-names>
</name>
<name>
<surname>Verma</surname>
<given-names>D.</given-names>
</name>
<etal/>
</person-group> (<year>2016</year>). <article-title>Quercetin attenuates neuronal death against aluminum-induced neurodegeneration in the rat hippocampus</article-title>. <source>Neuroscience</source> <volume>324</volume>, <fpage>163</fpage>&#x2013;<lpage>176</lpage>. <pub-id pub-id-type="doi">10.1016/j.neuroscience.2016.02.055</pub-id>
</citation>
</ref>
<ref id="B101">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sies</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Berndt</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Jones</surname>
<given-names>D. P.</given-names>
</name>
</person-group> (<year>2017</year>). <article-title>Oxidative stress</article-title>. <source>Annu. Rev. Biochem.</source> <volume>86</volume>, <fpage>715</fpage>&#x2013;<lpage>748</lpage>. <pub-id pub-id-type="doi">10.1146/annurev-biochem-061516-045037</pub-id>
</citation>
</ref>
<ref id="B102">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Silva</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Alves</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Pinteus</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Mendes</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Pedrosa</surname>
<given-names>R.</given-names>
</name>
</person-group> (<year>2018</year>). <article-title>Neuroprotective effects of seaweeds against 6-hydroxidopamine-induced cell death on an <italic>in vitro</italic> human neuroblastoma model</article-title>. <source>BMC Complement. Altern. Med.</source> <volume>18</volume> (<issue>1</issue>), <fpage>58</fpage>. <pub-id pub-id-type="doi">10.1186/s12906-018-2103-2</pub-id>
</citation>
</ref>
<ref id="B103">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Singh</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Murthy</surname>
<given-names>V.</given-names>
</name>
<name>
<surname>Ramassamy</surname>
<given-names>C.</given-names>
</name>
</person-group> (<year>2013</year>). <article-title>Neuroprotective mechanisms of the standardized extract of Bacopa monniera in a paraquat/diquat-mediated acute toxicity</article-title>. <source>Neurochem. Int.</source> <volume>62</volume> (<issue>5</issue>), <fpage>530</fpage>&#x2013;<lpage>539</lpage>. <pub-id pub-id-type="doi">10.1016/j.neuint.2013.01.030</pub-id>
</citation>
</ref>
<ref id="B104">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Singh</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Murthy</surname>
<given-names>V.</given-names>
</name>
<name>
<surname>Ramassamy</surname>
<given-names>C.</given-names>
</name>
</person-group> (<year>2012</year>). <article-title>Standardized extracts of Bacopa monniera protect against MPP&#x2b;- and paraquat-induced toxicity by modulating mitochondrial activities, proteasomal functions, and redox pathways</article-title>. <source>Toxicol. Sci.</source> <volume>125</volume> (<issue>1</issue>), <fpage>219</fpage>&#x2013;<lpage>232</lpage>. <pub-id pub-id-type="doi">10.1093/toxsci/kfr255</pub-id>
</citation>
</ref>
<ref id="B105">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Singh</surname>
<given-names>V.</given-names>
</name>
<name>
<surname>Essa</surname>
<given-names>M. M.</given-names>
</name>
<name>
<surname>Guizani</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Balakrishnan</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Hemalatha</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Manivasagam</surname>
<given-names>T.</given-names>
</name>
<etal/>
</person-group> (<year>2018</year>). <article-title>Protective effect of Zizyphus spinachristi on MPP&#x2b;-induced oxidative stress</article-title>. <source>Front. Biosci. (Scholar Ed.</source> <volume>10</volume> (<issue>2</issue>), <fpage>285</fpage>&#x2013;<lpage>299</lpage>. <pub-id pub-id-type="doi">10.2741/s516</pub-id>
</citation>
</ref>
<ref id="B106">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Soleimani</surname>
<given-names>V.</given-names>
</name>
<name>
<surname>Delghandi</surname>
<given-names>P. S.</given-names>
</name>
<name>
<surname>Moallem</surname>
<given-names>S. A.</given-names>
</name>
<name>
<surname>Karimi</surname>
<given-names>G.</given-names>
</name>
</person-group> (<year>2019</year>). <article-title>Safety and toxicity of silymarin, the major constituent of milk thistle extract: An updated review</article-title>. <source>Phytother. Res.</source> <volume>33</volume> (<issue>6</issue>), <fpage>1627</fpage>&#x2013;<lpage>1638</lpage>. <pub-id pub-id-type="doi">10.1002/ptr.6361</pub-id>
</citation>
</ref>
<ref id="B107">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Suarez-Rivero</surname>
<given-names>J. M.</given-names>
</name>
<name>
<surname>Villanueva-Paz</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>de la Cruz-Ojeda</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>de la Mata</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Cotan</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Oropesa-Avila</surname>
<given-names>M.</given-names>
</name>
<etal/>
</person-group> (<year>2016</year>). <article-title>Mitochondrial dynamics in mitochondrial diseases</article-title>. <source>Diseases</source> <volume>5</volume> (<issue>1</issue>), <fpage>1</fpage>. <pub-id pub-id-type="doi">10.3390/diseases5010001</pub-id>
</citation>
</ref>
<ref id="B108">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Talib</surname>
<given-names>W. H.</given-names>
</name>
<name>
<surname>Awajan</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Hamed</surname>
<given-names>R. A.</given-names>
</name>
<name>
<surname>Azzam</surname>
<given-names>A. O.</given-names>
</name>
<name>
<surname>Mahmod</surname>
<given-names>A. I.</given-names>
</name>
<name>
<surname>Al-Yasari</surname>
<given-names>I. H.</given-names>
</name>
</person-group> (<year>2022</year>). <article-title>Combination anticancer therapies using selected phytochemicals</article-title>. <source>Molecules</source> <volume>27</volume> (<issue>17</issue>), <fpage>5452</fpage>. <pub-id pub-id-type="doi">10.3390/molecules27175452</pub-id>
</citation>
</ref>
<ref id="B109">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Teerapattarakan</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Benya-Aphikul</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Tansawat</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Wanakhachornkrai</surname>
<given-names>O.</given-names>
</name>
<name>
<surname>Tantisira</surname>
<given-names>M. H.</given-names>
</name>
<name>
<surname>Rodsiri</surname>
<given-names>R.</given-names>
</name>
</person-group> (<year>2018</year>). <article-title>Neuroprotective effect of a standardized extract of <italic>Centella asiatica</italic> ECa233 in rotenone-induced parkinsonism rats</article-title>. <source>Phytomedicine</source> <volume>44</volume>, <fpage>65</fpage>&#x2013;<lpage>73</lpage>. <pub-id pub-id-type="doi">10.1016/j.phymed.2018.04.028</pub-id>
</citation>
</ref>
<ref id="B110">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Twig</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Elorza</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Molina</surname>
<given-names>A. J.</given-names>
</name>
<name>
<surname>Mohamed</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Wikstrom</surname>
<given-names>J. D.</given-names>
</name>
<name>
<surname>Walzer</surname>
<given-names>G.</given-names>
</name>
<etal/>
</person-group> (<year>2008</year>). <article-title>Fission and selective fusion govern mitochondrial segregation and elimination by autophagy</article-title>. <source>EMBO J.</source> <volume>27</volume> (<issue>2</issue>), <fpage>433</fpage>&#x2013;<lpage>446</lpage>. <pub-id pub-id-type="doi">10.1038/sj.emboj.7601963</pub-id>
</citation>
</ref>
<ref id="B111">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>van der Merwe</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>van Dyk</surname>
<given-names>H. C.</given-names>
</name>
<name>
<surname>Engelbrecht</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>van der Westhuizen</surname>
<given-names>F. H.</given-names>
</name>
<name>
<surname>Kinnear</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Loos</surname>
<given-names>B.</given-names>
</name>
<etal/>
</person-group> (<year>2017</year>). <article-title>Curcumin rescues a PINK1 knock down SH-SY5Y cellular model of Parkinson&#x27;s disease from mitochondrial dysfunction and cell death</article-title>. <source>Mol. Neurobiol.</source> <volume>54</volume> (<issue>4</issue>), <fpage>2752</fpage>&#x2013;<lpage>2762</lpage>. <pub-id pub-id-type="doi">10.1007/s12035-016-9843-0</pub-id>
</citation>
</ref>
<ref id="B112">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ventura-Clapier</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Garnier</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Veksler</surname>
<given-names>V.</given-names>
</name>
</person-group> (<year>2008</year>). <article-title>Transcriptional control of mitochondrial biogenesis: The central role of PGC-1alpha</article-title>. <source>Cardiovasc Res.</source> <volume>79</volume> (<issue>2</issue>), <fpage>208</fpage>&#x2013;<lpage>217</lpage>. <pub-id pub-id-type="doi">10.1093/cvr/cvn098</pub-id>
</citation>
</ref>
<ref id="B113">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Voigt</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Berlemann</surname>
<given-names>L. A.</given-names>
</name>
<name>
<surname>Winklhofer</surname>
<given-names>K. F.</given-names>
</name>
</person-group> (<year>2016</year>). <article-title>The mitochondrial kinase PINK1: Functions beyond mitophagy</article-title>. <source>J. Neurochem.</source> <volume>139</volume> (<issue>1</issue>), <fpage>232</fpage>&#x2013;<lpage>239</lpage>. <pub-id pub-id-type="doi">10.1111/jnc.13655</pub-id>
</citation>
</ref>
<ref id="B114">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Voon</surname>
<given-names>V.</given-names>
</name>
<name>
<surname>Napier</surname>
<given-names>T. C.</given-names>
</name>
<name>
<surname>Frank</surname>
<given-names>M. J.</given-names>
</name>
<name>
<surname>Sgambato-Faure</surname>
<given-names>V.</given-names>
</name>
<name>
<surname>Grace</surname>
<given-names>A. A.</given-names>
</name>
<name>
<surname>Rodriguez-Oroz</surname>
<given-names>M.</given-names>
</name>
<etal/>
</person-group> (<year>2017</year>). <article-title>Impulse control disorders and levodopa-induced dyskinesias in Parkinson&#x27;s disease: An update</article-title>. <source>Lancet Neurol.</source> <volume>16</volume> (<issue>3</issue>), <fpage>238</fpage>&#x2013;<lpage>250</lpage>. <pub-id pub-id-type="doi">10.1016/S1474-4422(17)30004-2</pub-id>
</citation>
</ref>
<ref id="B115">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wallace</surname>
<given-names>D. C.</given-names>
</name>
<name>
<surname>Brown</surname>
<given-names>M. D.</given-names>
</name>
<name>
<surname>Lott</surname>
<given-names>M. T.</given-names>
</name>
</person-group> (<year>1999</year>). <article-title>Mitochondrial DNA variation in human evolution and disease</article-title>. <source>Gene</source> <volume>238</volume> (<issue>1</issue>), <fpage>211</fpage>&#x2013;<lpage>230</lpage>. <pub-id pub-id-type="doi">10.1016/s0378-1119(99)00295-4</pub-id>
</citation>
</ref>
<ref id="B116">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wang</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Dong</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>Z.</given-names>
</name>
<name>
<surname>Zhu</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Fan</surname>
<given-names>W.</given-names>
</name>
<etal/>
</person-group> (<year>2018</year>). <article-title>Resveratrol suppresses rotenone-induced neurotoxicity through activation of SIRT1/akt1 signaling pathway</article-title>. <source>Anat. Rec. Hob.</source> <volume>301</volume> (<issue>6</issue>), <fpage>1115</fpage>&#x2013;<lpage>1125</lpage>. <pub-id pub-id-type="doi">10.1002/ar.23781</pub-id>
</citation>
</ref>
<ref id="B117">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wang</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Gao</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Wu</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Yang</surname>
<given-names>H.</given-names>
</name>
</person-group> (<year>2016</year>). <article-title>Protection effect of piperine and piperlonguminine from Piper longum L. alkaloids against rotenone-induced neuronal injury</article-title>. <source>Brain Res.</source> <volume>1639</volume>, <fpage>214</fpage>&#x2013;<lpage>227</lpage>. <pub-id pub-id-type="doi">10.1016/j.brainres.2015.07.029</pub-id>
</citation>
</ref>
<ref id="B118">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wang</surname>
<given-names>X. H.</given-names>
</name>
<name>
<surname>Zhou</surname>
<given-names>S. Y.</given-names>
</name>
<name>
<surname>Qian</surname>
<given-names>Z. Z.</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>H. L.</given-names>
</name>
<name>
<surname>Qiu</surname>
<given-names>L. H.</given-names>
</name>
<name>
<surname>Song</surname>
<given-names>Z.</given-names>
</name>
<etal/>
</person-group> (<year>2013</year>). <article-title>Evaluation of toxicity and single-dose pharmacokinetics of intravenous ursolic acid liposomes in healthy adult volunteers and patients with advanced solid tumors</article-title>. <source>Expert Opin. Drug Metab. Toxicol.</source> <volume>9</volume>, <fpage>117</fpage>&#x2013;<lpage>125</lpage>. <pub-id pub-id-type="doi">10.1517/17425255.2013.738667</pub-id>
</citation>
</ref>
<ref id="B119">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wang</surname>
<given-names>X. L.</given-names>
</name>
<name>
<surname>Feng</surname>
<given-names>S. T.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>Y. T.</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>N. N.</given-names>
</name>
<name>
<surname>Guo</surname>
<given-names>Z. Y.</given-names>
</name>
<name>
<surname>Yan</surname>
<given-names>X.</given-names>
</name>
<etal/>
</person-group> (<year>2022</year>). <article-title>Mangiferin, a natural glucoxilxanthone, inhibits mitochondrial dynamin-related protein 1 and relieves aberrant mitophagic proteins in mice model of Parkinson&#x27;s disease</article-title>. <source>Phytomedicine</source> <volume>104</volume>, <fpage>154281</fpage>. <pub-id pub-id-type="doi">10.1016/j.phymed.2022.154281</pub-id>
</citation>
</ref>
<ref id="B120">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wang</surname>
<given-names>X. L.</given-names>
</name>
<name>
<surname>Feng</surname>
<given-names>S. T.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>Z. Z.</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>N. H.</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>Y.</given-names>
</name>
</person-group> (<year>2021</year>). <article-title>Role of mitophagy in mitochondrial quality control: Mechanisms and potential implications for neurodegenerative diseases</article-title>. <source>Pharmacol. Res.</source> <volume>165</volume>, <fpage>105433</fpage>. <pub-id pub-id-type="doi">10.1016/j.phrs.2021.105433</pub-id>
</citation>
</ref>
<ref id="B121">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wang</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Zhao</surname>
<given-names>L.</given-names>
</name>
</person-group> (<year>2016</year>). <article-title>Calycosin ameliorates diabetes-induced cognitive impairments in rats by reducing oxidative stress via the PI3K/Akt/GSK-3beta signaling pathway</article-title>. <source>Biochem. Biophys. Res. Commun.</source> <volume>473</volume> (<issue>2</issue>), <fpage>428</fpage>&#x2013;<lpage>434</lpage>. <pub-id pub-id-type="doi">10.1016/j.bbrc.2016.03.024</pub-id>
</citation>
</ref>
<ref id="B122">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wang</surname>
<given-names>Y. H.</given-names>
</name>
<name>
<surname>Xuan</surname>
<given-names>Z. H.</given-names>
</name>
<name>
<surname>Tian</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Du</surname>
<given-names>G. H.</given-names>
</name>
</person-group> (<year>2015</year>). <article-title>Echinacoside protects against 6-hydroxydopamine-induced mitochondrial dysfunction and inflammatory responses in PC12 cells via reducing ROS production</article-title>. <source>Evid. Based Complement. Altern. Med.</source> <volume>2015</volume>, <fpage>189239</fpage>. <pub-id pub-id-type="doi">10.1155/2015/189239</pub-id>
</citation>
</ref>
<ref id="B123">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wang</surname>
<given-names>Y. H.</given-names>
</name>
<name>
<surname>Yu</surname>
<given-names>H. T.</given-names>
</name>
<name>
<surname>Pu</surname>
<given-names>X. P.</given-names>
</name>
<name>
<surname>Du</surname>
<given-names>G. H.</given-names>
</name>
</person-group> (<year>2014</year>). <article-title>Myricitrin alleviates methylglyoxal-induced mitochondrial dysfunction and AGEs/RAGE/NF-&#x3ba;B pathway activation in SH-SY5Y cells</article-title>. <source>J. Mol. Neurosci.</source> <volume>53</volume> (<issue>4</issue>), <fpage>562</fpage>&#x2013;<lpage>570</lpage>. <pub-id pub-id-type="doi">10.1007/s12031-013-0222-2</pub-id>
</citation>
</ref>
<ref id="B124">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Westermann</surname>
<given-names>B.</given-names>
</name>
</person-group> (<year>2012</year>). <article-title>Bioenergetic role of mitochondrial fusion and fission</article-title>. <source>Biochim. Biophys. Acta</source> <volume>1817</volume> (<issue>10</issue>), <fpage>1833</fpage>&#x2013;<lpage>1838</lpage>. <pub-id pub-id-type="doi">10.1016/j.bbabio.2012.02.033</pub-id>
</citation>
</ref>
<ref id="B125">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wright Willis</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Evanoff</surname>
<given-names>B. A.</given-names>
</name>
<name>
<surname>Lian</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Criswell</surname>
<given-names>S. R.</given-names>
</name>
<name>
<surname>Racette</surname>
<given-names>B. A.</given-names>
</name>
</person-group> (<year>2010</year>). <article-title>Geographic and ethnic variation in Parkinson disease: A population-based study of US medicare beneficiaries</article-title>. <source>Neuroepidemiology</source> <volume>34</volume> (<issue>3</issue>), <fpage>143</fpage>&#x2013;<lpage>151</lpage>. <pub-id pub-id-type="doi">10.1159/000275491</pub-id>
</citation>
</ref>
<ref id="B126">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wu</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Gao</surname>
<given-names>Z. Y.</given-names>
</name>
<name>
<surname>Lin</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Zhao</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Sun</surname>
<given-names>Y.</given-names>
</name>
<etal/>
</person-group> (<year>2021</year>). <article-title>Icaritin provides neuroprotection in Parkinson&#x27;s disease by attenuating neuroinflammation, oxidative stress, and energy deficiency</article-title>. <source>Antioxidants (Basel)</source> <volume>10</volume> (<issue>4</issue>), <fpage>529</fpage>. <pub-id pub-id-type="doi">10.3390/antiox10040529</pub-id>
</citation>
</ref>
<ref id="B127">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wu</surname>
<given-names>L. K.</given-names>
</name>
<name>
<surname>Agarwal</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Kuo</surname>
<given-names>C. H.</given-names>
</name>
<name>
<surname>Kung</surname>
<given-names>Y. L.</given-names>
</name>
<name>
<surname>Day</surname>
<given-names>C. H.</given-names>
</name>
<name>
<surname>Lin</surname>
<given-names>P. Y.</given-names>
</name>
<etal/>
</person-group> (<year>2022</year>). <article-title>Artemisia Leaf Extract protects against neuron toxicity by TRPML1 activation and promoting autophagy/mitophagy clearance in both <italic>in vitro</italic> and <italic>in vivo</italic> models of MPP&#x2b;/MPTP-induced Parkinson&#x27;s disease</article-title>. <source>Phytomedicine</source> <volume>104</volume>, <fpage>154250</fpage>. <pub-id pub-id-type="doi">10.1016/j.phymed.2022.154250</pub-id>
</citation>
</ref>
<ref id="B128">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Yadav</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Yadav</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Khan</surname>
<given-names>M. M. U.</given-names>
</name>
<name>
<surname>Singh</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Verma</surname>
<given-names>A.</given-names>
</name>
</person-group> (<year>2022</year>). <article-title>Resveratrol: A potential therapeutic natural polyphenol for neurodegenerative diseases associated with mitochondrial dysfunction</article-title>. <source>Front. Pharmacol.</source> <volume>13</volume>, <fpage>922232</fpage>. <pub-id pub-id-type="doi">10.3389/fphar.2022.922232</pub-id>
</citation>
</ref>
<ref id="B129">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Yang</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Lim</surname>
<given-names>G. P.</given-names>
</name>
<name>
<surname>Begum</surname>
<given-names>A. N.</given-names>
</name>
<name>
<surname>Ubeda</surname>
<given-names>O. J.</given-names>
</name>
<name>
<surname>Simmons</surname>
<given-names>M. R.</given-names>
</name>
<name>
<surname>Ambegaokar</surname>
<given-names>S. S.</given-names>
</name>
<etal/>
</person-group> (<year>2005</year>). <article-title>Curcumin inhibits formation of amyloid beta oligomers and fibrils, binds plaques, and reduces amyloid <italic>in vivo</italic>
</article-title>. <source>J. Biol. Chem.</source> <volume>280</volume> (<issue>7</issue>), <fpage>5892</fpage>&#x2013;<lpage>5901</lpage>. <pub-id pub-id-type="doi">10.1074/jbc.M404751200</pub-id>
</citation>
</ref>
<ref id="B130">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Yarla</surname>
<given-names>N. S.</given-names>
</name>
<name>
<surname>Bishayee</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Sethi</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Reddanna</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Kalle</surname>
<given-names>A. M.</given-names>
</name>
<name>
<surname>Dhananjaya</surname>
<given-names>B. L.</given-names>
</name>
<etal/>
</person-group>(<year>2016</year>). <article-title>Targeting arachidonic acid pathway by natural products for cancer prevention and therapy</article-title>. <source>Semin. Cancer Biol.</source> <volume>40-41</volume>, <fpage>48</fpage>&#x2013;<lpage>81</lpage>. <pub-id pub-id-type="doi">10.1016/j.semcancer.2016.02.001</pub-id>
</citation>
</ref>
<ref id="B131">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Yew</surname>
<given-names>M. Y.</given-names>
</name>
<name>
<surname>Koh</surname>
<given-names>R. Y.</given-names>
</name>
<name>
<surname>Chye</surname>
<given-names>S. M.</given-names>
</name>
<name>
<surname>Othman</surname>
<given-names>I.</given-names>
</name>
<name>
<surname>Ng</surname>
<given-names>K. Y.</given-names>
</name>
</person-group> (<year>2014</year>). <article-title>Edible bird&#x27;s nest ameliorates oxidative stress-induced apoptosis in SH-SY5Y human neuroblastoma cells</article-title>. <source>BMC complementary Altern. Med.</source> <volume>14</volume>, <fpage>391</fpage>. <pub-id pub-id-type="doi">10.1186/1472-6882-14-391</pub-id>
</citation>
</ref>
<ref id="B132">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zhang</surname>
<given-names>X. L.</given-names>
</name>
<name>
<surname>Huang</surname>
<given-names>W. M.</given-names>
</name>
<name>
<surname>Tang</surname>
<given-names>P. C.</given-names>
</name>
<name>
<surname>Sun</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Qiu</surname>
<given-names>L.</given-names>
</name>
<etal/>
</person-group> (<year>2021</year>). <article-title>Anti-inflammatory and neuroprotective effects of natural cordycepin in rotenone-induced PD models through inhibiting Drp1-mediated mitochondrial fission</article-title>. <source>Neurotoxicology</source> <volume>84</volume>, <fpage>1</fpage>&#x2013;<lpage>13</lpage>. <pub-id pub-id-type="doi">10.1016/j.neuro.2021.02.002</pub-id>
</citation>
</ref>
<ref id="B133">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zhang</surname>
<given-names>Z.</given-names>
</name>
<name>
<surname>Cui</surname>
<given-names>W.</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Yuan</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Xu</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Hoi</surname>
<given-names>M. P.</given-names>
</name>
<etal/>
</person-group> (<year>2012</year>). <article-title>Baicalein protects against 6-OHDA-induced neurotoxicity through activation of Keap1/Nrf2/HO-1 and involving PKC&#x3b1; and PI3K/AKT signaling pathways</article-title>. <source>J. Agric. Food Chem.</source> <volume>60</volume> (<issue>33</issue>), <fpage>8171</fpage>&#x2013;<lpage>8182</lpage>. <pub-id pub-id-type="doi">10.1021/jf301511m</pub-id>
</citation>
</ref>
<ref id="B134">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zhou</surname>
<given-names>Z. D.</given-names>
</name>
<name>
<surname>Xie</surname>
<given-names>S. P.</given-names>
</name>
<name>
<surname>Saw</surname>
<given-names>W. T.</given-names>
</name>
<name>
<surname>Ho</surname>
<given-names>P. G. H.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Lei</surname>
<given-names>Z.</given-names>
</name>
<etal/>
</person-group> (<year>2019</year>). <article-title>The therapeutic implications of tea polyphenols against dopamine (DA) neuron degeneration in Parkinson&#x27;s disease (PD)</article-title>. <source>Cells</source> <volume>8</volume> (<issue>8</issue>), <fpage>911</fpage>. <pub-id pub-id-type="doi">10.3390/cells8080911</pub-id>
</citation>
</ref>
<ref id="B135">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zhu</surname>
<given-names>J. H.</given-names>
</name>
<name>
<surname>Gusdon</surname>
<given-names>A. M.</given-names>
</name>
<name>
<surname>Cimen</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Van Houten</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Koc</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Chu</surname>
<given-names>C. T.</given-names>
</name>
</person-group> (<year>2012</year>). <article-title>Impaired mitochondrial biogenesis contributes to depletion of functional mitochondria in chronic MPP&#x2b; toxicity: Dual roles for ERK1/2</article-title>. <source>Cell Death Dis.</source> <volume>3</volume> (<issue>5</issue>), <fpage>e312</fpage>. <pub-id pub-id-type="doi">10.1038/cddis.2012.46</pub-id>
</citation>
</ref>
<ref id="B136">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zou</surname>
<given-names>Y. M.</given-names>
</name>
<name>
<surname>Tan</surname>
<given-names>J. P.</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Yang</surname>
<given-names>J. S.</given-names>
</name>
<name>
<surname>Yu</surname>
<given-names>B. C.</given-names>
</name>
<name>
<surname>Yu</surname>
<given-names>J. M.</given-names>
</name>
<etal/>
</person-group> (<year>2014</year>). <article-title>The prevalence of Parkinson&#x27;s disease continues to rise after 80 years of age: A cross-sectional study of Chinese veterans</article-title>. <source>Eur. Rev. Med. Pharmacol. Sci.</source> <volume>18</volume> (<issue>24</issue>), <fpage>3908</fpage>&#x2013;<lpage>3915</lpage>.</citation>
</ref>
</ref-list>
</back>
</article>